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Abstract
This thesis presents the structural investigation of human carbonic anhydrase II (hCA-
II) inhibitor complexes by pseudocontact shift (PCS) NMR spectroscopy. Five different
single cystein mutants of hCA-II were prepared in different isotope labelling schemes.
These protein mutants were tagged with LnM8-SPy complexes for the determination
of PCS. Triple labelling of one protein mutant allowed the unambiguous assignment
of 90 % of the protein backbone. For four out of five protein mutants reasonable
PCS were observed and the assignment of the PCS was possible for more than 90 %
of the assigned residues. This large number of assigned PCS showed an excellent
agreement between the protein structure in solution and the X-ray structure. In order
to determine precise ∆χ-tensor parameters based on the X-ray structure PCS in the
neighbourhood of the tag and in fluctional parts of the protein were systematically
excluded. 19F PCS were determined for two different fluorinated inhibitors bound
to hCA-II, for each of the four protein mutants. Based on the determined ∆χ-tensor
parameters the fluorine position was determined based on the 19F PCS alone. This is
the first example of the localization of a fluorine-containing ligand within a protein,
based only on one-dimensional 19F-nuclear magnetic resonance (NMR) spectra and
the PCS derived from this data.
While the fluorine-fluorine distance in the ligand that contains two F-atoms, was
reproduced very precisely by the 19F-PCS, the positioning of the two ligands within
the hCA-II protein was significantly different compared to the X-ray structures of the
two complexes. For one of the two protein inhibitor complexes, a deviation of up to
8 Å was observed. The most likely reason for this systematic error was identified to be
residual anisotropic chemical shift (RACS) that could not be taken in account in the
structure calculation. This was supported by the second protein-inhibitor complex,
where a higher degree of motional freedom of the fluorine atoms and therefore smaller
RACS were observed and consequently the determined PCS position was closer to the
X-ray structure. A validation of the PCS structure determination suggested a precision
of the proton position from PCS alone of 1-2 Å. Finally, the principle of using an 1H-
19F-heteronuclear Overhauser effect spectroscopy (HOESY) spectra to determine 1H
PCS of protons close to the fluorine was demonstrated.
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CHAPTER 1
Introduction
Nuclear magnetic resonance (NMR) spectroscopy nowadays is a standard method for
the structure determination in chemistry and molecular biology. NMR spectroscopy
determines the interaction of a nuclear spin with a magnetic field. In order to observe
such interactions a nuclear spin is required thus limiting this method to those atoms
i.e. to those isotopes with nuclear spin. Especially well suited for NMR spectroscopy
are nuclei with a nuclear spin of ½, such as 1H, 13C, 15N and 19F. The interaction of the
nuclear spin with the magnetic field strongly depend on the chemical environment of
a nucleus and therefore allows to determine structural information.1
1.1 Protein NMR spectroscopy
The determination of protein structures in solution2 as well as the detailed characteri-
sation of dynamic processes, that can be observed for a large range of time-scales (from
picoseconds to days)3 are two of the main advantages of protein NMR spectroscopy.
The first protein structure determined by NMR was solved in 1984.2 The first protein
structure solved by X-ray crystallography was determined already 26 years before, in
1958.4 Today still the vast majority of published protein structures are determined by
X-ray crystallography as this can be seen from the RCSB protein data bank (PDB).5
X-ray structures, however, have the drawback that they only deliver static information
about the protein structure. If dynamic processes are involved, NMR spectroscopy
remains the only source that can deliver detailed residue specific information.3
1
2 1 Introduction
In order to record multidimensional NMR spectra of protein samples stable isotope
labelling of the protein is an important requirement due to the low natural abundance
of 13C and 15N. For standard 1H-15N heteronuclear single quantum coherence (HSQC)
experiments at least uniform 15N or amino acid selective 15N labelling of the protein is
required.6 For standard triple resonance experiments that are used for protein back-
bone assignment additionally uniform 13C labelling of the protein is necessary. For
larger proteins >20 kDa protein NMR spectroscopy becomes more challenging due to
the decreasing transversal relaxation time and consequently smaller signal intensity
with increasing molecular weight. Deuteration of the protein decreases the relaxation
rates of the remaining protons and therefore improves the signal intensity.7
Nuclear Overhauser effects (NOEs) are one of the major restraints used for protein
structure determination. Although they deliver more or less precise structural in-
formation due to their distance dependence of 1⁄r6 they are limited to a distance of
5 Å. Because the median protein size for human proteins is in the order of 60 Å8 it
becomes obvious that with increasing protein size NOE restraints lose more and more
significance because they deliver only local structural information. Especially with
regard that this number only represents the size of monomeric proteins and does not
consider protein-protein complexes that are observed in many important biological
processes. In the last century different methods have been developed to enable so-
lution state NMR studies of large proteins and protein-protein complexes, among
them paramagnetic restraints have gained a very important role because they deliver
unique long-range information for protein structure determination.3
1.2 Paramagnetic NMR
Paramagnetic ions, especially paramagnetic lanthanide ions induce several long range
effects on nuclear spins that can be used for structure determination. Several of these
effects are known for a long time in NMR spectroscopy. For example pseudocontact
shift (PCS) have been observed for the first time in 1960.9 And the use of paramagnetic
relaxation enhancement (PRE) for the study of biological systems has already been
proposed in 1971.10
PRE is an effect observable for every paramagnetic center. The interaction of a nuclear
spin with a paramagnetic center leads to a increased relaxation rate and therefore to
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an increase of the linewidth of the corresponding NMR signal.11 PRE depend with 1⁄r6
on the distance of the nuclear spin to the paramagnetic center and are observable for
distances up to 30 Å.12 In general for every paramagnetic effect, it is very important to
determine an experimental parameter with respect to a suitable diamagnetic reference,
in order to cover for every interaction of the paramagnetic center that is not related
with paramagnetism.
If the unpaired electrons have an anisotropic distribution, which is the case for all
trivalent paramagnetic lanthanide ions apart from gadolinium, then additional effects
such as PCS, residual dipolar couplings (RDC) and residual anisotropic chemical shift
(RACS) can be observed.
1.3 Pseudocontact shifts
PCS are differences in the chemical shift of a nuclear spin that are induced by the inter-
action of a paramagnetic ion with anisotropic distribution of the unpaired electrons.13
PCS can be described according to the following equation:14
δPCS =
1
12pir3
[︂
∆χax
(︀
3cos2θ−1)︀+ 3
2
∆χrhsin2θcos2φ
]︂
(1.1)
Where δPCS is the observed PCS and ∆χax and ∆χrh are the axial and rhombic compo-
nents of the anisotropic magnetic susceptibility tensor (∆χ-tensor). And r, θ and φ
are the polar coordinates describing the position of the nuclear spin with respect to
the paramagnetic center. Due to the 1⁄r3 distance dependence PCS are observable for
much larger distances than NOE or PRE. PCS have been observed for distances of 70 Å
and theoretically they should last as far as 150 Å.15 The angular dependence of the PCS
illustrates why a tight attachment of the paramagnetic ion is necessary in order to
observe large PCS, because residual motion of the paramagnetic ion with respect to
the protein leads to averaged and only very small PCS. The solutions of equation 1.1
for a given PCS, ∆χax and ∆χrh for the polar coordinates r, θ and φ deliver an isosurface
describing all positions where a certain PCS can be observed as displayed in figure 1.1
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Figure 1.1: Isosurfaces representing the solutions of equation 1.1 of an arbitrary tensor
for a PCS of 0.5 ppm (transparent) and 2 ppm (solid). Blue surfaces represent a positive
and red a negative PCS.
1.4 Residual dipolar couplings
Paramagnetic ions with an anisotropic ∆χ tensor weakly align in the magnetic field.
When such ions are tightly bound to a protein this leads to partial alignment of the
whole protein and therefore compared to the isotropic case residual dipolar couplings
are observable. These couplings add to the scalar coupling constant of two coupled
nuclei. Such RDC can be described by the following equation:14,16
DI S =− B
2
0 γI γSħh
120k Tpi2r 3I S
[︂
∆χax
(︀
3 cos2θ−1)︀+ 3
2
∆χrh sin2θcos 2φ
]︂
(1.2)
where DI S is the observed RDC between the coupled nuclear spins I and S, B0 the
magnetic field, γI and γS the gyromagnetic ratios of two spins, ħh the reduced Planck
constant, rI S the internuclear distance between the coupled spins. ∆χax and ∆χrh
are again the axial and rhombic components of the ∆χ-tensor and θ and φ the polar
angles describing the orientation of the IS vector with respect to the orientation of
the ∆χ-tensor. RDC do not depend on the distance to the paramagnetic center that is
responsible for the molecular alignment and therefore can be observed for every pair
of coupled nuclear spins in a protein.
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1.5 Residual anisotropic chemical shifts
For partially aligned protein small chemical shift changes are observable, because
similar to the RDC, the chemical shift anisotropy (CSA) is not completely averaged to
an isotropic chemical shift any more which results in small shift changes depending
on the orientation of the nuclear spin in the protein. These shifts, called RACS, have
been studied in proteins aligned by an external alignment media.17 In the case of an
alignment due to anisotropic paramagnetic metal ion these small shifts add to the
effective PCS resulting in the experimentally observed PCS. RACS can be determined
according to the following equation:
δRACS =
B 20
15µ0k T
∑︁
i , j∈{x ,y ,z }
−σCSAi i cos2θi j∆χ j j (1.3)
where B0 is the magnetic field, µ0 the permeability of vacuum, k the Boltzmann con-
stant, T the temperature, σCSAi i the principal components of the CSA-tensor, ∆χ j j the
principal components of the ∆χ-tensor and θi j the angle between the corresponding
principal axis of the CSA-tensor and the ∆χ-tensor.18,19 For protons RACS are negli-
gible small, but not for 13C or 15N. For protein backbone carbonyl depending on the
orientation RACS can exceed 0.1 ppm.20 Similar to the RDC, RACS can be observed
throughout an aligned protein.
1.6 Lanthanide chelating tags
Early studies of proteins that included paramagnetic restraints were carried out with
metal binding proteins, such as cytochrome c that contains heme group consisting of
a paramagnetic FeIII-porphyrin complex21 or the calcium binding protein calbindin
where a calcium binding to the protein was replaced by a lanthanide ion.22 This ap-
proach was restricted to metal binding proteins, but the study on calbindin has shown
the large potential of lanthanide ions for paramagnetic restraints.23 During the first
decade of the new millennium several lanthanide chelating tag (LCT) have been de-
veloped that allowed the attachment of a lanthanide metal to a protein via a cysteine
residue on the protein surface. Such a cysteine residue can be introduced at a desired
position in the protein sequence by site directed mutagenesis.24 This permitted to
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determine paramagnetic restraints for theoretically every protein, independent of a
metal binding site. Early lanthanide chelating tags showed only poor PCS and RDC
in the order of 0.12 ppm and 5 Hz respectively.25 The reason for the small shifts was
the high flexibility of the tags, as well as their low affinities towards lanthanide metals.
The low affinity could be resolved by the development of tags based on the 1,4,7,10-
tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA) framework, that shows an
extremely high affinity towards lanthanide ions.26 To ensure a rigid attachment of the
tag to the protein a strategy of a two point anchoring of a DOTA based tag showed a
rigid attachment to the protein based on the large PCS that were observed.27 Never-
theless this approach requires the introduction of two cysteine residues to the protein
surface at a defined distance. Therefore a single point attachment of a tag would be
much simpler for the production of a corresponding protein mutant.
1.7 DOTA-M8-SPy
DOTA-M8-SPy (M8-SPy) is an extremely rigid lanthanide chelating tag, based on the
DOTA framework. The stereoselective introduction of eight methyl groups provide
only one single confomer of the corresponding lanthanide complex, which has been
demonstrated on the diamagnetic LuM8-SPy complex.28 When the dysprosium-tag is
attached to a single cystein mutant of ubiquitin extremely large PCS were observed,
that are still unprecedented for such a type of attachment.
The lanthanide complexes of DOTA have a rather complex stereochemistry (shown in
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Figure 1.2: Lanthanide complexes of DOTA and M8-SPy.
figure 1.3) with in total four different stereoisomers.29 Depending on the orientation
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of the side-arms and the conformation of the twelve-membered cyclen ring either
a square anti prism (SAP) or a twisted square anti prism (TSAP) coordination poly-
hedron around the metal center is obtained. In the case of the lutetium complexes
of M8-SPy, depending on the stereochemistry of the methyl groups only one distinct
stereoisomer is obtained. The S configuration of the stereocenters at the cyclen ring
selectively results in the (δδδδ) conformation of the cyclen ring. Where the R and
the S configuration of the side-arm direct the complex in the Λ and ∆ conformation
respectively. Therefore for (8S)-LuM8-SPy only the TSAP (∆δδδδ) conformation and
for the 4R,4S stereoisomer only the SAP (Λδδδδ) conformation is observed.
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Figure 1.3: Stereoisomers of LnDOTA complexes.
The synthesis of the lanthanide complexes of M8-SPy is carried out in a six step
synthesis starting from tetramethylcyclen 1 as shown in figure 1.4. Detailed conditions
are given in the experimental section.
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Figure 1.4: Synthesis of lanthanide complexes of M8-SPy.
1.8 GPS-like position determination from PCS of multiple sites
For the determination of the position of one or more atoms in a protein by PCS alone,
it is far better to determine the PCS from protein samples that have been tagged at
different sites of the protein. When the PCS of different lanthanide metals tagged
the same position in the protein are used for the position determination, then the
isosurfaces defining the possible positions for a certain PCS are very likely to intersect
in a small angle, leading to a poor precision of the position in directions parallel to the
isosurfaces. When the position is determined from PCS obtained for different tagging
sites the probability of the isosurfaces to intersect in an angle close to 90° is much
higher and therefore the position is usually better defined.
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In figure 1.5 the principle of determining a position from PCS is illustrated. When
Figure 1.5: Structure determination from PCS of different tagging sites.
PCS of at least three different tagging sites are available for one certain nuclear spin,
and for a certain part of the protein, the structure is known to allow the determination
the ∆χ-tensor parameters, the position of the nuclear spin can be determined similar
to the global positioning system (GPS).30 Due to the more complex shape of the iso-
surfaces for PCS a larger number of positions is possible. Usually up to four distinct
positions can be obtained when three isosurfaces intersect with each other. This can
be recognised when the possible solutions from the intersection of two isosurfaces
are considered (figure 1.5 B). These are represented by a circular line with a particular
three dimensional shape, very often this shape resembles to the line that is found
on a tennis ball. When a third isosurface intersects with this circular line it becomes
clear that it is possible that only two solutions are obtained for the position, but in
most cases four solutions are obtained. Therefore it is useful to determine at least four
different PCS for the determination of a position. This reduces the possible solution
to only one position which is better defined as well, because an additional data point
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is available. In the unlikely case that still more than one solution is found normally
only one of them is reasonable.
1.9 Artificial metalloenzymes
Artificial metalloenzymes are designed proteins that combine the selectivity of en-
zymes with the broad substance range of homogeneous transition metal catalysts.31
Artificial metalloenzymes can be formed by anchoring an achiral metal catalyst in
the binding pocket of a protein. The chiral environment of the protein enables stere-
oselective catalysis. Furthermore, point mutations of the protein sequence allow to
enhance the selectivity as well as the activity of such a system.32 An artificial metal-
loenzyme that allows different stereoselective or regioselective conversions has been
presented on the base of iridium catalysts that are bound to streptavidin by a biotin
anchor.33 Recently a similar approach was presented, where such iridium catalysts
were anchored to human carbonic anhydrase II (hCA-II) by a sulfonamide linker.34,35
For this system computational optimization was successfully applied to improve the
selectivity as well as the activity of this artificial metalloenzyme.36 Such optimisations
have been carried out on basis of the X-ray structures determined for the correspond-
ing protein-inhibitor complex, because a solution state structure of hCA-II is not
available. Because the catalytic reactions are processes running in solution, structural
information determined by NMR spectroscopy in solution could reveal important
information about such a system. Therefore such an hCA-II-inhibitor complex has
been chosen for the investigation by PCS NMR spectroscopy.
1.10 Human carbonic anhydrase II
HCA-II is a 29 kDa protein consisting of 260 amino acids. In vivo the protein catalyses
extremely efficiently the reaction from CO2 to bicarbonate (equation 1.4). The catalytic
turnovers of this reaction are among the highest known for proteins.
CO2 +H2O −−*)−−HCO −3 +H+ (1.4)
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hCA-II is a monomeric globular protein with a diameter of size 40 Å to 55 Å. The
structure consists of a dominant ten stranded twisted anti-parallel β-sheet. Seven
α-helices surround this central structure. Only very small structural differences were
observed for a wide range of pH (5.7 - 8.4) and upon binding of ligands. The catalytic
site consists of a zinc atom bound to three histidine side-chains and to a hydroxide
ion or to a water molecule. Phenyl-sulfonamide inhibitors have a very high affinity to
hCA-II (Kd in the nM range are reported, and even down to 30 pM).
37
1.11 Objectives of the thesis
DOTA-M8 showed very large PCS when the corresponding dysprosium complex is
tagged to Ubiquitin.28 In this thesis we planned to further characterise the utility of
this LCT on a medium sized protein. The 29 kDa protein hCA-II was chosen as viable
candidate, because the group of Prof. Tom Ward already targeted this protein for
the generation of artificial metallo enzymes. Structural information of such protein
constructs usually is gained from X-ray crystal structures, because no solution state
structure of this protein is available. Therefore it was decided to:
• Prepare different single cystein mutants of the protein in order to attach LnM8-
SPy complexes to different sites of the protein.
• Assign PCS based on a available X-ray structure in order to determine ∆χ-tensor
parameters for the determination of further structural information.
• Determine 19F PCS of two different fluorinated inhibitor in complex with hCA-II.
• Determine the position of these fluorines based only on PCS
Up to now only few studies are presented where PCS are determined for different tag-
ging sites of a protein. Therefore this study will contribute to the characterisation of the
usefulness of PCS for protein structure determination. Furthermore, fluorinated small
molecules play an important role as drugs38 and the potential determination of the
site of such ligands within a protein receptor is highly relevant for medicinal chemistry.

CHAPTER 2
Results
In the following Chapter the sections 2.3, 2.4, 2.6 and 2.7 were carried out in collabora-
tion with Dr. Elisa S. Pereira Nogueira and are described as well in her PhD thesis39.
Throughout the whole thesis the numbering system for the residues of human car-
bonic anhydrase I (hCA-I) was used for hCA-II, where Thr-125 is followed directly by
Lys-127. hCA-I has an additional alanine residue at the position 126 which is missing
for hCA-II.40 And the ligand M8-SPy and it’s corresponding lanthanide complexes refer
to the (8S) stereoisomer, if not stated otherwise.
2.1 LnM8-SPy Synthesis
The synthesis of M8-SPy was repeated based on published procedures28 and for two
steps reaction conditions could be improved. An overview of the five step synthesis is
given in figure 1.4 in the introduction. In step three, the duration of the benzyl depro-
tection reaction could be reduced by 95 %, from 20 h to 1 h when 0.5 L of hydrogen gas
was bubbled directly through the solution over the period of 1 h, instead of stirring
the reaction mixture under an hydrogen atmosphere. In the fourth step the reaction
time of the initial amide coupling reaction could be reduced from 2 h to 1 h when 2 eq.
of diisopropylethylamine (DIPEA) were used as base instead of 1 eq. of triethylamine
(NEt3). One equivalent of the base is needed for the deprotonation of the ammonium
salt, leaving another equivalent, required for the amide coupling. The subsequent
deprotection step was also subject of optimization but all attempts like purification
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of the intermediate after the amide coupling or different deprotection conditions
(H2SO4 in CH2Cl2) led to a significant reduction of the overall yield. Therefore the
deprotection was carried out according to the described conditions and was followed
closely by electrospray ionisation mass spectrometry (ESI-MS) in order to find the
optimal reaction time. As shown in figure 2.1 the progress of the reaction could be
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Figure 2.1: Progress of the tBu deprotection step of the M8-SPy synthesis followed by
ESI-MS. The product peak intensity is normalized by the intensity of an unaffected peak
at m/z 515.
monitored, when the intensities of the product signals at m/z 685 ([M+H]+) and 707
([M+Na]+) were normalised by the intensity of the signal at 515 which is not affected
during the course of the whole deprotection step. This signal is expected to be a
byproduct of the coupling reagent, benzotriazol-1-yl-oxytripyrrolidinophosphonium
hexafluorophosphate (pyBOP), used in the initial amide coupling step. According
to this data, the deprotection reaction is terminated when the intensity of the prod-
uct started to reach a plateau after 6 h. In the final metallation step of M8-SPy with
the according lanthanide metal it could be shown that a buffered solution (100 mM
ammonium acetate) is required for a complete reaction. When the metallation was
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carried out in pure aqueous solution only partial conversion could be observed. For
the (8S)-LnM8-SPy complexes in the final high performance liquid chromatography
(HPLC) purification step two fractions for the product could be separated both con-
taining the same product as detected in the ESI-MS spectra. When the two fractions
were conjugated later to hCA-II_S50C_C206S, exactly the same 1H-15N HSQC spectra
was observable. The ratio of these two fractions depends on the lanthanide metal, for
Gd a ration of 8:2 was observed for the earlier to the later fraction, for Dy 6:4, for Tm
1:19 and for Lu only the second fraction was observable. This was in good agreement
with published findings.41 In contrast to this, for the (4R,4S)-LnM8-SPy complexes
only one fraction was observable in the HPLC for each Lanthanide mentioned above.
2.2 Selection of the mutation sites
For the tagging of proteins with Ln-M8-SPy complexes a solvent exposed cysteine
residue in the protein is required. We decided to introduce such a cysteine residue
at the position of a native serine residue. Serine and cysteine residues have a similar
shape in terms of their covalent radius as well as comparable polarity and electronic
properties, therefore the protein structure is not expected to be affected significantly
from such kind of mutation. An X-ray crystal structure (PDB code 3KS3) was used
to select five different solvent exposed serine residues at the edge of a secondary
structure element (compare to figure 2.2). These positions were chosen because the
cystein residues should be in a well structured part of the protein to promote a rigid
attachment of the tag to the protein. Additionally the mutation must not influence
the overall tertiary structure of the protein to ensure the comparability of all different
mutants. Residues at the beginning or the end of a secondary structure element are
less likely involved in significant interactions defining the overall fold of the protein.
Because the protein already contains a cysteine residue the introduction of a second
cystein to the protein sequence can lead to the formation of an undesired disulfide
bond during the expression of the protein and thus to miss-folded protein. To avoid
this the present cysteine at position 206 was planed to be replaced by a serine residue.
Serine was chosen because bovine carbonic anhydrase II, an isocyme of hCA-II with
81 % sequence similarity contains a serine at this position. Additionally this mutation
was already reported not to affect either the stability or the activity of the protein.42,43
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Figure 2.2: X-ray structure of hCA-II (3KS3), the colours correspond to: red: selected
serine to cysteine mutation sites, yellow: native cysteine residue, blue: leucine residues
and orange: catalytic zinc.
To have an alternative in case of difficulties due to the mutation of Cys-206 to serine
we decided to prepare also a second set of mutants where the Cys-206 is replaced by an
alanine residue. This resulted in ten different double mutants, listed in the following
table 2.1.
Table 2.1: List of all planed hCA-II mutants.
hCA-II_S50C_C206S hCA-II_S50C_C206A
hCA-II_S166C_C206S hCA-II_S166C_C206A
hCA-II_S173C_C206S hCA-II_S173C_C206A
hCA-II_S217C_C206S hCA-II_S217C_C206A
hCA-II_S220C_C206S hCA-II_S220C_C206A
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2.3 Mutation of the pACA plasmid encoding for human carbonic
anhydrase II
The pACA plasmid used for the production of hCA-II was generous gift from Prof.
Carol A. Fierke (University of Michigan, USA).44 It consists of the hCA-II gene45 behind
a T7 ribonucleic acid (RNA) polymerase promoter, a f1 origin of replication,46 and
an ampicillin resistance (ampr) gene as well as a chloramphenicol resistance (cmr)
gene in a pMa5-8 vector.47 The gene for hCA-II has an alanine instead of a serine at
position 2 which does not affect the expression of the protein nor its catalytic activity.
Starting from this plasmid, site-directed mutation was carried out according described
procedures.24 In a first step C206 was mutated either to serine or alanine and in the
second step the five different serine to cysteine mutations were introduced to the
plasmid. Primers and details to the procedure are given in the experimental section.
2.4 Expression of uniformly 15N labelled hCA-II mutants
Test expression showed no differences between the C206S and the C206A mutants,
therefore we decided to use use only the C206S mutants for over-expression. The
C206A constructs were not investigated further.
Optimised protocols for the expression of hCA-II were derived by E. Nogueira from
protocols provided by Prof. Carol A. Fierke. Uniform 15N labelling was achieved by
the use of minimal medium containing 15N ammonium chloride as the sole nitrogen
source. This resulted in yields of 60 mg to 95 mg of protein per litre medium. All details
are given in the experimental section.
2.5 Tagging of 15N-hCA-II mutants
To ensure having only monomeric protein present, with accessible thiol groups for the
tagging with Ln-M8-SPy, a solution of 300µM to 350µM protein was reduced using
1 mM tris(2-carboxyethyl)phosphine (TCEP) at 4 ◦C over night. Buffer exchange to
reduce the TCEP concentration was achieved by ultrafiltration followed by a single
use size exclusion column. To keep the dimerisation of the protein by the formation
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of a disulfide bond as low as possible, the protein was eluted from the size exclusion
column directly into a solution of the desired Ln-M8-SPy. The tagging of the protein
could be followed by ESI-MS. After one hour already more than 70 % conversion was
observed (figure 2.3 B). For complete conversion the reaction continued at 4 ◦C over
night. The resulting ESI-MS spectra showed more than 98 % conversion (figure 2.3
C). This was confirmed by the 1H-15N-HSQC spectrum where only traces of untagged
protein were observable. Tagging with Ln-M8-SPy was possible for all five different
hCA-II mutants with yields in a range of 60 % to 90 %. Observation of the protein
concentration after each step of the tagging procedure (see experimental section) by
ultraviolet-visible (UV) absorption showed that the amount of protein decreased only
during the ultrafiltration steps before and after the tagging reaction. This is attributed
to the tendency of hCA-II to aggregate37 During the entire tagging reaction the protein
concentration remained constant.
Figure 2.4 shows the overlay of hCA-II_S50C_C206S tagged either with the paramag-
netic Tm-M8-SPy or the diamagnetic Lu-M8-SPy. Almost all signals show a significant
PCS. For some isolated peaks, the assignment of the PCS was straight forward, but
for the majority of the peaks this was not the case. The main reason was the large
number of peaks clustering in the central region of the spectrum. This could lead to
false PCS assignments which could result in a self consistent but wrong assignment of
the PCS. Furthermore NMR assignment of hCA-II was only available for the wild type
protein48 and not for the double mutants we prepared. Therefore we can expect some
of the peaks of residues in the vicinity of the mutation sites to be shifted compared
to the wild type protein. Although this is only an issue for a small number of peaks,
it further increases the possibility of a false PCS assignment. In order to avoid these
problems we decided to prepare selectively 15N labelled protein samples, where only
one type of amino acid is 15N labelled. This will reduce significantly the complexity
of the spectrum when only a fraction of the peaks are observable. In addition to this,
we decided to fully assign the protein backbone of one double mutant to exclude any
wrong assignments for this mutant and thus to simplify the assignment of the other
protein mutants.
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Figure 2.3: Deconvoluted ESI-MS spectra of uniformly 15N labelled hCA-II showing the
progress of the tagging reaction. A Protein before reaction, B after one hour reaction time
and C after overnight reaction.
20 2 Results
4 ppm681012 1H
100
15N
110
120
130
Figure 2.4: Overlay of the 1H-15N-HSQC spectra (600 MHz, 298 K) of uniformly 15N la-
belled hCA-II_S50C_C206S-LuM8 (black) and hCA-II_S50C_C206S-TmM8 (red). Artefacts
from non perfect water suppression are observable at 4.7 ppm in the 1H-dimension. NH2-
groups are indicated with dashed lines.
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2.6 Expression of selectively 15N-Leu labelled hCA-II mutants
With a number of 26 residues leucine is the most abundant amino acid in hCA-II,
therefore we decided to express the protein selectively 15N-leucine labelled. The
protocol for expression of selectively 15N labelled hCA-II was based on the protocol
for uniformly 15N labelled protein where instead of 15N ammonium chloride a mixture
of all unlabelled amino acid apart from leucine is used for the media. 15N labelled
leucine is added to the media at the time of induction to avoid isotope scrambling by
biochemical conversion of leucine to other amino acids like isoleucine. The expresion
yielded 140 mg to 230 mg of protein per litre media for all five mutants. The resulting
1H-15N-HSQC spectra showed exactly the expected 26 signals for all five mutants and
no isotope scrambling from the expression was observable. The assignment based on
the shifts for wild type hCA-II was straight forward for all five mutants. The signals
of Leu-79 and Leu-120 showed strong overlap for all mutants, with the exception of
S50C where these peaks were separated but Leu-47 and Leu-212 were overlapping
instead. This assignment could be also confirmed by the later backbone assignment
of hCA-II_S50C_C206S.
2.7 Expression of uniformly 2H, 15N and 13C labelled human carbonic
anhydrase II
Triply labelled protein was prepared for the construct S50C_C206S using media pre-
pared from D2O instead of H2O containing
15N ammonium chloride and D7-
13C-
glucose as the sole nitrogen source and carbon source respectively. Expression in
shaking flasks provided the desired protein but only in poor yields (below 20 mg pro-
tein per litre media. Therefore the expression was carried out in a 2 L bench-top
fermenter. This allowed better control of parameters like temperature and oxygen
content of the media and on top of that it even allowed to control the addition of
D7-
13C-glucose optimizing the amount of protein which is produced per gram of
glucose. All details to the procedure are given in the experimental section. From
1 L media 84 mg triple labelled protein were obtained. The determined molecular
weight of 32 157 Da corresponds to a deuteration level of 85 % assuming the cleavage
of the N-terminal methionine and uniform labelling of 13C and 15N. 1D proton spectra
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confirmed this assumption when the residual intensity of the signals in the aliphatic
region is compared to the spectra of a fully protonated protein.
2.8 Backbone assignment of triply labelled hCA-II_S50C_C206S
2.8.1 Refolding of hCA-II
Protons were reintroduced to the deuterated protein by refolding of the protein using
guanidinium chloride as chaotropic agent. This procedure replaces all exchangable
deuterons by protons. Based on published conditions49 the protein was denatured in
5 M guanidinium chloride (GdmCl) and refolding was initiated by a subsequent fast
dilution to 0.3 M GdmCl. The conditions were optimised using selectively 15N leucine
labelled protein. In the best case 50 % of 15N labelled protein could be recovered after
refolding. In order to cope with the large volume of buffer after the dilution step it
was decided to load the protein on a sulfonamide affinity column, which results in
around 120 mL of solution. In addition this method selectively separates only correctly
folded active protein, because unfolded protein would not bind to the column. The
detailed conditions are given in the experimental section. Unfortunately when these
conditions were applied to a larger amount of protein, 17 mg instead of 2 mg to 5 mg,
the final yields turned out to be only 20 %. Monitoring of the protein concentration by
UV after every step the whole process showed that around 40 % of the protein is lost
during the denaturation and renaturation steps. Another 30 % was lost in the affinity
column and additional 10 % was lost in the final dialysis and concentration steps.
Nevertheless an NMR sample of refolded triply labelled hCA-II was obtained and the
1H-15N-HSQC spectra showed that out of 193 well separated signals only 25 showed a
significant increase in signal intensity of more than 1.5 times the intensity that was
measured before refolding (see figure 2.5). This means that only for a small number of
residues the signal intensity improves due to the refolding. Because of limited amount
of triple labelled protein we decided therefore to carry out the backbone assignment
with non refolded protein.
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Figure 2.5: Comparison of signal intensity of triply labelled hCA-II_S50C_C206S before
and after refolding of the protein. Out of 193 signals only 25 residues show an increase in
signal intensity by a factor of more than 1.5
2.8.2 Backbone assignment
For the backbone assignment triply labelled hCA-II_S50C_C206S was tagged with
LuM8-SPy following the procedure described in the experimental section. A NMR sam-
ple with a concentration of 460µM was prepared and transverse relaxation optimized
spectroscopy (TROSY) based 1H-15N-HSQC, HNCO, HNCA, HN(CO)CA, HN(CA)CO
as well as HNCACB spectra were recorded. Backbone assignment was carried out
according to described procedures.50. Using 15N leucine labelled protein it was pos-
sible to confirm the correct assignment of the leucine residues. 90 % of the protein
backbone was successfully assigned. Residues 2 to 20 were not assigned as well as
H64, I91, P155, G156, T199, T200, P201 (The N-terminal methionine was assumed
to be cleaved based on the molecular weight obtained from the ESI-MS spectra. For
Thr-200 later an assignment was found based on PCS.) For the N-terminal residues
(Ala-2 to Phe-20) some sequential assignments were possible for remaining unas-
signed peaks in the spectra but an unambiguous assignment of these segments to the
protein sequence was not possible. On top of that for some of the unassigned peaks
cis-trans isomerisation was observable, indicating a certain flexibility of this part of
the protein, which is unfavourable for a reliable assignment of PCS. The assignment of
hCA-II_S50C_C206S-LuM8 could be transferred directly to the other mutants except
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for residues in close vicinity to the cysteine mutation site which were shifted either
due to the Ser→Cys mutation or due to interactions with the tag bound to this cystein.
For these residues a tentative assignment could later be confirmed using the PCS.
2.9 PCS assignment
For convenience, in the following section only a part of the figures for the different
protein mutants are shown. All remaining figures for the other mutants are given in
the appendix section (see Figures A.1 - A.6). Every determination of magnetic suscep-
tibility tensor parameters was carried out using the same X-ray structure (PDB code:
3KS3). Because X-ray structures do not contain protons, their position had to be added
to the protein structure file. There are several different algorithm available for this task.
We decided to use the HAAD algorithm, because of its higher accuracy compared to
other widely used programs.51 All other X-ray structures used were aligned to the 3KS3
X-ray structure meaning all given coordinates in this thesis are given in the coordinate
system of this structure.
As already described in section 2.5 tagging with LnM8-SPy was possible for all five
different mutants. However when the S173C mutant was tagged with TmM8-SPy two
peaks were observable for each residue. This can easily be shown for the selectively
15N-leucine labelled protein (see figure 2.6) The spectra of the uniformly labelled pro-
tein turned out to be very crowded and is therefore not shown. The reason for these
two sets of signals has to be the tag, which orients in two different directions either at
the same or at different positions when bound to Cys-173. Therefore for each residues
two different PCS are observable. Although the two sets of signals showed different in-
tensities it turned out to be much more demanding than this was the case for the other
mutants. On top of this the signals of the set with higher intensity were broader than
the signals of the other set. This could be either explained by a higher dynamic of the
tag or by another set of signals overlapping with these signals which could be well seen
for Leu-185. Because all other mutants showed reasonable spectra when tagged with
TmM8-SPy we decided to leave out the S173C mutant for the determination of the PCS.
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Figure 2.6: Overlay of the 1H-15N-HSQC spectra (600 MHz, 298 K) of selectively 15N leucine
labelled hCA-II_S173C_C206S-LuM8 (black) and hCA-II_S173C_C206S-TmM8 (red). Two
sets of PCS are observable.
Having selectively 15N leucine labelled protein and a reliable assignment of uni-
formly 15N labelled protein in hand, assignment of the PCS was carried out as follows.
Form an overlay of LuM8 and TmM8 tagged selectively 15N leucine labelled protein
(see figure 2.7 and Appendix) more than eight shifted peaks could readily be assigned
for each mutant. Parameters describing the magnetic susceptibility tensor of the
lanthanide metal were determined from the program Numbat18 using this initial set
of PCS. This tensor set allowed to back calculate the expected PCS for the remaining
leucine residues. This allowed the unambiguous assignment of all remaining shifted
peaks apart from those leucine residues close to the tag, where the signals were either
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broadened beyond the limit of detection due to PRE or shifted outside of the spectral
window (for S50C this is the case for Leu-79). From this larger set of PCSs refined
tensor parameters could be calculated, since a larger set of data points was used.
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Figure 2.7: Overlay of the 1H-15N-HSQC spectra (600 MHz, 298 K) of selectively 15N leucine
labelled hCA-II_S50C_C206S-LuM8 (black) and hCA-II_S50C_C206S-TmM8 (red). Assign-
ment and PCS are indicated.
The tensors obtained from the leucine PCS could be transferred to the uniformly
15N labelled samples and allowed to assign further PCS following the same strategy of
calculating expected PCS based on current tensor, assigning further shifted peaks and
recalculating refined tensors including the newly assigned PCS. Backbone assignment
delivered for the S50C_C206S mutant 221 signals in the 1H-15N-HSQC for which a
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reliable assignment was available. The assignment of the PCS was restricted to these
residues. For 205 residues a shifted peak could be assigned which corresponds to
93 % of these considered signals or to 84 % of the total number of backbone amide NH
groups in the protein. The remaining residues where an assignment in the diamag-
netic spectra was available but no PCS could be assigned, were found close to the tag
in the protein structure. Due to the PRE these signals were not observable any more
in the paramagnetic spectra. For the S166C mutant the PCS of 208 residues could be
assigned which corresponds to 97 % of the residues where a reliable assignment was
possible or to 86 % of all backbone amide NH groups. For the S217C mutant these
ratios turned out to be 91 % or 82 % respectively. And for the S220C mutant these
were 90 % and 81 %. For reasons of clarity in figure 2.8 only well separated peaks are
assigned. A table with all PCS assigned is given in the Appendix (see table A.2).
In all spectra of TmM8 tagged protein of the four considered mutants a minor second
shifted species was observable analogue to ubiquitin where this already has been
observed.28 The intensity of this species in the order of 10 % of the main peak intensity
apart from the S220C mutant where up to 15 % have been observed, independently
of the protein sample. In figure 2.7 the second species can be observed for example
for residue 141. Because these small peaks for most residues were not observable,
no assignment was carried out. Due to the low intensity this second species never
interfered with the assignment of the main peaks.
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Figure 2.8: Overlay of the 1H-15N-HSQC spectra (600 MHz, 298 K) of uniformly 15N la-
belled hCA-II_S50C_C206S-LuM8 (black) and hCA-II_S50C_C206S-TmM8 (red). Aliased
signals with negative intensity are shown with dashed contour lines. PCS are indicated
with solid and NH2 groups with dashed lines.
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2.10 Determination of the magnetic susceptibility tensors
Magnetic susceptibility tensors were determined using the program Numbat18, using
the X-ray structure (PDB code: 3KS3). As starting point to the tensor fit, for each
mutant the coordinates of the side-chain oxygen of the corresponding serine in the
X-ray structure were used. The Euler angles defining the orientation of the magnetic
susceptibility tensor, were applied in the ZYZ’ convention (default in Numbat) and
a value of 0° was used fore every angle as initial orientation for the optimisation.
Correction for RACS, small shifts which arise from partial alignment of the protein
in the magnetic field20, was applied at the corresponding spectrometer frequency. It
was found that the resulting errors of the tensor were slightly smaller when the RACS
correction was applied, showing a small improvement of the agreement between PCS
and X-ray structure. The uncertainties of the tensors were estimated by the application
of a Monte-Carlo protocol which is implemented in Numbat. Described procedures
for the error analysis were applied.18 For each tensor the uncertainties were estimated
twice with two different methods. The first was a structure variation, where the atomic
coordinates of the x-ray structure were varied according to a Gaussian distribution
with a standard deviation σ of 0.5 Å which results in a average displacement of each
atom by 0.8 Å. The second method was the random selection of PCS subsets, where
only 20 % of all PCS were used to recalculate the tensor. For each method and tensor
1000 samples were calculated and the average values and their standard deviation were
reported. To avoid artefacts arising from the use of the same set of random numbers,
for each mutant a different random seed was chosen. In order to be able to compare
different tensors, calculated for one specific protein mutant, always the same seed was
used for this construct. For the S220C mutant the γ Euler angle turned out to be close
to 0° or 180°. According to the ZYZ’ convention for the Euler angles implemented in
Numbat and because of the symmetry of the magnetic susceptibility tensor a rotation
of the γ angle by 1° is equivalent to a rotation by 181°. When during the 1000 iterations
of the Monte-Carlo procedure for the γ angle angles close to 0° as well as to 180° were
found the angles were corrected manually by either addition or subtraction of 180° to
obtain proper average values and corresponding standard deviation. For two mutants
(S217C and S220C) when tensor parameters were determined with the full set of PCS for
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10 % of the iterations of the Monte-Carlo procedure two or even all three Euler angles
showed a large difference to the average value. This happens when the optimisation
converges in a different local minimum. But this was only the case for the full sets
of PCS for these two mutants, later for the subsets this was not observed any more,
indicating one single coherent minimum for each optimisation. For convenience
those iterations were excluded from the error analysis of the full tensor sets for these
mutants.
Table 2.2: Magnetic susceptibility tensor parameters for the different hCA-II mutants. All
PCS that could be assigned were used. The values and their uncertainties are calculated
by a Monte-Carlo protocol applying two different random inputs given below.
S50C S166C S217C S220C
∆χax [10-32m3] 20.2 ± 1.9 38.7 ± 2.0 18.9 ± 1.0 24.6 ± 2.2
∆χrh [10-32m3] 8.1 ± 1.0 7.5 ± 1.2 11.4 ± 0.5 2.9 ± 0.6
x [Å] -27.6 ± 0.4 -16.1 ± 0.5 -23.9 ± 0.3 -14.6 ± 0.4
y [Å] 13.5 ± 0.4 -3.5 ± 0.3 -16.5 ± 0.3 -26.5 ± 0.5
z [Å] 18.9 ± 0.3 -11.2 ± 0.4 20.2 ± 0.3 3.9 ± 0.4
α [ °] 107.0 ± 2.7 51.5 ± 2.0 148.4 ± 1.4 3.6 ± 2.2
β [ °] 140.9 ± 1.2 123.1 ± 1.3 65.7 ± 1.2 151.1 ± 1.4
γ [ °] 116.8 ± 2.2 143.1 ± 5.0 126.9 ± 1.4 164.3 ± 8.4
Monte Carlo structure variation with a σ= 0.5 Å
∆χax [10-32m3] 19.8 ± 1.5 37.3 ± 1.2 22.7 ± 4.3 23.2 ± 4.7
∆χrh [10-32m3] 7.7 ± 0.9 7.8 ± 0.9 12.3 ± 1.7 3.7 ± 1.2
x [Å] -27.3 ± 0.4 -16.1 ± 0.3 -24.2 ± 0.7 -13.7 ± 0.9
y [Å] 13.4 ± 0.4 -3.5 ± 0.2 -16.9 ± 1.4 -26.0 ± 1.2
z [Å] 18.6 ± 0.3 -10.9 ± 0.2 19.8 ± 0.6 3.5 ± 0.9
α [ °] 106.8 ± 2.8 52.7 ± 1.5 144.6 ± 3.3 13.0 ± 7.7
β [ °] 141.1 ± 1.2 122.7 ± 0.9 68.7 ± 3.8 153.5 ± 3.0
γ [ °] 117.1 ± 2.8 142.7 ± 3.6 125.6 ± 2.5 176.6 ± 19.2
Monte Carlo protocol where random subsets consisting of 20 % of the available PCS were used
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Table 2.2 lists the tensor parameters obtained for the the different protein mutants
and the two Monte-Carlo methods. All metal coordinates turned out to be found
in a reasonable distance of 5 Å to 8 Å to the γ-oxygen of the serine residue at the
position where the corresponding sulfur atom of the protein mutant is expected. For
the mutants S50C, S217C and S220C similar values for ∆χax were found, whereas this
value was almost twice as large for the S166C mutant. This was also reflected in the
PCS where significantly larger shifts were found for the S166C mutant. Values of ∆χrh
did not vary to the same extend, here the largest value was found for S217C and the
smallest for S220C. The smaller ∆χrh the closer is the magnetic susceptibility tensor to
having axial symmetry. This explains why for the S220C mutant the largest differences
in the Euler angels with the biggest uncertainties were observed. Because the closer a
tensor is to axial symmetry the larger the number of orientations that become more
and more equivalent. The orientation of a perfect axial symmetrical tensor eventually
can be described by two Euler angles alone.
The agreement of the experimental PCS with the back calculated values is shown in
figures 2.10 and 2.11 for the two different Monte-Carlo methods applied to the tensor
calculation. The given Q-factors are calculated according the following equation:
Q =
√︃∑︀
(PCSexp−PCScalc)2∑︀
PCS2exp
(2.1)
Q-factors basically are the root mean square deviation (RMSD) of experimental and
calculated PCS divided by the root mean square (RMS) of the experimental PCS, they
are getting smaller the better the agreement is between experimental and calculated
PCS and the larger the average PCS is in a certain dataset. The Q-factors show an
excellent agreement of experimental and calculated PCS for the S166C mutant. For this
mutant the largest number of PCS could be assigned and all of them showed a smaller
deviation than 0.2 ppm compared to the calculated PCS. Only 5 PCS diverged more
than 0.15 ppm and 6 additional PCS showed a deviation in the range of 0.1 ppm to
0.15 ppm. This mutant has also the largest range of PCS with −11.20 ppm to 3.73 ppm,
whereupon it has to be mentioned, that the four largest negative PCS corresponding
to residues 167 and 168 were assigned only based on their predicted PCS. Large chem-
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ical shift changes of the residues in this region of the protein due to the Ser to Cys
mutation and the subsequent conjugation with the tag were observed. These made an
unambiguous assignment of the diamagnetic peaks close to residue 166 impossible
for this mutant.
The mutant with the second smallest Q-factor and the second most assigned PCS is
Table 2.3: Number of PCS per mutant with deviations between experimental and calcu-
lated PCS in the given ranges.
PCS Deviation S50C S166C S217C S220C
>0.2 ppm 5 0 23 6
0.2 ppm to 0.15 ppm 11 5 19 6
0.15 ppm to 0.1 ppm 21 4 44 12
Total >0.1 ppm 37 9 86 24
Total no. of PCS: 410 416 398 394
S50C. Here the number of differing PCS already is larger (compare to table 2.3) The
largest PCS deviation with 0.32 ppm was found for residue A54. For this residue the
second largest PCS of this mutant (−3.57 ppm) was recorded.
Although the Q-factor indicates a lesser agreement between experimental and calcu-
lated PCS of S220C compared to S50C, the S220C mutant shows a smaller total number
of PCS with deviations exceeding 0.1 ppm. This can be explained by the smaller range
of PCS which is with −1.44 ppm to 0.85 ppm more than 3 times smaller than for S50C
(−3.57 ppm to 4.15 ppm). With smaller absolute PCS the average distance increases to
the paramagnetic center and consequently the absolute PCS deviation decreases too
in general because of the r-3 distance dependence of the PCS. For the S220C mutant
the largest PCS deviation was found for residue S99 with 0.44 ppm.
In the case of the S217C mutant which showed the largest Q-factor and by far the largest
number of deviating PCS (more than a fifth of all PCS) also the largest PCS deviation
was found for residue L148 exceeding 1.2 ppm for both (1H and 15N) PCS. These two
PCS clearly stick out in figures 2.10 and 2.11. In the selectively 15N-Leu labelled protein
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Figure 2.10: Correlation of experimental and back calculated PCS obtained from tensors
determined with the given type of Monte-Carlo protocol. All assigned PCS were used.
the PCS of L148 could be assigned unambiguously, because for each of the 26 leucine
residues a corresponding PCS was found. Therefore these PCS were included in the
tensor calculation for this mutant. This mutant also shows the biggest differences in
the tensor parameters calculated with the two different Monte-Carlo methods (see
table 2.2) which indicates that either the variation of the atomic coordinates in the
X-ray structure or the exclusion of some of the PCS from the tensor calculation has
an impact on the tensor. Both reasons point out that the X-ray structure does not
agree for every residue with the determined PCS. When subsets consisting of 20 % of
all PCS are randomly selected then the probability that both L148 PCS are excluded
from the tensor calculation is 64 % and the probability that at least one of these PCS is
excluded is 96 % this means that these PCS have none or only very small influence on
the majority of the 1000 calculated tensors. The fact that the PCS deviation increases
(1.2 ppm to 1.8 ppm) for residue L148 when the PCS are calculated using the tensor
obtained by random selection of 20 % subsets (see figure 2.11) supports the assumption
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Figure 2.11: Correlation of experimental and back calculated PCS obtained from tensors
determined with the given type of Monte-Carlo protocol. All assigned PCS were used.
that indeed this residue’s position seems to differ from the X-ray structure. This is
in accordance to the X-ray structure where the residue L148 is found very close to
the mutation site of the S217C mutant. L148 is located at the end of a β-sheet which
crosses the β-sheet where residue 217 is present. Therefore it is likely that the mutation
or the tagging as well can have an effect on the position of L148, which would explain
the deviation in the corresponding PCS. From this it follows that the large number of
differing PCS for S217C can at least partially be explained by the circumstance that the
two PCS of the residue L148 which were included in the tensor calculation, resulted in
biased tensor parameters and thereby caused increased PCS deviations for some of
the residues. Other deviating PCS could as well differ in their position observed by
PCS compared to the X-ray structure but the effect was not that obvious as for L148 in
the case of the S217C mutant, therefore the next step was finding a method to sort out
such PCS from the tensor calculation in order to refine the tensor parameters.
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2.11 Refinement of the magnetic susceptibility tensors
The magnetic susceptibility tensors obtained from the PCS assigned as described in
the section above allowed to calculate in Numbat the expected shifts based on the
X-ray structure (PDB code: 3KS3). When these calculated PCS were compared with
the experimental shifts apart from the S166C mutant, for all other mutants, some PCS
showed deviations of more than 0.2 ppm. After close examination of the NMR spectra
and the X-ray structure possible reasons explaining these deviations were found:
• The approach in this thesis is based on the assumption that the protein structure
in buffered solution is comparable to the X-ray structure used for the determina-
tion of the magnetic susceptibility tensor. Based on the large number of PCS that
could be assigned, the protein in solution has to have high structural similarity
to the available X-ray structure. This is not necessarily true for every part of the
protein. Crystal artefacts arising from the crystal packing, as well as dynamic
behaviour of flexible loop regions in solution are both well known phenomena
explaining structural differences in certain parts of the protein.
• The X-ray structure available was recorded form wild type protein. But the
PCS were determined from double mutants which were tagged with LnM8-SPy.
Both, the tagging as well as the mutations can cause small structural differences.
Especially for residues close to the tag only a very small displacement in their
position compared to the X-ray structure can lead to large differences in the PCS
due to their r-3 distance dependence.
• In the 1H-15N-HSQC spectra of uniformly labelled protein peak overlap can
limit the precision of the determined PCS. This is more pronounced for the 15N
dimension because of lower resolution and a larger spectral window.
Based on these considerations we defined three criteria upon which we excluded some
PCS from the final tensor calculation:
(i) If the weighted chemical shift distance of LuM8 tagged compared to untagged
protein is larger than 5σ, whereσ is the standard deviation of unaffected residues,
1H and 15N PCS were removed regardless of the according PCS deviation.
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(ii) If the PCS deviation is larger than a defined cut off and if the residue is either
in a flexible loop region of the protein or at the edges of a secondary structure
element close to the tag, 1H and 15N PCS were removed.
(iii) If the PCS deviation is larger than a defined cut off and peak overlap in the 1H-
15N-HSQC spectra could explain the observed PCS deviation. In this case only
the PCS of the concerned nucleus was removed.
The aim of the first criterion is to detect residues whose position could be affected
by the tagging with LnM8-SPy. We decided to follow the approach of chemical shift
mapping, where chemical shift differences are used to determine and characterise
protein ligand or protein protein interaction sites.52 In this case the site where the tag
is bound to the protein is already known, but information could be obtained about
which residues are strongly affected by the tagging. Chemical shift changes show
changes in the chemical environment of the observed nuclei. This has not necessarily
to be caused by a structural change in the protein, but nevertheless it is a possibility.
The number of PCS compared to the full set, that were excluded based on this criteria,
consisted of only 5 % or even less PCS. Therefore priority was laid on exclusion of
candidates whose structure may differ instead of maximising the number of PCS per
subset. Chemical shift changes between untagged and LuM8 tagged protein were
determined as weighted chemical shift distance with a weighting factor of 0.25 for the
nitrogen shift according to equation 2.2.
∆δ=
1
2
√︁
(∆δ1H )
2 + (0.25∆δ15N )
2 (2.2)
Well separated peaks in the 1H-15NHSQC spectra which were not shifted after tagging
were used to determine the standard deviation of the chemical shift differences (σ)
of unaffected peaks. Only residues showing a larger weighted shift differences than
5σ were excluded from the PCS set (see figures 2.12 to 2.15). The value of 5σ was
obtained experimentally by comparing different sizes of this cut-off, in order to keep
the number of excluded residues as small as possible, but still observe a significant
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improvement of the determined tensor values.
The second criterion takes the possibility into account that loop regions of a protein
in solution can adopt a different conformation than in the X-ray structure. As well as
to cover for possible structural changes due to the serine to cysteine mutation, which
could not be approached by chemical shift changes, because no wild type protein was
available for such a comparison.
The third criterion considers residues where the corresponding peak in the 1H-15N-
HSQC overlaps with another signal either the diamagnetic or in the paramagnetic
spectra. It was found that in several cases one of the two PCS (in most cases the 1H-
PCS) fitted well to the tensor whereas the deviation of the other PCS could be explained
by the lowered accuracy of the shift in the respective dimension due to the overlap.
Therefore only the deviating PCS was removed.
To see whether the exclusion of different number of PCS has a large influence on the
tensor we decided to define three different subsets of PCS each with a different cut
off for the PCS deviation. The values chosen were 0.2 ppm, 0.15 ppm and 0.1 ppm
respectively. The three corresponding subsets will be called further on set 1 to 3 where
for set 1 all PCS with deviations exceeding 0.2 ppm were excluded leaving set 3 to be
the one with the smallest PCS deviations.
In the following sections it will be discussed in detail for each mutant individually,
which PCS have been removed and what impact on the tensor the three different
subsets have.
2.11.1 S50C tensor
For this mutant a total of 410 PCS (1H and 15N) for 205 residues could be assigned
unambiguously. This corresponds to 85 % of all residues or to 95 % of those residues
where a reasonable assignment was available.
Set 1
In total 28 PCS were removed for set 1 to obtain a set where the largest PCS deviation
was below 0.2 ppm. This set consists of 93 % of all available PCS.
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• Residues 22, 23, 36, 47, 54, 72, 74, 82, 87, 88, 95 and 198 showed a shift of more
than 5σ when the protein was tagged with LuM8-SPy (see figure 2.12). Of these
residues 47 to 88 are all found in the β-sheet where the tag is attached, in the
parallel β-sheet or in the adjacent loop regions to the two β-sheet. Except residue
88 is the first residue of the second next β-sheet. For all these residues it is very
likely that they are influenced by the attachment of the tag. Residues 22, 23,
36, 95 and 198 were found further away from the tag. Nevertheless they were
removed from the tensor set to exclude all residues with possible structural
changes. Of these residues both PCS (1H and 15N) were removed.
• After excluding the residues mentioned above, residues 71 and 89 still showed a
PCS deviation of more than 0.2 ppm. Both residues were found in a loop region
close to the tag and next to a residue that showed a large chemical shift change.
Therefore both PCS of these residues were excluded from set 1.
Set 2
In total 32 PCS were removed for set 2 (all PCS that were excluded for set 1 and 4
additional), to obtain a set where the largest PCS deviation was below 0.15 ppm. This
set consists of 92 % of all available PCS.
• Residue 189 was found in a loop region close to the tag. Both PCS of these residue
were excluded.
• The the deviation of 15N PCS of residue 197 could be explained by peak overlap
in the 1H-15N-HSQC spectra.
• After exclusion of all PCS above, the 15N PCS of residue 119 still showed a PCS
deviation of more than 0.15 ppm. For this PCS no explanation of the deviation
could be found. Nevertheless it could be shown, that the exclusion of this PCS
did not have an influence on the tensor parameters. Therefore it was decided to
remove this PCS too in order to exclude any possible source of errors.
Set 3
In total 44 PCS were removed for set 3 (all PCS that were excluded for set 2 and 12
additional), to obtain a set where the largest PCS deviation was below 0.10 ppm. This
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Figure 2.12: Plot of weighted chemical shift differences of hCA-II_S50C_C206S-LuM8
compared to untagged protein, calculated using 0.5[(∆δ1H )2+(0.25(∆δ15N ))2]0.5. Residues
with well separated signals in the 1H-15N-HSQC spectra used for calculation of the stan-
dard uncertainty (σ) of the peak position are shown in white. The dashed line indicates
the 5σ cut off. Residues exceeding this value (shown in red) were excluded from tensor
calculation. Residues with black and white bars remained in the tensor set with respect to
this criterion. Secondary structure elements of the protein are indicated (β-sheets: yellow,
helices: blue and hydrogen bonded turns: green).
set consists of 89 % of all available PCS.
• Residue 84 and 190 were found in a loop region close to the tag. Both PCS were
removed for these residues.
• The the deviation of 15N PCS of residues 32, 60, 96, 106, 128 and 203 could be
explained by peak overlap in the 1H-15N-HSQC spectra.
• After exclusion of all PCS above, the 15N PCS of residues 29 and 135 still showed
a PCS deviation of more than 0.1 ppm. For these PCS again no explanation of
the deviation could be found. Nevertheless it could be shown, that the exclusion
of these PCS did not have an influence on the tensor parameters. Therefore it
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was decided to remove these PCS too in order to exclude any possible source of
errors.
Magnetic susceptibility tensors of the different subsets
when the tensor parameters obtained from the different subsets were compared with
each other, only very small effects on the tensor parameters were found (see table 2.4).
Obviously the determined uncertainties decreased when a more consistent set of PCS
was used for the tensor calculation. The differences in the tensor parameters for the
two Monte-Carlo methods were much smaller for the three subsets than for the full
set of PCS for this mutant (compare to table 2.2).
Table 2.4: Tensors of the S50C mutant for the different subsets of PCS
S50C Set 1 Set 2 Set 3 Set 1 Set 2 Set 3
∆χax [10-32m3] 20.8 ± 1.2 21.1 ± 1.2 21.6 ± 1.2 20.7 ± 1.1 20.9 ± 1.1 21.1 ± 0.9
∆χrh [10-32m3] 8.4 ± 0.7 8.4 ± 0.7 8.5 ± 0.7 8.5 ± 0.7 8.5 ± 0.7 8.5 ± 0.6
x [Å] -27.5 ± 0.3 -27.6 ± 0.3 -27.8 ± 0.3 -27.3 ± 0.4 -27.4 ± 0.4 -27.5 ± 0.3
y [Å] 13.7 ± 0.3 13.7 ± 0.3 13.7 ± 0.3 13.7 ± 0.3 13.7 ± 0.3 13.6 ± 0.2
z [Å] 18.3 ± 0.3 18.3 ± 0.3 18.1 ± 0.3 18.3 ± 0.3 18.3 ± 0.3 18.2 ± 0.2
α [ °] 104.8± 1.6 104.8± 1.6 104.1± 1.6 103.9± 2.3 103.8± 2.2 104.0± 1.8
β [ °] 141.8± 1.1 141.8± 1.1 142.3± 1.1 141.8± 1.0 141.7± 1.0 141.8± 0.8
γ [ °] 116.4± 1.7 116.4± 1.7 116.2± 1.7 116.2± 2.1 115.9± 1.9 115.9± 1.7
Error analysis: Monte-Carlo structure variation with a
σ= 0.5 Å
Monte-Carlo protocol for random subset se-
lection of 20 % of PCS
2.11.2 S166C tensor
For this mutant in total 416 PCS corresponding to 208 residues could be assigned.
These are 86 % of all residues that show a resonance in the 1H-15N-HSQC spectra, or
97 % of those residues, where a reasonable assignment was available.
Set 1
Only 2 residues (4 PCS) were removed for this set. It consists of 99 % of all available
PCS. Residue 167 and 168 both showed a PCS deviation smaller than 0.2 ppm but their
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PCS could only be assigned tentatively, because unambiguous assignment of their
corresponding peaks in the diamagnetic spectra was not possible due to the large
change in the chemical shift upon tagging. Anyway these residues would have been
excluded due to the criteria that was defined based on the change in the chemical shift.
Every possible candidate in the diamagnetic spectra for these two residues would
have shown a change in the chemical shift of more than 5σ compared to the untagged
protein.
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Figure 2.13: Plot of weighted chemical shift differences of hCA-II_S166C_C206S-LuM8
compared to untagged protein. For further details, compare to figure 2.12.
Set 2
Set 2 consists of 402 PCS which corresponds to 96 % of all assigned PCS. In total 14
PCS of 7 different residues were excluded (The two from set 1 and 5 additional).
• Residues 22, 58, 160 and 206 were removed due to the chemical shift change
(compare to figure 2.13).
• Residue 172 was excluded according criteria (ii) as it was found at the edge of a
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β-sheet close to the tag.
Set 3
In total 19 PCS were removed for this set, all from set 2 and 5 additional PCS which
showed a PCS deviation of more than 0.1 ppm. This set consists of 95 % of all available
PCS.
• The 15N PCS of residues 75, 79, 197 and 235, as well as the 1H PCS of residue 171
were excluded due to peak overlap.
Magnetic susceptibility tensors of the different subsets
The tensor parameters in table 2.5 show almost no differences, depending on the
different PCS subsets and even compared to the full set (see table 2.2). This shows
the excellent agreement of PCS and protein structure for this mutant. Compared
to the S50C mutant larger differences are found for the two Monte-Carlo methods.
Where the uncertainties for the subset selection were in the same range as for S50C,
the uncertainties for the structure variation turned out to be around twice as large.
This supports the good agreement between X-ray structure and experimental PCS
since the distortion of the protein structure leads to an decreased agreement to the
recorded PCS. This effect could be amplified by the larger average PCS determined for
this mutant, because the larger a PCS the higher the sensitivity to structural changes.
2.11.3 S217C tensor
In total 398 PCS could be assigned for this mutant, these cover 82 % of all backbone
amide NH groups or 91 % of the residues where a reasonable assignment was possible.
Set 1
Set 1 consists of 94 % of all assigned PCS. 22 PCS were excluded.
• Residues 62, 93, 113, 116, 148, 190, 220, 221, 223 and 246 were removed due to
their chemical shift change (compare to figure 2.14).
• Residue 112 was found in a loop region close to the tag.
As already discussed in section 2.10 residue 148 showed a strong indication that the
determined PCS does not fit to the position in the X-ray structure. Here this residue
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Table 2.5: Tensors of the S166C mutant for the different subsets of PCS
S166C Set 1 Set 2 Set 3 Set 1 Set 2 Set 3
∆χax [10-32m3] 38.7 ± 2.0 38.7 ± 1.9 38.5 ± 2.0 37.3 ± 1.2 37.6 ± 1.0 37.4 ± 0.9
∆χrh [10-32m3] 7.5 ± 1.2 8.4 ± 1.0 8.0 ± 1.0 7.8 ± 0.9 8.3 ± 0.8 7.8 ± 0.6
x [Å] -16.1 ± 0.5 -16.4 ± 0.4 -16.3 ± 0.4 -16.1 ± 0.3 -16.3 ± 0.3 -16.2 ± 0.2
y [Å] -3.5 ± 0.3 -3.6 ± 0.4 -3.6 ± 0.4 -3.5 ± 0.2 -3.6 ± 0.2 -3.6 ± 0.2
z [Å] -11.2 ± 0.4 -11.2 ± 0.4 -11.2 ± 0.4 -10.9 ± 0.3 -11.0 ± 0.2 11.0 ± 0.2
α [ °] 51.5 ± 2.0 52.8 ± 1.8 52.2 ± 1.8 52.7 ± 1.5 53.3 ± 1.4 52.7 ± 1.2
β [ °] 123.1± 1.3 123.6± 1.4 123.6± 1.4 122.7± 0.9 123.0± 0.8 123.1± 0.7
γ [ °] 143.1± 5.0 140.5± 5.6 140.3± 5.6 142.7± 3.6 141.5± 3.0 141.1± 2.7
Error analysis: Monte-Carlo structure variation with a
σ= 0.5 Å
Monte-Carlo protocol for random subset se-
lection of 20 % of PCS
was excluded because of the chemical shift change. This shows that this method is
suitable to sort out residues which are affected by structural changes due to the tagging
of the protein.
Set 2
For set 2 all PCS of set 1 and 4 additional, in total 26 PCS were removed. Set 2 consists
of 93 % of all available PCS.
• Residue 147 was found at the edge of a β-sheet close to the tag. This residue is
next to L148 which already showed several indications for a very likely structural
change.
• Residue 191 was found in a loop region close to the tag.
Set 3
This set consists of 91 % of all assigned PCS. In total 34 PCS were excluded (all from
set 2 and 8 additional).
• Residues 101, 109, 110 and 111 were removed according to criteria (ii), due to
their PCS deviation which exceeded 0.1 ppm and in addition because they were
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Figure 2.14: Plot of weighted chemical shift differences of hCA-II_S217C_C206S-LuM8
compared to untagged protein. For further details, compare to figure 2.12.
found in a loop region close to the tag .
For this subset 34 PCS were removed to obtain a set where the largest PCS deviation is
below 0.1 ppm. In contrast to 86 PCS that showed a PCS deviation larger than 0.1 ppm
when the full set of PCS was used (see table 2.3). This clearly shows that it was possible
to increase the overall agreement of PCS and X-ray structure by a proper selection of
the right subset.
Magnetic susceptibility tensors of the different subsets
The tensor parameters of the different subsets for this mutant (compare to table 2.6)
do not show differences worth mentioning. Whereas the differences to the tensor
parameters determined for the full set of PCS (see table 2.2) clearly show the effect
of the refinement. The tensor parameters showed clear differences depending on
the Monte-Carlo method, when the full set of PCS was used. This was not the case
any more for the three subsets, showing that PCS and protein structure become more
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consistent and less dependant on the mode of error estimation.
Table 2.6: Tensors of the S217C mutant for the different subsets of PCS
S217C Set 1 Set 2 Set 3 Set 1 Set 2 Set 3
∆χax [10-32m3] 26.0 ± 1.0 25.8 ± 1.0 25.7 ± 1.0 25.5 ± 1.4 25.4 ± 1.3 25.5 ± 1.1
∆χrh [10-32m3] 13.4 ± 0.6 13.4 ± 0.5 13.2 ± 0.6 13.2 ± 0.7 13.2 ± 0.7 13.1 ± 0.6
x [Å] -24.9 ± 0.2 -24.9 ± 0.2 -24.9 ± 0.2 -24.7 ± 0.3 -24.7 ± 0.3 -24.8 ± 0.2
y [Å] -17.9 ± 0.3 -17.8 ± 0.3 -17.7 ± 0.3 -17.6 ± 0.4 -17.6 ± 0.3 -17.5 ± 0.3
z [Å] 19.6 ± 0.2 19.7 ± 0.3 19.6 ± 0.2 19.7 ± 0.3 19.7 ± 0.3 19.6 ± 0.2
α [ °] 143.7± 0.8 143.7± 0.8 143.7± 0.8 143.4± 1.0 143.3± 0.9 143.3± 0.8
β [ °] 70.4 ± 0.6 70.3 ± 0.5 70.9 ± 0.5 70.6 ± 0.9 70.7 ± 0.8 71.2 ± 0.7
γ [ °] 126.1± 1.0 126.2± 1.1 125.5± 1.0 125.7± 1.3 125.7± 1.3 125.1± 1.1
Error analysis: Monte-Carlo structure variation with a
σ= 0.5 Å
Monte-Carlo protocol for random subset se-
lection of 20 % of PCS
2.11.4 S220C tensor
For this mutant 396 PCS were assigned, covering 81 % of all possible backbone amide
PCS, or 90 % of those residues where an assignment was available.
Set 1
For set 1 in total 7 residues (14 PCS) were excluded. The set consists of 96 % of all
assigned PCS.
• Residues 99, 102, 104, 148, 150, 153 and 161 showed a large chemical shift change,
when the protein was tagged (compare to figure 2.15) All of these residues are
found close to the tag.
Set 2
All residues of set 1 and 4 additional residues (in total 22 PCS) were removed for set 2.
It consists of 94 % of all available PCS.
• Residues 96, 98 and 114 were removed also because of their chemical shift
differences. Because both, their PCS deviation (between 0.2 ppm and 0.15 ppm)
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Figure 2.15: Plot of weighted chemical shift differences of hCA-II_S220C_C206S-LuM8
compared to untagged protein. For further details, compare to figure 2.12.
as well as their chemical shift differences (between 7σ and 5σ) were smaller,
compared to the residues removed for set 1, these residues were kept for set 1.
• Residue 116 was excluded due to the PCS deviation and because it was found in
a loop region close to the tag (according to criteria (ii) ).
Set 3
For set 3 in total 28 PCS were removed (all from set2 and 6 additional). It consists of
93 % of all assigned PCS.
• Residue 157 was found at the edge of a α-helix close to the tag.
• Residue 229 was found in a loop region close to the tag.
• The 15N PCS of residues 58 and 197 were excluded due to peak overlap in the
HSQC spectrum.
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Magnetic susceptibility tensors of the different subsets
Compared to the tensor parameters determined with the full set of PCS (compare
to table 2.2) the values in table 2.7 clearly show smaller uncertainties. When the
different subsets are compared with each other the differences in the values of the
tensor parameters are only marginal. Except for the Euler angles, where the differences
and larger uncertainties (especially for γ) are attributed to the smaller ∆χrh and hence
a tensor closer to axial symmetry. But what attracts attention is the fact that the
uncertainties for the parameters determined by structure variation are more than
twice as small as the uncertainties determined by random subset selection. This is
the other way round as found for the S166C mutant before. Possibly the uncertainties
determined by structure variation are dependent on the size of the corresponding
PCS. For S166C the largest average absolute PCS were determined, where S220C these
were the smallest of all four mutants (for S50C and S217C these were in the same order
in between the other two mutants). An explanation for the smallest uncertainties
obtained for this mutant from the structure variation could be that structure variation
with the same magnitude has a smaller effect on the resulting tensor parameters if the
average absolute PCS are getting smaller.
Table 2.7: Tensors of the S220C mutant for the different subsets of PCS
S220C Set 1 Set 2 Set 3 Set 1 Set 2 Set 3
∆χax [10-32m3] 23.2 ± 1.0 23.6 ± 0.9 23.6 ± 0.9 22.5 ± 2.4 22.9 ± 2.3 23.0 ± 2.1
∆χrh [10-32m3] 4.0 ± 0.3 4.3 ± 0.3 4.3 ± 0.3 4.1 ± 0.9 4.4 ± 0.9 4.4 ± 0.8
x [Å] -13.0 ± 0.2 -13.4 ± 0.3 -13.1 ± 0.3 -13.0 ± 0.7 -13.3 ± 0.7 -13.0 ± 0.6
y [Å] -26.2 ± 0.3 -26.6 ± 0.3 -26.7 ± 0.3 -26.0 ± 0.7 -26.3 ± 0.6 -26.4 ± 0.6
z [Å] 3.1 ± 0.2 3.3 ± 0.2 3.2 ± 0.2 3.1 ± 0.6 3.2 ± 0.6 3.2 ± 0.5
α [ °] 16.7 ± 1.6 14.9 ± 1.3 14.9 ± 1.4 17.8 ± 4.7 16.7 ± 4.0 16.2 ± 3.5
β [ °] 154.2± 0.6 154.3± 0.6 153.6± 0.6 154.3± 1.8 154.4± 1.7 153.7± 1.5
γ [ °] 1.2 ± 3.0 1.8 ± 2.6 1.0 ± 2.6 4.7 ± 8.1 5.4 ± 7.1 3.9 ± 6.6
Error analysis: Monte-Carlo structure variation with a
σ= 0.5 Å
Monte-Carlo protocol for random subset se-
lection of 20 % of PCS
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2.11.5 Comparison of tensor parameters for the different protein mutants
As it was is shown in tables 2.4 to 2.7 there was no significant difference depending on
which subset was used for determination of the sensor parameters. For convenience
in this section the comparison between the four mutants is based only on the tensor
parameters determined with the PCS set 3. All other tensor parameters are already
given above, and all corresponding correlation plots (compare to figure 2.16 and 2.17)
are given in the appendix section.
After the refinement, the magnitude of the tensor parameters remained the same
as for the full set of PCS. ∆χax for S166C is still almost twice as large as for the other
three mutants, where for ∆χrh the biggest value was found for S217C and the smallest
for S220C. The most likely reason for the differences would be that for the S166C
the paramagnetic metal has the least motional freedom with respect to the protein.
For the other mutants residual dynamic behaviour of the tag could allow different
orientations of the lanthanide metal which would result in averaged and therefore
reduced tensor parameters. Interestingly this motional freedom has to be similar for
all three mutants, to result in such comparable tensor parameters.
As shown in table 2.8 even the smallest subset (set 3) still contains a very large number
of PCS as compared to other tensors reported in the literature18,23,30,53–56. Set 3 for the
mutants S50C, S217C and S220C still contains 75 % and S166C even covers 82 % of
all possible backbone amide PCS for the whole protein. For every mutant we have
an excellent agreement between experimental and back-calculated PCS as shown in
figures 2.16 and 2.17. The plot is shown for both tensor parameters obtained with the
different Monte-Carlo methods to show again that there is basically no difference any
more between these two approaches of the error analysis. The higher Q-factor for the
S220C mutant is mainly affected by the fact that this mutant shows the smallest RMS
of the PCS which can be seen directly from the smallest range of PCS for this mutant.
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Table 2.8: Number of PCS total assigned and finally used for the different subsets. Number
of removed PCS are given in brackets.
S50C S166C S217C S220C
Full Set 410 416 398 396
1H 191 (14) 206 (2) 188 (11) 191 (7)
Set 1 15N 191 (14) 206 (2) 188 (11) 191 (7)
Tot. 382 (28) 412 (4) 376 (22) 382 (14)
1H 190 (15) 201 (5) 186 (13) 187 (11)
Set 2 15N 188 (17) 201 (5) 186 (13) 187 (11)
Tot, 378 (32) 402 (10) 372 (26) 374 (22)
1H 188 (17) 200 (8) 182 (17) 185 (13)
Set 3 15N 178 (27) 197 (11) 182 (17) 183 (15)
Tot. 366 (44) 397 (19) 364 (34) 368 (28)
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Table 2.9: Refined magnetic susceptibility tensor parameters The values and their uncer-
tainties are calculated by a Monte Carlo protocol applying two different random inputs
given below.
S50C S166C S217C S220C
∆χax [10-32m3] 21.6 ± 1.2 38.5 ± 2.0 25.7 ± 1.0 23.6 ± 0.9
∆χrh [10-32m3] 8.5 ± 0.7 8.0 ± 1.0 13.2 ± 0.6 4.3 ± 0.3
x [Å] -27.8 ± 0.3 -16.3 ± 0.4 -24.9 ± 0.2 -13.1 ± 0.3
y [Å] 13.7 ± 0.3 -3.6 ± 0.4 -17.7 ± 0.3 -26.7 ± 0.3
z [Å] 18.1 ± 0.3 -11.2 ± 0.4 19.6 ± 0.2 3.2 ± 0.2
α [ °] 104.1 ± 1.6 52.2 ± 1.8 143.7 ± 0.8 14.9 ± 1.4
β [ °] 142.3 ± 1.1 123.6 ± 1.4 70.9 ± 0.5 153.6 ± 0.6
γ [ °] 116.2 ± 1.7 140.3 ± 5.6 125.5 ± 1.0 1.0 ± 2.6
Monte Carlo structure variation with a σ= 0.5 Å
∆χax [10-32m3] 21.1 ± 0.9 37.4 ± 0.9 25.5 ± 1.1 23.0 ± 2.1
∆χrh [10-32m3] 8.5 ± 0.6 7.8 ± 0.6 13.1 ± 0.6 4.4 ± 0.8
x [Å] -27.5 ± 0.3 -16.2 ± 0.2 -24.8 ± 0.2 -13.0 ± 0.6
y [Å] 13.6 ± 0.2 -3.6 ± 0.2 -17.5 ± 0.3 -26.4 ± 0.6
z [Å] 18.2 ± 0.2 -11.0 ± 0.2 19.6 ± 0.2 3.2 ± 0.5
α [ °] 104.0 ± 1.8 52.7 ± 1.2 143.3 ± 0.8 16.2 ± 3.5
β [ °] 141.8 ± 0.8 123.1 ± 0.7 71.2 ± 0.7 153.7 ± 1.5
γ [ °] 115.9 ± 1.7 141.1 ± 2.7 125.1 ± 1.1 3.9 ± 6.6
Monte Carlo protocol where random subsets consisting of 20 % of the available PCS were used
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Figure 2.16: Correlation of experimental and back calculated PCS obtained from tensors
determined with the given type of Monte-Carlo protocol using the PCS of set 3.
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Figure 2.17: Correlation of experimental and back calculated PCS obtained from tensors
determined with the given type of Monte-Carlo protocol using the PCS of set 3.
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2.12 Comparison of (4R,4S)-LnM8-SPy with (8S)-LnM8-SPy
Depending on the configuration of the lactic acid used for the synthesis of M8-SPy the
resulting ligand can be obtained as (8S) or as (4R,4S) stereoisomer. At the beginning
of the project described in this thesis only the (8S)-M8-SPy was available, therefore
this isomer has been selected for the detailed PCS analysis. (4R4S)-M8-SPy as well as
protein samples tagged with (4R,4S)-TmM8-SPy and (4R,4S)-DyM8-SPy respectively,
were synthesized by Dr. Roché Walliser in the course of his masters thesis.57 Here
the comparison of these samples with the corresponding (8S)-M8-SPy analogues is
presented.
Figure 2.18 shows the 1H-15N HSQC spectra of (4R,4S)-TmM8-SPy and (8S)-TmM8-
SPy tagged to 15N-leucine labelled hCA-II_S50C_C206S. With (4R,4S)-TmM8 several
PCS with opposite sign are observable compared to (8S)-TmM8-SPy. This already
indicates that for the two tags different orientations of the ∆χ tensor can be expected.
In contrast to the (8S) tagged protein where a minor second species was observable, as
already discussed in section 2.9, for the (4R,4S) samples only one peak was observable
per residue in the paramagnetic spectra.
For a more detailed comparison the magnetic susceptibility parameters based only
on the leucine PCS were determined. Leucine residues that were excluded for the
uniformly labelled protein from PCS were excluded as well. These residues were
number 47, 84 and 189. All of them are close to the tagging site. With this condition
reasonable PCS can be expected for the (4R,4S) sample as well when determined as
the difference from (8S)-LuM8 tagged protein, because (4R,4S)-LuM8 tagged protein
as reference was not available. In total 44 PCS corresponding to 22 residue were used
for tensor determination. Due to the small set of PCS and because for the comparison
the size of the tensor parameters was sufficient, no error discussion was carried out.
As shown in table 2.10 the tensor parameters for (8S)-TmM8 determined from leucine
PCS only are very close to the full set of PCS from the uniformly 15N labelled protein.
Therefore the tensors for the other three tags can be expected to be representative as
well. As already expected the Tm tensors of the two stereoisomers indeed show a large
difference in their orientation. Furthermore, the size of the (4R,4S) tensor is larger
than than (8S) tensor which is in agreement with the on average larger PCS that are
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Figure 2.18: Overlay of the 1H-15N-HSQC spectra (600 MHz, 298 K) of selectively 15N
leucine labelled hCA-II_S50C_C206S-(8S)LuM8 (black), hCA-II_S50C_C206S-(8S)TmM8
(red) and hCA-II_S50C_C206S-(4R,4S)TmM8 (blue). Assignment and PCS are indicated.
observed for this stereoisomer. The Dy tensors were in both cases smaller than for Tm
as opposed to the general trend in the literature where for the Dy larger susceptibility
tensors are expected than for Tm.58 Again the tensor for the (4R,4S) Dy sample is larger
compared to the (8S) stereoisomer. The difference in the orientation of the tensors for
the two setereoisomers in the case of Dy is much smaller compared to the Tm samples.
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Table 2.10: Tensor parameters determined from selectively 15N-leu labelled hCA-
II_S50C_C206S tagged with two different stereoisomers of M8-SPy and two different
lanthanide metals. The same set consisting of 22 Leu-Residues (44 PCS) was used for each
tensor.
S50C tagged with 8S-TmM8 4R,4S-TmM8 8S-DyM8 4R,4S-DyM8
∆χax [10-32m3] 22.1 30.5 -12.1 -20.6
∆χrh [10-32m3] 8.6 11.7 -5.0 -6.9
x [Å] -27.9 -28.8 -30.9 -30.4
y [Å] 13.5 13.1 9.4 12.3
z [Å] 18.2 20.9 20.1 20.2
α [ °] 104.7 176.1 6.7 5.8
β [ °] 142.1 85.2 107.9 93.9
γ [ °] 115.6 121.1 59.8 81.9
2.13 19F PCS of hCA-II inhibitors
To access PCS of protein inhibitors NMR signals of the inhibitor have to be determined
unambiguously. This is usually not a trivial task. Proton signals overlap with the signals
of the protein making an assignment very difficult. Especially for inhibitors which
strongly bind to the protein. They have the same rotational correlation time as the
protein and their signals therefore are broadened to a similar extend as the protein.
This usually makes a discrimination between protein and inhibitor signals impossible.
Isotope filtered experiments are very demanding, because isotope enrichment of the
inhibitor carbon and heteroatoms in the normal case includes time consuming chemi-
cal modification of the inhibitor. However NMR active isotopes such as 19F or 31P have
a high natural abundance, and therefore no isotope enrichment is necessary for these
elements. If inhibitors containing 19F are used, their signals can be recorded directly
from one dimensional 19F NMR spectra, where for aqueous solutions no solvent signal
suppression has to be applied.
Two sulfonamide inhibitors containing fluorine atoms were selected for the determi-
nation of 19F PCS(see figure 2.19). For F2-Inh bound to hCA-II an X-ray structure (PDB
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Figure 2.19: Structures of sulfonamide inhibitors containing fluorine atoms.
code: 1G52) was available59, therefore this compound was selected to validate the
method of obtaining structural information from 19F PCS of a protein ligand complex.
F2-complex is an analogue of an Ir-complex used for the formation of an artificial
metallo enzyme, which is capable of catalysing enatioselective transfer hydrogenation
reactions, when bound to hCA-II.[60] Structural information of this protein ligand
complex in solution is very important for the further optimisation of this artificial
enzyme. The two fluorine atoms were introduced to the inhibitor in order to be able
to approach this protein ligand complex by 19F PCS.
The inhibitors were added to the protein as a dimethyl sulfoxide (DMSO) solution with
concentrations in the order of 25 mM in a small excess of 1.1 eq. to ensure complete
loading of the protein with inhibitor. F2-complex was found to be only soluble in
aqueous solution at pH below 3.5 and even in DMSO the solution had to be acidified
by bubbling some gaseous HCl through the solution to ensure complete solubility.
Nevertheless when this solution was added to the protein at pH 6.8 complete loading
of the protein with inhibitor was possible as confirmed by 1H-15N-HSQC spectra. The
excess of inhibitor could be removed by ultafiltation without removing any bound
inhibitor showing that both inhibitors have a very high affinity to hCA-II. This is usually
observed for phenyl-sulfonamide compounds.37 For F2-Inh the dissociation constant
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(Kd) is reported to be 0.29 nM.
61,62 For the F2-complex this is expected to be in the
nM range as well but experimental data is not available. In the 1H-15N-HSQC spectra
both inhibitors are found, as expected from dissociation constants in such an order
of magnitude, in the slow exchange regime in terms of their exchange rates. When
subequivalent amounts of the inhibitor were added to the protein, those residues
that show a chemical shift changes due to the inhibitor binding, clearly show two
distinct peaks in the spectra and the intensity is dependant on the amount of inhibitor.
Otherwise only one averaged signal would be observable whose chemical shift depend
on the ligand concentration. Chemical shift changes upon inhibitor binding are only
observed for the residues in the binding pocket of the protein, which indicates that
the overall structure of the protein does not change due to the interaction with the
inhibitor. This is very important because the magnetic susceptibility tensors that are
later used for structural calculation are determined form protein without any bound
inhibitor.
Figure 2.20 shows the 19F spectra of free and bound F2-Inh. For all four protein mutants
the spectra with the inhibitor bound to LuM8 tagged protein show the same chemical
shift for the two fluorine atoms. The same shift is observed, when the inhibitor is
bound to untagged protein. This demonstrates that the inhibitor is not affected by
the tagging of the lanthanide complex to the protein. 19F PCS were determined for all
four protein mutants and are given in figure 2.19. 19F chemical shift was calibrated
to the fluorine signal of internal trifluoroacetic acid (TFA) at −79.0 ppm. For the full
fluorine spectra including the TFA reference see Figure A.11 in the Apendix section.
The largest PCS was found for the S166C mutant where the tag is the closest to the
binding site. For the TmM8 tagged S50C mutant still some traces of free inhibitor
were observable which was not removed completely from the protein sample. Small
signals attributed to the minor second species, arising from reorientation of the tag,
as discussed in section 2.9 are observable for S166C and S220C. Again for the S220C
mutant these signals are significantly larger. For the other two residues these signals
are not observable due to peak overlap.
For the F2-complex the two fluorine atoms are symmetry equivalent and show there-
fore only one signal in the 19F NMR spectrum of the free inhibitor (not shown). This
has been observed as well, when the complex is bound to the protein (see figure 2.21).
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Figure 2.20: 1D 19F NMR spectra (600 MHz, 298 K) of F2-Inh and F2-Inh in the presence
of different hCA-II constructs. Spectra of LuM8 tagged hCA-II with F2-Inh did not show
any differences, therefore only one diamagnetic reference spectra is displayed.
Therefore the aromatic ring with the fluorine atoms still has to be able to rotate freely,
otherwise two different signals would be observable for the two fluorine atoms due
to the chiral environment in the protein. Consequently only one averaged 19F PCS
can be observed for the F2-complex corresponding to an averaged position of the two
fluorines.
Because no differences for the untagged protein and all four LuM8 tagged proteins
were observed for the F2-Inh, we decided to use untagged protein as a diamagnetic
reference for the F2-complex. PCS are given with respect to internal TFA at −79.0 ppm.
Reasonable 19F PCS could be observed for three of the four mutants. For the S217C
mutant a shift very close to 0 ppm was observed. This is possible when the fluorine
atom is located exactly on a nodal plane between two cones of the tensor with opposite
signs. Therefore in this case even a PCS of 0 ppm bears structural information when
the atom is within a reasonable distance to the tag. This clearly is the case because for
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Figure 2.21: 1D 19F NMR spectra (600 MHz, 298 K) of F2-complex in the presence of
different hCA-II constructs. As diamagnetic reference untagged hCA-II with F2-complex
is used.
the other mutants the PCS are not zero. Unfortunately the tensor has a large gradient
in terms of the position for PCS close to zero. Hence a small difference in the PCS can
have a large influence on the determined position. This will be discussed again in
section 2.14. Excess of F2-complex that was not removed completely is still observable
in the topmost spectra of untagged protein and F2-complex in figure 2.21. Most likely
this was caused due to the lower solubility of the complex at the pH it was added to
the protein.
1H-19F-HOESY experiments for 1H PCS of the inhibitor and the protein side-chain
1H-19F-Heteronuclear Overhauser effect spectroscopy (HOESY) allows to determine
proton signals which are close in space to the fluorine atoms. When these spectra are
determined of the protein inhibitor complex, F2-Inh ⊂ hCA-II, this would not only
result in intramolecular correlations of the inhibitor alone but also in intermolecular
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correlations to protons of the protein. The most likely intermolecular correlations
are expected to be interactions with sidechain protons of the protein. These signals
have not been assigned, so far especially not for the protein inhibitor complex, where
significant chemical shift changes due to the inhibitor can be expected. Nevertheless
PCS offer a possibility to obtain structural information of the neighbouring protons of
the fluorine. PCS of these protons can be determined directly from HOESY spectra of
the Lu and Tm tagged protein-inhibitor complex. In this context the fluorine atom act
as relay stations delivering selectively proton signals in their vicinity. This circumvents
the problem of signal overlap which is often encountered when proton signals of fully
protonated protein are determined.
HOESY spectra were recorded of hCA-II in complex with F2-Inh for all four mutants
tagged with TmM8 and for the S217C mutant tagged with LuM8. As already discussed
above for the protein inhibitor complex one diamagnetic reference is expected to be
sufficient. To increase the resolution in the indirect dimension for the proton chemical
shift, only a small spectral window of 3.5 ppm was recorded centred to 7 ppm. Signals
lying outside of this window still appear in the spectra at a corresponding aliased
frequency, which depends on the original chemical shift. PCS which are determined as
shift differences can still be determined precisely from aliased signals and benefit from
higher resolution of the signals. Figure 2.22 shows the section for the meta-fluorine
where the most intensive signals were observed. The ortho-fluorine showed only two
weak correlations at the same proton frequency as the two most intensive signals for
the meta-fluorine. In total four different signals with variable intensities were observ-
able. A second experiment with a spectral window of 4 ppm allowed to determine
the original shift of the aliased signals. This revealed that only the topmost signal at
7.12 ppm was not aliased. This signal was the most intensive and is considered to be
the correlation to the proton in para position of the benzylic ring in the F2-Inh. For
aliased signals an original shift in the aliphatic region between 0.4 ppm and 0.75 ppm
was determined. Therefore they were expected to be correlations to neighbouring
methyl groups.
Unfortunately at the time when these HOESY spectra were recorded the protein
samples used were more than two years old and for two samples partial degradation
of the protein was observable. Therefore these experiments serve only as a proof of
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Figure 2.22: HOESY spectra (600 MHz, 298 K) of F2-Inh ⊂ hCA-II showing trough space
interaction of 19F with 1H. Determined PCS are indicated. All signals, appart from the one
at 7.12 ppm appear at their aliased frequency, due to the small sweep width.
principle, for the feasibility of such experiments. It was clearly possible to demonstrate
that additional PCS information could be obtained from HOESY experiments but the
obtained structural information should be interpreted with utmost care.
2.14 Determination of fluorine position from PCS
When structural information would be obtained form recorded PCS the following
considerations have to be taken into account: All PCS of a certain value lie on top of a
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so called isosurface defined by equation 2.3
δPCS =
1
12pir3
[︂
∆χax
(︀
3cos2θ−1)︀+ 3
2
∆χrhsin2θcos2φ
]︂
(2.3)
Where δPCS is an experimentally determined PCS and ∆χax and ∆χrh are the axial and
rhombic components of the magnetic susceptibility tensor. The solutions for a given
PCS, ∆χax and ∆χrh of this equation for the polar coordinates r, θ and φ deliver the
mentioned isosurface. The position and orientation of this isosurface within a refer-
ence coordinate system has to be specified additionally. Here this is given by three
euclidean coordinates of the corresponding lanthanide metal and three Euler angles
(α,β,γ) in the ZYZ’ convention respectively.
When two PCS for two different tensors are available for the same nucleus then the
position is restricted to the intersection of these two isosurfaces. This intersection
usually is one circular line which very often has a shape similar to the line that is found
on a tennis ball. Depending on the shape and the size of the isosurfaces it is even
possible to obtain two individual circular lines as intersections if two isosurfaces. Thus
when three PCS from different tensors are available, the position is restricted to two or
more points in space which are represented by the intersections of three isosurfaces.
Consequently from four different PCS one unique position can be obtained, unless the
isosurfaces intersect in a way that still allows more than one point as solution which is
very unlikely.
According to these considerations, when at least four PCS of different tensors are are
available for one certain nucleus the position is overdetermined and can be obtained
by the method of least squares. A sum of square residuals was defined according to
equation 2.4
s (x ,y ,z ) =
n∑︁
i=1
(︀
δPCSi (x˜i , y˜i ,z˜i )−δPCSi (exp)
)︀2
(2.4)
where i is the index of a corresponding tensor and n is the total number of individual
tensors available (here n was 4). δPCSi (exp) is the experimental PCS for the different
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tensors and δPCSi (x˜i , y˜i ,z˜i ) is defined by equation 2.5
δPCSi (x˜i , y˜i ,z˜i ) =
1
12pir 3i
[︂
∆χaxi
2z˜ 2i − x˜ 2i − y˜ 2i
r 2i
+
3
2
∆χrhi
x˜ 2i − y˜ 2i
2r 2i
]︂
(2.5)
x˜i , y˜i ,z˜i are the coordinates x ,y ,z transformed into the according tensor frame. This
transformation is carried out by translation of the reference coordinate system to the
position of the corresponding metal center and rotation of the coordinate system by
the three Euler angles (α,β,γ) which are given for each tensor. ∆χaxi , ∆χrhi and ri are
the axial and rhombic tensor components and the distance between lanthanide metal
and the observed position (x ,y ,z ) respectively.
The coordinates of the fluorine atoms were determined from the four different PCS
that were determined for each fluorine atom as described in section 2.13 and the
described method of least squares. The optimised position was determined by min-
imisation of the function s (x ,y ,z ) defined in equation 2.4. All calculations of fluorine
positions from PCS were carried out in Matlab.63 Minimisation of the target function
s (x ,y ,z ) was executed using the internal "fminsearch" routine. Error analysis of the
determined fluorine position was performed applying a Monte-Carlo protocol where
the tensor parameters were varied for every iteration according to the uncertainties
determined in Numbat (as described in section 2.10). For each fluorine position 1000
iterations were carried out with the same random seed in order to ensure comparabil-
ity. The resulting values and uncertainties were the average and standard deviation
of these 1000 iterations. It could be shown that 1000 iterations were sufficient for
reasonable results, neither the average position nor the standard deviation did change
significantly, when 10 000 or 100 000 iterations were used for the calculation.
Fluorine positions of F2-Inh
The fluorine position was calculated for all tensors determined in section 2.11. As
shown in table 2.11 the position did not change significantly with the different PCS
subsets. Compared to the X-ray structure of F2-complex the determined fluorine
positions differed by as much as 8 Å. Interestingly the determined fluorine fluorine
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distance was very close to the expected 2.8 Å from the X-ray structure. The fluorine
fluorine distance and the corresponding uncertainty were determined directly during
the Monte-Carlo simulation. The distance was determined for every single iteration
individually and then the average distance and the standard deviation was evaluated.
Because the same random seed was applied for both fluorine calculations the dis-
tances were determined with respect to exactly the same pair of tensor parameters.
This procedure gave results closer to the expected value and with much lower uncer-
tainties as obtained when different random seeds were applied or when the fluorine
fluorine distance was determined from the two fluorine positions in table 2.11.
The large difference between X-ray structure and PCS position can be explained in two
Table 2.11: Flourine positions of F2-Inh calculated for the 6 different tensor sets (of the 3
different pcs subsets and the the 2 Monte-Carlo methods), the corresponding F-F distance
and the deviation from the position in the X-ray structure (1G52). All coordinates and
distances are given in Å with respect to the coordinate system of the X-ray structure 3KS3.
PCS Set: Set 1 Set 2 Set 3 Set 1 Set 2 Set 3
Tensor by structure variation Tensor by subset selection
x -7.4 ± 1.7 -7.4 ± 1.7 -7.3 ± 1.7 -7.5 ± 1.7 -7.4 ± 1.5 -7.3 ± 1.4
F_ortho y 6.1 ± 0.8 6.1 ± 0.8 6.0 ± 0.8 6.0 ± 0.9 6.0 ± 0.8 6.0 ± 0.8
z 15.5 ± 0.7 15.7 ± 0.7 15.7 ± 0.7 15.6 ± 0.5 15.7 ± 0.5 15.7 ± 0.4
x -7.1 ± 2.5 -7.0 ± 2.5 -6.8 ± 2.5 -7.1 ± 2.4 -6.9 ± 2.1 -6.7 ± 1.8
F_meta y 8.4 ± 0.8 8.5 ± 0.8 8.3 ± 0.8 8.3 ± 0.9 8.4 ± 0.8 8.4 ± 0.7
z 16.7 ± 0.7 16.9 ± 0.8 16.9 ± 0.7 16.8 ± 0.6 16.9 ± 0.5 16.9 ± 0.5
F-F dist. 2.9 ± 0.3 2.9 ± 0.3 2.9 ± 0.4 2.8 ± 0.3 2.8 ± 0.2 2.8 ± 0.2
F_ortho dev. 7.9 ± 1.2 8.0 ± 1.2 8.0 ± 1.1 8.0 ± 1.3 7.9 ± 1.1 7.9 ± 1.0
F_meta dev. 8.0 ± 2.0 8.1 ± 2.0 8.0 ± 1.9 8.1 ± 2.0 7.9 ± 1.7 7.8 ± 1.4
ways: either the structure of the protein inhibitor complex in solution is different from
the crystal structure, or there has to be an error on the fluorine PCS that is responsible
for the deviation.
Figure 2.23 shows the point clouds for the two fluorine atoms from the Monte-Carlo
calculation. It can be seen that when the phenyl ring with the two fluorines is rotated
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Figure 2.23: Point cloud of the Monte-Carlo fluorine position calculation for F2-Inh⊂hCA-
II. Red points are obtained from the PCS of the ortho-F and the blue points from the meta-F
PCS respectively.
by 180° around the benzylic C-C bond the deviation to the calculated position would
be smaller, but the fluorines would still lie outside of the point cloud. Other conforma-
tional changes that would bring the fluorines closer to the PCS position would include
reorientation of the protein side chains, especially of the phenyl ring of F-131. Docking
simulations where the determined PCS position were taken into account were not able
to support the assumption of a larger reorientation of the inhibitor and the protein
side chains. The structures from the docking experiments were in agreement with the
crystal structure.
A possibility for a systematic error on the fluorine PCS are RACS, these are small chem-
ical shift changes due to partial alignment of the protein in the magnetic field. They
were not considered so far because prior knowledge of the structure is necessary for
their determination. This subject will be discussed in more detail later in this section.
The very close agreement of the PCS fluorine fluorine distance with the X-ray structure,
where 2.8 Å are measuerd, supports this assumption. A small error on both PCS of the
two fluorines which is equally large would still allow the determination of a reasonable
distance between them, because both positions would be affected to a similar extent,
2.14 Determination of fluorine position from PCS 67
provided the gradient of the isosurfaces is not too large. This can be assumed since
the difference in the back calculated PCS for the X-ray position and the determined
PCS position was in the order of 0.02 ppm, except for S217C where this was as large as
0.1 ppm (see table 2.14).
Proton position from 1H-19F HOESY PCS of F2-Inh
As already mentioned in section 2.13 due to partial degradation of the protein sample
after two years in storage, these results should be interpreted with care. However they
are presented in order to show the potential of this new method.
Proton positions from the PCS determined in the 1H-19F HOESY experiment were
calculated by the same procedure as for the fluorine. For the Hpara position three
outliers of the 1000 iterations were removed before determining the average position.
The determined proton positions relative to the X-ray structure (1G52) are shown in
figure 2.24.
Figure 2.24: Average proton positions from PCS determined in the 1H-19F-HOESY experi-
ment of F2-Inh⊂ hCA-II. In red the position of Hpara and in blue the proton in the aliphatic
region.
The distances to the expected proton position in the X-ray structure are given in
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table 2.12. For the signal at 7.12 ppm indeed the expected aromatic proton was the
closest candidate. For the aliphatic signal at 0.41 ppm the closest candidate were
the methyl protons of V-135. The second next candidate was the Hα of G-132 with a
deviation of 3.2 Å to the determined proton position. But for the α proton of glycine a
different chemical shift, in the order of 3.9 ppm would be expected.
Table 2.12: Proton positions from 1H-19F-HOESY PCS of F2-Inh ⊂ hCA-II calculated using
the tensor parameters obtained from PCS set 3 with subset selection. The deviation to
the closest proton in the X-ray structure (1G52) is given. All coordinates are given with
respect to the coordinate system of PDB structure 3KS3.
Assign. δ x y z Dev.
[ppm] [Å] [Å] [Å] [Å]
Hpara F2-Inh 7.12 -0.1 ± 1.2 10.2 ± 1.0 14.8 ± 0.8 1.4
Hγ2 V-135 0.41 -2.1± 1.2 11.1 ± 0.8 15.6 ± 0.7 2.3
Fluorine positions of F2-Complex
In the case of the F2-complex ⊂ hCA-II no X-ray structure was available but for the
analogue complex without the two fluorines a structure was published in 2015.35 It
was assumed that for the F2-Complex the structure would be very similar. The ter-
minal phenyl ring at the sulfonamide group that binds to the iridium metal, in the
PDB structure (3ZP9) showed two different conformations in the crystal structure.
This is in agreement with the observation that for the F2-Complex, the corresponding
phenyl ring has to be able to rotate freely in solution, even when the complex is bound
to hCA-II. Due to the free rotation only one fluorine signal could be observed and
therefore only an average fluorine position was determined from the corresponding
PCS. For the comparison of the X-ray structure with the PCS position for the fluorine
position in the X-ray structure the average position of the quaternary carbon of the
terminal phenyl ring for the two different conformations was selected.
The initially determined PCS position for the F2-complex showed a deviation of
more than 15 Å compared to the expected fluorine position. In a direction that could
not possibly be adopted by the fluorine when the F2-Complex binds as expected
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Table 2.13: Flourine positions of F2-Compex calculated for the 6 different tensor sets
(of the 3 different pcs subsets and the the 2 Monte-Carlo methods), the deviation from
the expected average fluorine position in the X-ray structure (5BRV). All coordinates and
distances are given in Å with respect to the coordinate system of the X-ray structure 3KS3.
Tensor by structure variation Tensor by subset selection
PCS Set: Set 1 Set 2 Set 3 Set 1 Set 2 Set 3
No. of solutions: 130 76 156 120 67 97
x -5.2 ± 1.6 -5.3 ± 1.8 -4.9 ± 1.7 -5.4 ± 1.7 -5.8 ± 1.8 -5.3 ± 1.4
y 11.1 ± 0.9 11.1 ± 0.9 11.0 ± 0.9 10.8 ± 1.0 11.1 ± 1.0 11.0 ± 0.9
z 6.6 ± 1.0 6.3 ± 1.2 6.7 ± 1.1 7.1 ± 1.3 7.0 ± 1.3 7.1 ± 1.1
F dev. 3.5 ± 0.8 3.8 ± 0.9 3.5 ± 0.8 3.2 ± 1.0 3.2 ± 1.1 3.0 ± 0.9
with the sulfonamide to the zinc of the protein. Additionally this position was found
below the protein surface right next to the residue 55. When the starting point for
the fluorine position calculation was set exactly to the expected fluorine position
for around 10 % of the iterations of the Monte-Carlo position calculation a second
minimum appeared much closer to the expected fluorine position as shown in table
2.13 and figure 2.25. The intersection of the four isosurfaces corresponding to the four
PCS of the F2-complex (figure 2.25 lower left) have indeed the closest intersection at
the position where the majority of points were found for the fluorine position. But
for three isosurfaces (for S50C,S166C and S220C) a second intersection is observed
closer to the expected fluorine position. This explains why the second minimum with
much smaller deviation was found. The PCS determined for the S217C mutant was
0.001 ppm implying that the fluorine lies in a node plane of the corresponding tensor
where the isosurfaces have the largest gradient with respect to their position compared
to the PCS. This could be illustrated by plotting the isosurface of the S217C mutant for
a PCS that is only 0.05 ppm smaller than the experimentally determined PCS (figure
2.25 lower right). This isosurface already lies exactly where the second minimum is
found. This indicates that only a small difference of the PCS can have a large influence
on the position determined from the PCS. This again supports the theory that there is
an unascertained systematic error that has not been considered so far.
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Figure 2.25: Point cloud of the Monte-Carlo fluorine position calculation for F2-Complex
⊂ hCA-II. Lower left figure shows the isosurfaces of the four different tensors and their
corresponding PCS (Red: S50C, green: S166C, blue: S217C and yellow: S220C). Lower right
figure: same isosurfaces except for S217C (Blue) which represents a PCS of −0.049 ppm
instead of 0.001 ppm.
2.14.1 RACS as a potential source of systematic error
Paramagnetic lanthanide metals with an anisotropic ∆χ tensor weakly align in the
magnetic field. When bound to a protein this leads to partial alignment of the whole
protein and therefore the CSA is not completely averaged to an isotropic chemical shift
any more which results in small shift changes due to the alignment of the protein.18
These shifts are called RACS and they add to the effective PCS resulting in the experi-
mentally observed PCS. RACS can be determined according to the following equation:
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Table 2.14: Expected PCS of the X-ray fluorine position and the calculated PCS position
using the tensor parameters of set 3 and subset selection. For F2-Inh the PDB structure
1G52 was used. For F2-Complex 5BRV was used where for the fluorine position the average
position of the quaternary carbon of the two conformations of the terminal phenyl ring
was assumed. All values are given in ppm.
S50C S166C S217C S220C
F-Position: X-ray PCS X-ray PCS X-ray PCS X-ray PCS
F2-Inh: F_ortho -0.116 -0.135 -0.378 -0.356 -0.061 -0.163 -0.102 -0.108
F_meta -0.116 -0.145 -0.283 -0.296 -0.061 -0.147 -0.080 -0.085
F2-Complex: -0.165 -0.126 -0.478 -0.470 -0.059 -0.045 -0.121 -0.119
δRACS =
B 20
15µ0k T
∑︁
i , j∈{x ,y ,z }
−σCSAi i cos2θi j∆χ j j (2.6)
where B0 is the magnetic field, µ0 the permeability of vacuum, k the Boltzmann con-
stant, T the temperature, σCSAi i the principal components of the CSA-tensor, ∆χ j j the
principal components of the ∆χ-tensor and θi j the angle between the corresponding
principal axis of the CSA-tensor and the ∆χ-tensor.18,19 This function is included in
Numbat and allows to determine the expected RACS for a given structure and a related
set of tensor parameters, for the protein backbone amide proton and nitrogen and for
the backbone carbonyl carbon. The values for the CSA-tensors for the three nuclei
used by default in Numbat were previously determined from a protein aligned in a
liquid crystalline phase.19 For protons the RACS are negligible, but not for 15N and
13C. For the S166C mutant with the largest tensor, the largest RACS for 15N were in
the order of ±0.1 ppm. For the other three mutants they were between ±0.07 ppm and
±0.05 ppm. Values reported for the CSA of aromatic fluorines64,65 were in a compa-
rable order of magnitude as for 15N, therefore comparable RACS can be expected for
19F. Such RACS could be responsible for the deviation between x-ray structure and
PCS position for F2-Inh. Unfortunately for the calculation of RACS in Numbat prior
knowledge of the structure is necessary. Which is not the case in the present approach,
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where only the position of the fluorine atoms can be determined.
To examine the effect of the RACS on the PCS structure determination, a validation of
the structure calculation was performed. For ten residues, the position of amide H
and N atoms was predicted using either directly the experimentally determined PCS
values or, for comparison, the PCS values that were corrected for RACS by Numbat.
The ten different residues were selected to be located either in a secondary structure
element or in a loop region that is not expected to be flexible therefore it could be
assumed, that x-ray structure and solution structure are in agreement with each other.
The residues were selected to be not too close to any of the four tagging sites to avoid
structural differences due to the mutation and tagging. In the paramagnetic as well
as in the diamagnetic 1H-15N-HSQC spectra for each of the four mutants, the signals
of the ten residues were well separated, to ensure that precise PCS are available. For
the ten residues the corresponding 1H and 15N PCS were excluded from the PCS set.
Tensor parameters were redetermined for the new subset and were found to be very
close to the parameters of the previous subset showing that the exclusion of these PCS
does not have a significant influence on the determined tensor parameters. For all
ten residues the expected RACS were calculated based on the position in the X-ray
structure for all four mutants. These values are given together with the experimentally
determined PCS in table 2.15. It was expected that the amide H and N position from
the experimental PCS alone should be less close to the X-ray position than when
the effective PCS is used which is the experimental PCS where the RACS have been
subtracted.
For the determined amide H and N positions the deviation from the crystal structure
for each of the 20 atoms and for both sets of PCS was determined and is given in
table 2.16 together with the calculated N-H distance determined from PCS alone,
analogously to the two fluorines of the F2-Inh. As expected, the differences in the
position of the protons does not change significantly when the experimental PCS
are compared to the effective PCS because the RACS for 1H are negligibly small. For
the nitrogen position no consistent effect of the RACS correction was observed. Two
residues, G-25 and E-205 show a significantly larger deviation from the X-ray position
than the other residues. In addition these two residues have the largest uncertainties
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Table 2.15: PCS and RACS of residues selected for validation of structure calculation
from PCS. The PCS were determined experimentally from 1H-15N HSQC spectra and the
RACS were calculated based on their orientation in the pdb structure 3KS3 using tensor
parameters where these residues have been excluded. All values are given in ppm.
Mutant Residue 1H 15N Residue 1H 15N
PCS RACS PCS RACS PCS RACS PCS RACS
S50C G-25 0.026 0.000 0.033 -0.014 G-183 -1.296 -0.001 -1.218 0.023
S166C -0.124 0.000 -0.146 -0.047 0.307 -0.001 0.410 0.039
S217C -0.141 0.001 -0.189 -0.032 -0.079 0.000 -0.068 -0.002
S220C -0.080 -0.001 -0.045 0.031 -0.319 -0.001 -0.334 -0.015
S50C V-31 0.135 -0.002 0.083 0.025 T-193 0.591 -0.002 0.646 0.047
S166C -0.096 -0.003 -0.178 0.066 -0.030 0.000 0.025 0.037
S217C -0.592 0.001 -0.538 -0.021 -0.865 0.003 -0.864 -0.004
S220C -0.087 0.000 -0.080 -0.022 -0.006 -0.002 0.015 0.038
S50C F-66 -0.149 -0.003 -0.079 0.047 E-205 -0.004 0.001 -0.035 -0.007
S166C -1.196 -0.003 -1.299 0.062 -0.151 0.005 -0.119 -0.039
S217C 0.011 0.000 -0.019 -0.009 -0.145 0.002 -0.167 -0.003
S220C -0.447 0.000 -0.395 0.011 -0.083 -0.001 -0.095 0.005
S50C G-132 -0.243 -0.003 -0.236 0.024 T-208 0.307 -0.003 0.385 0.048
S166C -0.228 -0.004 -0.297 0.060 -0.137 -0.005 -0.110 0.061
S217C -0.055 0.002 -0.077 -0.026 -0.275 -0.001 -0.329 -0.013
S220C -0.092 0.000 -0.094 -0.019 -0.085 0.000 -0.063 0.013
S50C Q-136 -0.162 -0.001 -0.089 0.030 W-209 0.418 0.000 0.469 -0.019
S166C -0.167 -0.004 -0.230 0.062 -0.101 -0.001 -0.186 -0.039
S217C -0.091 0.002 -0.111 -0.027 -0.456 0.004 -0.513 -0.062
S220C -0.078 0.002 -0.092 -0.010 -0.067 0.002 -0.061 -0.004
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which is in agreement with the fact that these two residues have the smallest PCS of the
ten residues and have the largest overall distance to the four different metal centres.
Both factors lead to less well defined positions in the PCS structure determination.
For the other eight residues an average deviation of 2.0 Å for the experimental PCS
and 1.9 Å for the effective PCS was observed for the proton position and for nitrogen
this was 3.5 Å and 4.2 Å respectively. The lower agreement for the nitrogen position
in both cases was attributed to the lower resolution and larger range of the nitrogen
chemical shift in the 1H-15N-HSQC spectra.
Table 2.16: Validation of structure calculation by PCS. The deviation from the expected
position in the X-ray structure (3KS3) is given for the position determined from experi-
mental PCS as well as from effective PCS which have been calculated by subtraction of the
expected RACS (see table 2.15) from the experimental PCS. All distances are given in Å.
Residue PCSexp PCSeff Residue PCSexp PCSeff
G-25 H 7.1 ± 4.6 6.9 ± 4.6 G-183 H 2.2 ± 1.1 2.2 ± 1.1
N 9.5 ± 3.4 13.0 ± 4.0 N 2.4 ± 1.3 2.3 ± 1.3
N-H dist. 12.4 ± 4.5 9.5 ± 4.8 N-H dist. 1.3 ± 0.8 1.1 ± 1.0
V-31 H 2.1 ± 1.5 2.0 ± 1.5 T-193 H 1.9 ± 1.2 1.8 ± 1.2
N 3.8 ± 1.5 5.7 ± 2.2 N 5.3 ± 1.5 2.2 ± 2.0
N-H dist. 2.1 ± 0.7 4.1 ± 1.9 N-H dist. 5.4 ± 1.0 1.1 ± 1.4
F-66 H 1.6 ± 0.9 1.6 ± 0.9 E-205 H 4.0 ± 2.6 4.1 ± 2.5
N 2.3 ± 1.0 1.6 ± 0.9 N 7.6 ± 1.7 8.5 ± 1.3
N-H dist. 2.1 ± 0.4 1.2 ± 0.2 N-H dist. 6.6 ± 3.9 7.8 ± 3.2
G-132 H 2.6 ± 1.6 2.4 ± 1.4 T-208 H 1.8 ± 1.1 1.6 ± 1.1
N 3.8 ± 1.1 8.2 ± 1.7 N 2.0 ± 0.7 3.4 ± 1.1
N-H dist. 3.4 ± 0.5 6.6 ± 0.9 N-H dist. 2.8 ± 0.5 2.4 ± 0.6
Q-136 H 2.2 ± 1.5 2.2 ± 1.7 W-209 H 1.6 ± 1.2 1.7 ± 1.3
N 5.3 ± 1.1 7.9 ± 1.2 N 3.2 ± 0.8 2.2 ± 1.0
N-H dist. 4.8 ± 0.6 7.5 ± 1.0 N-H dist. 3.3 ± 1.0 2.2 ± 0.6
2.15 Assignment of sidechain NH resonances of arginine and tryptophan based on PCS 75
2.15 Assignment of sidechain NH resonances of arginine and tryptophan
based on PCS
Sidechain NH resonances in the diamagnetic spectra for tryptophan and arginine
sidechain NH groups were identified based on the list of average reported chemical
shift taken from the Biological Magnetic Resonance Data Bank[66] (list updated on the
17th of March 2016). The reported 1H and 15N chemical shift values were 7.46±0.60
and 84.59±1.62 for the arginine sidechain NH at the ε-position and 10.08±0.64 and
129.29±2.08 for the aromatic sidechain NH of tryptophan. For both residues seven
different resonances were expected. Because the resonances for the arginine NH are
outside of the spectral window in the indirect dimension these residues were easily
identified as aliased peaks with negative intensity in the range of 116 ppm to 117 ppm
in the 15N dimension. Tryptophan sidechain resonances were identified indirectly as
those resonances in the lower left region in the 1H-15N HSQC spectra which showed
no correlation in the HNCO spectra due to the absence of a carbonyl carbon next to
the nitrogen.
For such a small number of residues unambiguous assignment of the corresponding
PCS was possible for several resonances. These could directly be identified by com-
parison of their experimental PCS with the back calculated PCS based on the tensor
obtained from the backbone amide PCS and the x-ray structure. In a second iteration
the remaining ambiguous resonances were assigned by comparing the predicted PCS
for those residues, thus allowing eventually the unambiguous assignment of every
resonance of the identified groups.
Alternatively the position of the resonance could be calculated as described in section
2.14. Here again the position determined for the 1H PCS turned out to give better re-
sults analogue to the findings in section 2.14.1. This would even allow the assignment
of resonances where the type of residue has not been identified, provided at least three
PCS were determined.
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2.16 RDC measurements
RDC can be observed for partially aligned proteins in solution. The dipolar coupling is
not averaged to zero any more, as it is the case for an isotropically oriented sample, and
therefore adds to the scalar coupling between two nuclei. NH-RDC can be described
by the following equation:14,16
DN H =− B
2
0 γH γNħhS
120k Tpi2r 3N H
[︂
∆χax
(︀
3 cos2θN H −1)︀+ 32∆χrh sin2θN H cos 2φN H
]︂
(2.7)
where DN H is the observed RDC, B0 the magnetic field, γH and γN the gyromagnetic
ratios of 1H and 15N, ħh the reduced Planck constant, rN H the distance between proton
and nitrogen and S the order parameter which covers for the effect of local mobility
of the NH-bond with respect to the metal center67. ∆χax and ∆χrh are the axial and
rhombic components of the magnetic susceptibility tensor and θN H and φN H the polar
angles describing the orientation of the NH bond vector with respect to the orientation
of the magnetic susceptibility tensor.
RDC were determined using triply labelled S50C protein samples tagged either with
LuM8 or with TmM8. An in phase anti phase (IPAP) variant of the 1H-15N HSQC
experiment was recorded for both samples, with an NMR spectrometer operating
at 900 MHz.68 In this experiment no decoupling is applied in the indirect dimension
thus resulting in spectra with two peaks for every residue separated in the indirect
dimension by the corresponding 1J coupling constant. A second experiment where
the two peaks resulting from the coupling are obtained with opposite sign then allows
either by addition or subtraction of the first spectra to selectively obtain spectra with
either only the upper or the lower signal. This reduces the number of peaks in the
spectra by a factor of two which is especially helpful in crowded regions. The coupling
constant is then determined from the shift difference in the indirect dimension of the
two spectra. Subsequently the RDC are determined as the difference in the coupling
constant of the paramagnetic and the diamagnetic protein sample. This requires that
the diamagnetic as well as the paramagnetic spectra are assigned. In total 178 RDC
could be assigned this corresponds to 74 % of all residues or to 81 % of the assigned
residues.
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RDC-tensors were determined using the program FANTEN16 which is available online.
The program allows the determination of ∆χ parameters from individual RDC and
PCS data sets as well as from combined PCS and RDC data sets. For the calculated
tensors in table 2.17, PCS were equally weighted as RDC for the combined sets, and
for the RDC an order parameter of 1.0 and an uniform N-H bond length of 1.02 Å was
applied. Because RDC do not depend on the distance to the lanthanide metal, only
the orientation and the size of ∆χax and ∆χrh of the tensor could be determined for
the sets where only RDC were used. In contrast to Numbat, in FANTEN Monte-Carlo
error analysis is only possible for ∆χax and ∆χrh and the three Euler angles but not
for the lanthanide metal position. Therefore no error analysis was applied to the
tensors below. It was expected that the tensor parameters would have comparable
uncertainties to the tensor parameters determined in Numbat. Also the convention
for principal tensor components is different in FANTEN than in Numbat therefore
a different set of tensor parameters is obtained but they describe a comparable ∆χ-
tensor. Q factors for RDC were determined analogously to the PCS as described in
equation 2.1 in section 2.10.
Very similar tensor parameters to the set with only PCS were obtained for the RDC-
tensor and the combined PCS and RDC tensor when for the RDC an order parameter
of 1.0 was used. Usually the ∆χ tensors parameters determined from RDC are 10 % to
20 % smaller compared to the tensors calculated from PCS69, which is attributed to the
local mobility of the NH bond vectors16 or to residual flexibility of the paramagnetic
tag with respect to the protein.28 To compensate for this effect order parameters (S)
in the order of 0.9 are applied to obtain comparable tensor parameters.70,71 On this
background it is remarkable that in the present case with an order parameter of 1.0
the same tensor parameters were obtained for PCS and RDC For the optimised set,
where all RDC with a deviation of more than 10 Hz were excluded the values for ∆χax
and ∆χrh are even larger compared to the set with only PCS.
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Table 2.17: Tensors determined using the program FANTEN for PCS, RDC and combined
data sets. PCS of subset 3 were used only. For the optimized set of RDC all couplings with
a deviation larger than 10 Hz to the predicted values were excluded.
S50C PCS only RDC only PCS and
RDC
RDC opt.
only
PCS and
RDC opt
∆χax [10-32m3] 21.1 21.2 21.2 23.3 23.3
∆χrh [10-32m3] -8.4 -9.0 -9.0 -9.2 -9.2
x [Å] -27.6 - -27.3 - -27.8
y [Å] 13.6 - 14.5 - 14.7
z [Å] 18.2 - 18.4 - 18.4
α [ °] 26.5 164.6 164.6 160.0 160.0
β [ °] -142.0 -39.0 -39.0 -39.2 -39.2
γ [ °] -75.5 94.1 94.2 96.2 96.2
QPCS 0.079 0.157 0.139
QRDC 0.48 0.48 0.31 0.31
No. of PCS 366 366 366
No. of RDC 178 178 161 161
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Figure 2.26: Correlation of experimental and back calculated RDC obtained for the tensors
determined only with RDC given in table 2.17
CHAPTER 3
Discussion
The results of this PhD thesis cover several different fîelds, starting from the synthesis
of a lanthanide chelate and the corresponding lanthanide complexes, to the design and
expression of single cysteine hCA-II mutants with various isotope labelling schemes,
to protein backbone assignment, as well as protein conjugation for the determination
of PCS on protein-inhibitor complexes and the subsequent analysis and application
of the PCS for structure determination. In the following section, these results will be
discussed in approximately the same chronological order as presented in the results
section.
3.1 LnM8-SPy Synthesis
The synthesis of M8-SPy (see figure 1.4), that was repeated for the first time in the
course of my masters thesis previous to this PhD thesis, was further improved. Mainly
optimization of reaction time was achieved as described in section 2.1. The amide
coupling reaction and the subsequent tBu deprotection step, with 40 % overall yield,
remained the most crucial step of the whole synthesis. Different deprotection condi-
tions (H2SO4 in CH2Cl2) or the purification of the intermediate followed by the usual
TFA deprotection both resulted in very poor yields in the order of 1 %. Of course this
step was not yet fully optimized, but main focus was laid on the preparation of the
final lanthanide complexes and there further application. The deprotection in TFA
was monitored by ESI-MS, following the peak intensity of the products normalized
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by an internal signal that was attributed to a byproduct of the previous amide cou-
pling and remained unaffected under deprotection conditions. The intensity of the
product peaks reached a plateau after 6 h thus confirming the reported reaction time.
Reasons for this could be that the reaction is already completed at this point of time,
but the fact that never more than 40 % yield was obtained shows that it is more likely
to expect the presence of a side-reaction competing with the desired deprotection
reaction. This could be confirmed by the observation that the overall intensity of the
peaks in the mass spectra corresponding to the desired product, starting material and
to the two mono- and di-deprotected intermediates, decreased over time. Because
no characteristic signals in the mass spectra were observable this side-reaction was
expected to be either the cleavage of the disulfide bond and thereby the loss of the
group in the molecule that is protonated most easily and therefore mainly responsible
for the inthensity observed in the ESI-MS, or the degradation of the macrocycle. This
confirmed the optimal reaction time for the TFA deprotection to be 6 h as reported.28
For the final metallation step yielding the desired lanthanide complexes only partial
conversion was observed when, in contrast to the described procedure, only water as
solvent was used. When the LnM8-SPy complex is formed, three protons are released
which lowers the pH of the reaction mixture and evidently preventing the deproto-
nation of the carbonic acids of the ligand. This was found to be important for the
coordination of the ligand to the lanthanide metal. This confirms the importance of the
described ammonium acetate buffer. Already an 100 mM ammonium acetate buffered
soulution with a pH of 5.6 for a ligand concentration of 2 mM to 4 mM was enough to
compensate for the released protons enabling complete conversion. The complexa-
tion was carried out with four different lanthanide metals, Gadolinium, Dysprosium ,
Thulium and Lutetium. Dysprosium was selected because for this lanthanide metal
the largest PCS are expected.58 On a ubiquitin sample tagged with TmM8 very large
PCS were observable for residues close to the tag. The corresponding signals in the
spectra of ubiquitin tagged with DyM8 were not observable any more. Either these
signals were shifted outside the spectral window and/or they were broadened beyond
the limit of detection due to the PRE. This shows that with the Tm tag information
could be obtained of regions of the protein much closer to the tagging site. Lutetium
was selected because the Lu3+ ion has no unpaired electrons and therefore is diamag-
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netic. It is used as diamagnetic reference, which compensates for all effects that are
not related with paramagnetism, such as chemical shift perturbation of residues close
to the tag. Gd3+ has a half filled f-shell and therefore seven unpaired electrons, these
electrons have an isotropic distribution around the metal center and consequently
Gd3+ induces no PCS. The Gd3+ metal complex was prepared for its application for
PRE and for its applications in electron paramagnetic resonance (EPR) spectroscopy,
both are not presented in this thesis.
In the course of the Masters thesis of Dr Roché M. Walliser the (4R,4S) stereoisomer
of M8-SPy was prepared which allowed the comparison with the (8S) stereoisomer.
At the beginning of this thesis only (8S)-M8-SPy was available and because the corre-
sponding (8S)-TmM8 tag soon showed satisfying results it was decided to carry out
the main body PCS analysis only with this tag. A more limited comparison of the two
stereoisomers is discussed later in this section.
3.2 Site directed mutation of human Carbonic Anhydrase II
In order to demonstrate the feasibility of structural analysis of a medium sized protein
ligand complex human Carbonic Anhydrase (EC 4.2.1.1.), hCA-II, was selected. This
protein has applications in the context of artificial metalloenzymes, where solution
structure information can be very useful. Up to now no solution state structure exists
of this protein. The reason for this seems to be the that the protein is very well char-
acterised by X-ray crystallography, up to the 9th of March 2016, in the RCSB protein
data bank5, 582 structures of hCA-II were reported, almost every structure solved by
X-ray diffraction. Only four structures were solved by neutron diffraction and for one
structure neutron diffraction in combination with solution state NMR was used. Here
the NMR information was used exclusively to characterise the protonation state of
thyrosine residues.72 Nevertheless solution state information of the protein structure
could still reveal some differences to the X-ray structure. Especially for artificial metal-
loenzymes where the enantioselective catalysis is carried out in solution, information
could be obtained that is not possible to determine by X-ray crystallography, e.g. when
dynamic processes are involved.
For the attachment of the LnM8-SPy tag to a protein only one single cysteine residue at
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the protein surface is necessary for the formation of a disulfide bond. Single cysteine
mutants of hCA-II were prepared successfully and it was shown, that the strategy of
replacing a serine at the edge of a secondary structure element on the protein surface
by cysteine, combined with a mutation of the native cysteine in the wild type protein
either to serine or alanine worked well. The total 10 different double mutants with
one single cysteine at different positions on the protein surface all showed reasonable
expression levels in a small scale protein expression. This illustrates the advantage of
a single point attachment of a paramagnetic tag over the strategy of using two point
anchoring to a double cysteine protein mutant.27 Because only one serine to cysteine
mutation is necessary, the possibility that this mutation affects the overall protein
structure is lower compared to two cysteine residue that have to be introduced at a
well defined distance to enable a two point anchoring. The restriction to only one
cysteine residue in the protein sequence avoids the possibility of the formation of
undesired disulfide bridges that would lead to misfolded protein.
It was, however, also possible to prepare double cysteine mutants of hCA-II where
additionally to the described two mutations a second cystein was introduced on the
protein surface, thus allowing the simultaneous attachment of two paramagnetic tags.
This type of construct has an application in EPR spectroscopy and is mentioned at
this place to illustrate another area of application for this protein that is accessible by
these cysteine mutations.
Uniformly 15N labelled protein was expressed successfully for all five protein mutants
for the set of C206S mutants. This set of mutants was selected because for bovine
carbonic anhydrase II, an isozyme with 81 % sequence similarity shows a serine at
position 206. Since both proteins catalyse the same reaction it is very likely that this
mutation does not affect the overall protein structure. Furthermore the later deter-
mined PCS suggested that this mutation did not affect the local protein structure
around residue 206 as well, because the PCS for these residues matched well to the
back calculated shifts based on the wild type X-ray structure. The expression was car-
ried out in minimal media with 15N ammonium chloride as the sole nitrogen source
and yielded 60 mg to 95 mg of protein per litre medium which was sufficient protein for
many NMR samples. For an average protein NMR sample with a final concentration
of 200µM, 2 mg of hCA-II was used.
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3.3 Tagging of human carbonic anhydrase II with LnM8-SPy
Tagging of hCA-II with LnM8-SPy complexes worked very well, independently of the
protein mutant, showing that all cysteine residues are accessible. With a threefold
excess of tag, the reaction was fast, after one hour already 70 % conversion was ob-
served in ESI-MS. The reaction runs under mild conditions at pH 6.80. Conversion
was higher than 98 %, based on the ESI-MS spectra as well as in the 1H-15N HSQC
spectra, where only traces of untagged protein were observable. The average yields of
the reaction were typically in the order 80 % with a range of 60 % to 90 %. Although
the exact protein concentration could not be determined during the tagging reaction
due to the excess of tag, whose UV absorption overlaps with the proteins, the protein
concentration is expected to stay constant during the tagging reaction, indicated by
constant absorption intensities observed during the reaction. It merely is expected
that protein is lost during the ultrafiltration steps, due to aggregation, because high
local concentrations can occur during centrifugation. hCA-II has been reported to be
prone to aggregation37. Either this was the case or the protein cannot be recovered
completely from the filter membrane. When the reaction was carried out at 4 ◦C over
night full labelling of the protein was achieved as well and no side-reactions were
observed. At lower pH down to 5.0 the reaction has been reported to proceed as well28.
Higher pH values have not been examined, but the reaction is expected to succeed at
physiological pH as well. It is even expected that with a moderate increase of the pH
the reaction could be accelerated along with the higher nucleophilicity of the thiol.
At a certain high value, finally, it is likely that the selectivity of the reaction will start
to drop, when other nucleophiles start attacking the tag. To summarise, the tagging
conditions presented will be applicable for a wide range of other proteins as well and
even are suitable for pH or temperature sensitive proteins.
The 1H-15N HSQC spectra of hCA-II tagged with TmM8-SPy showed large PCS for sev-
eral signals and for almost every peak a significant PCS were detected. Unfortunately,
for the S173C mutant at least two main sets of shifted signals were observed. The
peaks of the set with the larger intensity had broader linewidth, which was caused
either due to a dynamic process or by overlap with an additional set of signals. In
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the X-ray structure the residue 173 is located in a β-sheet at the edge of the binding
pocket of the protein, where the protein surface is more curved than for the other four
tagging sites. It is assumed that the tag can therefore adopt different positions on the
protein surface for residue 173 which leads to multiple sets of shifted signals. Because
of the large large number of signals which made the correct assignment of the PCS
much more difficult it has been decided not to assign this protein mutant, especially
because for the other four mutants satisfying PCS were observed.
3.4 Second minor species in HSQC spectra of LnM8-tagged protein
In 1H-15N HSQC spectra with a good signal to noise a small second set of shifted signals
was observable for the four TmM8 tagged protein mutants, this can be observed well
for residue 141 in figure 2.7 in section 2.9. These peaks were in the order of 10 % of
the main signal, except for the S220C mutant these have been slightly larger, with
intensities up to 15 % of the main species. This was found independently of the protein
sample for this mutant. For the majority of residues this second set was not observ-
able, most likely due to signal overlap with the main peak. This second species was
already observed for ubiquitin tagged with DyM8-SPy28 where the relative intensity
was reported to be in the order of 15 % to 20 %. Similar intensities have been observed
for DyM8 tagged hCA-II. The second set of signals has to be caused due to a different
orientation of the tag on the surface of the protein. It was speculated that this is caused
by cis-trans isomerisation of the amide bond in the linker of the tag, but this would not
explain why different intensities for the second species are observed for the DyM8-SPy
tagged protein compared to the protein tagged with TmM8-SPy. Another possibility
would be the interconversion of the coordination polyhedron around the metal center
from a twisted square anti prism (∆ conformation) to a square anti prism (Λ confor-
mation). If this is the case then it will be in accordance to the observation from HPLC
where after the complexation of M8-SPy with a lanthanide metal two fraction with
the same mass in ESI-MS were separated. The ratio between these fractions depends
on the lanthanide metal and can be explained by by the lanthanide contraction, the
reduction in the ionic radius of the lanthanides with increasing atomic number. This
could explain the observed intensities between the major and the minor species in
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the 1H-15N HSQC of the tagged protein because the same trend observed in the HPLC
for Dy and Tm could be observed. For Dy a ratio between the first and the second
fraction of 6:4 was observed and for Tm 1:19. When the two separated fractions of the
tag were attached to a protein for both samples exactly the same HSQC spectra was
obtained57 this would be in accordance with a slow equilibrium between the ∆ and
the Λ conformation. Additionally this could explain the intensity difference between
the S220C mutant and the other three that were observed because this equilibrium
can be affected by interactions between the tag and the protein surface leading to a
increase of the second species for this mutant. The same observations are described
as well in a recent publication.41
Because the second species was smaller for the TmM8 tagged protein than for DyM8
and the observed PCS were comparable in size, and to restrict the number of samples
that had to be prepared and analysed it has been decided to carry out the PCS assign-
ment and all subsequent experiment only for the TmM8 tagged protein. For TmM8 it
would also be possible to detect PCS of residues closer to the tagging site. These would
not be observable for Dy because of the larger number of unpaired electrons and
therefore higher PRE which broadens the signals of residues close to the tag beyond
the limit of detection.
3.5 Comparison of (4R,4S)-LnM8-SPy with (8S)-LnM8-SPy
At the beginning of this thesis only (8S)-M8-SPy was available, therefore all initial
experiments were carried out with this stereoisomer and when reasonable PCS were
observed for this tag it was decided to carry out all experiments using this stereoiso-
mer. Later, when the (4R,4S)-M8-SPy stereoisomer was prepared by Dr. Roché M.
Walliser it was possible to directly compare the two seteroisomers. In contrast to
the (8S)-LnM8-SPy complexes where two fractions were observed in the HPLC, for
the (4R,4S)-LnM8-SPy complexes only one fraction was observed. When the 4R,4S
complexes of Dy and Tm were attached to hCA-II there as well only one shifted set of
signals was observed (see figure 2.18).
It could be shown that the ∆χ tensor for the (8S)-TmM8 tagged S50C mutant was
orientated differently than for the (4R,4S)-TmM8 tagged mutant. In the case of Dy
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the differences in the orientation between the two stereoisomers were smaller. In the
HPLC for the (8S)-DyM8-SPy the earlier fraction was more intensive than the later one
and for (8S)-TmM8-SPy it was the other way round. For (4R,4S)-LuM8-SPy a twisted
square anti prism (Λ) was observed28 If all these observations are combined then it
would be possible to assume that for (8S)-DyM8-SPy mainly the Λ conformation is
observed where for (8S)-TmM8-SPy the equilibrium lies on the side ∆ conformation.
When the size of the tensor is compared as listed in table 2.10 in section 2.11.5 the ten-
sors for the 4R,4S stereoisomer are larger than these of the corresponding 8S isomers.
Such a comparison is appropriate because for all four tensors PCS for the same set
of residues were used. All residues that could be influenced by the attachment of tag
were excluded from the tensor determination and therefore the possible difference
between the (4R,4S)-LuM8 tagged protein compared to the (8S)-LuM8 tagged sample
could be neglected as well. Only a small set of 44 leucine PCS was used but because
for the (8S)-TmM8 very similar tensor parameters were obtained for this small set of
PCS as for the full set of PCS, the same should be true for the other three constructs
where no detailed PCS assignment was carried out. The reason for the different size of
the tensors between the two different stereoisomers of the tag, has to be most likely
that the 4R,4S tag is more rigidly attached to the protein and therefore the tensor is
less affected by motional averaging. The tensor parameters for Dy are smaller than
the corresponding Tm tensor, this is opposed to the literature58 where a larger tensor
for Dy than for Tm is expected. What is consistent is, that the Dy and Tm tensor have
the opposite sign and therefore most PCS in a comparable sample are shifted in the
opposite direction. About the reasons for the smaller Dy tensor, one can only specu-
late. Probably the difference in the ionic radius could have an influence in such a way
that the whole tag has more motional freedom with respect to the protein, leading
to an averaging of of the tensor parameters. Or it could be a direct influence of the
differences in the coordination polyhedron on the molecular magnetism.73 Due to
the different ionic radii between the different lanthanides, a slight difference in the
coordination polyhedron for the different M8 complexes can be expected and similar
to the influence of the molecular magnetism, the anisotropy of the χ-tensor could
be affected as well. The tensor values presented in the literature for the different
lanthanide metals that expect a larger tensors for Dy than for Tm, are determined
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for lanthanide metals bound to a metal binding site of the same protein.23 As the
coordination polyhedron in this protein can be different to the LnM8 complexes, these
values not necessarily have to be valid for both systems in the same extend.
3.6 Strategy for PCS assignment
As already discussed above the detailed PCS analysis was carried out using only TmM8-
SPy and the four protein mutants S50C, S166C, S217C and S220C. PCS assignment in
the uniform 15N labelled protein sample turned out to to be a non trivial task. In the
present case of hCA-II a backbone assignment of the residues was available48 and and
this assignment could be transferred for most of the residues. But this assignment
was carried out based on the wild type protein and in our case the protein used was a
double mutant, this leads at least in the regions of the mutations to uncertainties of
the transferred assignment due to changes in the chemical shift of the neighbouring
residues. Additionally for hCA-II so far no solution structure of the protein is available.
The protein is well characterised by X-ray crystallography, nevertheless, there could
be differences between the crystal structure and the structure in solution. Although
it was possible to assign PCS in less crowded regions of the spectra to determine an
initial tensor based on which the expected PCS can be back calculated based on the
X-ray structure, for the assignment of further PCS, this direct approach bears several
insecurities. Either wrongly assigned PCS, wrongly assigned residues in the diamag-
netic spectra or differences between the effective structure in solution and the x-ray
structure can be responsible for a wrong initial tensor that is determined. If based on
this deviant tensor further PCS are assigned this can lead in the worst case to a self
consistent but wrong solution. Usually at a certain point the discrepancies between
the deviant tensor and the recorded spectra that is assigned should become obvious,
when it is getting more and more difficult to assign further PCS. Nevertheless this can
cost a lot of time, and therefore it would be much easier to start with a smaller set
of shifts that have to be assigned, where the assignment of the residues in the dia-
magnetic spectra are unambiguous and if there were ambiguities in the paramagnetic
spectra at least the number of possibilities is limited. Amino acid selective 15N labelled
protein would fulfil all these requirements. In order to exclude any wrong assignments
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of the diamagnetic protein samples it was decided to assign the backbone residues for
on of the four mutants.
3.6.1 Selective 15N leucine labelled hCA-II
In hCA-II the most abundant residue is leucine, which is found 26 times in the whole
protein. Selective 15N leucine labelled protein was expressed successfully for all five
protein mutants that were already expressed uniformly 15N labelled. The expression
was carried out again in minimal media where instead of ammonium chloride a mix-
ture of all amino acids with natural abundance of the nitrogen was added with the
exception of leucine. This amino acid was added to the media 15N labelled at the time
of induction in order to keep possible isotope scrambling at a minimal level. The
yields were with 140 mg to 230 mg per litre of media more than two times as high as
for the uniform 15N labelled protein. It is expected that the use of an amino acid mix-
ture instead of only ammonium chloride supports the production of protein in E.coli
because the amino acids do not have to be prepared trough biosynthetic pathways.
3.6.2 Triply labelled hCA-II for backbone assignment
In order to confirm the assignment of the diamagnetic 1H-15N HSQC spectra is was
decided to assign the protein backbone for one mutant. Therefore uniform 2H, 15N
and 13C labelled protein of the hCA-II_S50C_C206S mutant was prepared. Because
expression in shaking flasks yielded only around 30 mg/L which was less protein than
expected the expression was carried out in an 2 L fermenter. This allowed to minimize
the amount of deuterated 13C glucose and resulted in better yields. From one litre
medium 84 mg triplely labelled protein was obtained. The deuteration level deter-
mined by ESI-MS was 85 %.
Refolding of triply labelled protein for reintroduction of exchangeable protons turned
out to be difficult. Based on published conditions49 a protocol was developed that
allowed the recovery of up to 50 % of protein after denaturation and refolding. Opti-
mization of this protocol was carried out with 2 mg to 5 mg of protein. Unfortunately
when these conditions were applied to 17 mg of triple labelled protein the method
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yielded only 20 % of refolded protein. Probably the protein is sensitive towards higher
concentration. Higher concentrations could trigger aggregation and hCA-II is known
to be prone to aggregation.37 Despite the low yield of the refolding, the experiment
revealed that only for 26 residues out of 193 well separated signals in the 1H-15N HSQC
the signal intensity increased significantly after refolding. Showing that for 87 % of
the residues the exchangable deuterons have been replaced by protons already when
the protein was dissolved in protonated buffer. Therefore backbone assignment was
carried out with a 460µM sample of triply labelled hCA-II_S50C_C206S that was not re-
folded. Here again the yields were with 67 % below the average for the tagging reaction
which could have a relationship with the higher concentration of the protein for this
sample than for most of the other samples. In the 1H-15N HSQC spectra of this sample
for the residues where the signal intensity increased after refolding a small signal was
observable due to the incomplete deuteration of the protein. The intensity of these
signals remained low due to the slow exchange rate of the deuterons with protons.
Nevertheless, it was possible to assignment several of these signals. In total 90 % of the
protein backbone could be assigned. Only the N-terminal residues up to residue 20
were not assigned, as well as residues H64, I91, P155, G156, T199, T200, P201. For the
N-terminal residues some sequential assignment were possible, but an unambiguous
assignment of these residues was not possible. Additionally for some of these residues
a broader linewidth was observed, or the signals showed a typical splitting in two
peaks due to cis-trans isomerisation of a proline amide bond. Both are indication of
a dynamic structure of the protein in this region and shows that for these residues a
deviation from the X-ray structure is very likely. This would make the assignment of
PCS for these residues more challenging and these PCS could be a source of errors
if they are included in the tensor determination. Therefore no further efforts were
made for the assignment of these residues. Of the remaining unassigned residues
the prolines were unimportant, because they have no resonance in the 1H-15N HSQC
spectra. Residue 64 and 91 are both located in the catalytic pocket of the protein and
residues next to them have low signal intensity, most likely due to a dynamic process.
Therefore, correlations for the sequential assignments were not observable as well.
L198 could only be assigned because this was the last leucine residue that could not be
assigned and the leucine residues were known from the selective 15N labelled protein
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sample. L198 has a low signal intensity due to broad lines. It is located as well in the
catalytic pocket of the protein and could be affected as well by dynamic processes in
this region. Anyhow, because of the low signal intensities no sequential assignment of
the neighbouring T199 was possible. Later residue T200 could be assigned form PCS
alone because all PCS determined for for the four protein mutants matched well to the
predicted shifts. Regardless assignment of residue 199 was not possible even from this
side, therefore it is assumed that the corresponding peak for this residue is affected
by similar processes as observed for residue 198 preventing a sequential assignment.
The comparison with possible PCS helped also in other cases to unravel ambiguities
of the assignment. This illustrates the potential of PCS to support the assignment of
proteins. Residue 156 could not be assigned because this residue is next to a proline
and from the following leucine no distinct correlation could be found. Here also no
peak could be identified from the PCS probably, because this residue is is located in a
crowded region of the 1H-15N HSQC.
The assignments of the other mutants using the assignments of the S50C mutant was
straight forward apart from the regions around the individual Ser→Cys mutation site.
There the residues where the chemical shifts have changed had to be assigned tenta-
tively. For the region around S50 for the other three mutants than S50C, the assignment
could again be confirmed from the corresponding PCS. This was not possible for the
region around the cysteine in the corresponding mutant, because there the PCS either
were not observable for most residues due to PRE or differences in the local structure
of this mutant around the cysteine made the predicted PCS inaccurate. The region
around the cysteine is anyway not important for the later structure determination
from PCS because to cover for the local structural changes caused by the mutation
and the tagging of the cysteine an individual structure would have to be determined
for each tagged protein mutant, which is not practical at all. Therefore, the proper
approach is anyway to exclude those PCS from structure determination, if differences
can be expected due to the mutation and the tagging.
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3.6.3 PCS assignment and tensor refinement
Having selective 15N leucine labelled protein and a backbone assignment of almost
the whole protein in hand, assignment of the PCS in the uniformly 15N labelled protein
turned out to be straight forward. The PCS in the 15N leucine labelled protein samples
could be assigned unambiguously and an initial tensor was determined. This tensor
allowed the prediction and the successive assignment of the PCS in the uniformly 15N
labelled samples. The detailed procedure is described in section 2.9. A very large num-
ber of PCS for each mutant in the order of 197 to 208 residues could be assigned. In
total more tha 1600 PCS. For several PCS a deviation exceeding 0.2 ppm was observed,
indicating differences between the X-ray structure and the structure in solution. Crite-
ria were defined for the exclusion of PCS from the final tensor calculation as described
in section 2.11 To estimate the effect of the refinement three different subsets of PCS
were determined with a smaller cut off for the maximum allowed PCS deviation for
each subset. It could be shown that the main effect on the determined tensor parame-
ters was achieved by the exclusion of those residues who showed the largest chemical
shift perturbations upon tagging of the protein. The further refinement then only had
small influence on the determined tensor parameters. For the smallest subset of PCS
still at least 364 PCS (for 1H and 15N) for every mutant and for S166C even 394 PCS,
in total almost 1500 PCS restraints, showed a smaller deviation than 0.1 ppm to the
predicted PCS. Figure 3.1 shows the high coverage of the PCS for the different residues,
comparable samples in the literature with up to four different tagging sites do not
reach comparable numbers of PCS or comparable numbers of PCS per residue.30,54,74
The assigned PCS prove a close agreement between the structure in solution and the
crystal structure otherwise such high numbers of PCS with such a small deviation
would not be possible. It should be possible to determine a PCS based solution state
structure of hCA-II using this set of data, even if it is very likely that a structure almost
identical to the X-ray structure would be obtained. Especially for future testing and
validation of algorithms for structure determination or protein assignment which
include PCS, such as Xplor-NIH75 or GPS-Rosetta30 or PARAssign76 this data set bears
great potential. The utility of the PCS for the shift assignment was additionally demon-
strated by the unambiguous assignment of the side-chain NH resonances of arginine
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20 30 40 50 60
| | | | |
PEHWHKDFP I AKGERQSPVD I DTHTAKYDPS LKPL SVSYDQATS LR I LNN
S50C - - - - - - - - - - - • • • • • ◦ - • ◦ • • • - • • • • • - • • • - - - - - - - - - • • • • • ◦ • •
S166C - - - - - - - - - - • • • • • • • - • • • • • • • • • • • - • • • - • • • • • • • • • • • - • • - •
S217C - - - - - - - - - • • • • • • • • - • • • • • • • • • • • - • • • - • • • • • • • • • • • • • • - -
S220C - - - - - - - - - • • - • • • • • - • • • • • • • • • • • - • • • - • • • • • • • • • • • ◦ • • • •
70 80 90 100 110
| | | | |
GHAFNVEFDDSQDKAVLKGGPLDGTYRL I QFHFHWGS LDGQGSEHTVDKK
S50C • - - • • • • • - - • - - - - - - - - - - - • • - - - • - • • • - ◦ • • • • • • • • • ◦ • • • • • •
S166C • - • • • • • • • • • • ◦ • • • ◦ • • • - • • • • • • • - • • • • • • • • • • • • • • • • • • • • •
S217C • - - • • - • • • • • • • • • • • • • • - • • • • • • • - • - • • • • • • • - • • • • • • • - - - -
S220C • - - • • • • • • • • • • • • • • • • • - • • • • • • • - • • • • - • - - - - - - - • • • • • • • •
120 130 140 150 160
| | | | |
KYAAELHLVHWNTKYGDFGKAVQQPDGLAVLG I FLKVGSAKPGLQKVVDV
S50C • • • • • • ◦ • • • • • • • ◦ • • • • • • ◦ • • - • • • • • • • • • • • • • • • • - - • • • • • • •
S166C • • • • • • • • • • • • • • • • • • • • • • • • - • • • • • • • • • • • • • • • • - - • • • - - - -
S217C - - - - • • • • • • • • • • • • • • • • • • • • - • • • • • • • • - - - - - - - - - - - • • - • • •
S220C • - - - • • • • • • • • • • • • • • • • • • • • - • • • • • • • • • - - - - - - - - - - • • • - • •
170 180 190 200 210
| | | | |
LDS I KTKGKSADFTNFDPRGLLPE S LDYWTYPGS LTTPPLLECVTWI VLK
S50C • • • • • • • • • • • • • • • • • - • • • • - • • - - • • • • - • ◦ - - - - - ◦ • • • • • • • • • •
S166C - - - - - • •  - - - - - - • • • - • • • • - • • • • • • • • - • ◦ • - • - - • • • - • • • • • • •
S217C • • • • • • • • • • • • • • • • • - • • • • - - - • - - • • • - • • • - • - - • • • • • • • • • • -
S220C • • • • • • • • • • • • • • • • • - • • • • - • • • • - • • • - • ◦ • - • - - • • • • • • • • • • •
220 230 240 250 260
| | | | |
EP I SVS SEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQ I KAS FK
S50C • - • • • • • • • • • • • • • • • • • • • • • - • • • • • • • • • - • • - • • • • • • • • • • •
S166C • - • • • • • • • • • • • • • • • • • • • ◦ • - • • • • • • • • • - • • - • • • • • • • • • • •
S217C - - - - - - - - • - • • • • • • • • • • • • • - • • • • • • • • - - • • - • • • • • • • • • • •
S220C • - • - - - - - - - - - - - - - • • • • • • • - • • • • • • • • • - • • - • • • • • • • • • • •
1
Figure 3.1: Summary for the different protein mutants of the PCS that showed a smaller
deviation than 0.1 ppm to the predicted value. Black circles represent residues where
both 1H- and 15N-PCS were available, for white circles only the 15N-PCS and for white
diamonds only the 1H-PCS was available.
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and tryptophan residues as described in section 2.15
An error analysis for the tensor parameters, following published procedures,18 was
performed. Two different random inputs were compared for the Monte-Carlo error
analysis. The selection of random subsets of only 20 % of the PCS showed the very
good consistency of the whole PCS set. With this method comparable uncertainties
were detemined as for the introduction random structural noise of 0.5 Å to the atomic
position in the X-ray structure, leading to an average displacement of each atom by
0.8 Å.
3.7 19F PCS of hCA-II inhibitor complexes
Protein ligand complexes with the fluorinated sulfonamide inhibitor, F2-Inh as well as
with the F2-Complex (see figure 2.19) were prepared successfully. Excess of inhibitor
could be removed by ultrafiltration without removing any of the inhibitor bound to
the protein, illustrating the extremely high affinity that is reported for such type of
inhibitors.37 19F spectra of the protein inhibitor complex show fluorine signals with
linewidth in the order of 60 Hz showing that the inhibitor binds tightly to the protein
and therefore shares the same rotational correlation time explaining the broad signals.
For the F2-complex pH dependent solubility was observed. This complex was only
well soluble at low pH. This effect was observed in aqueous solution as well as in
DMSO. Once bound to the protein the protein inhibitor complex remained soluble
even at pH 6.8 where the ligand complex alone would have precipitated quantitatively
as shown by 19F NMR. Because all protein NMR spectra have been recorded at pH
6.8 and the protein inhibitor complex of F2-complex remained soluble at this pH all
NMR experiments of this construct were carried out at this pH as well, in order to
be able to apply the already determined data to this sample. Nevertheless a closer
examination of the influence of the pH could reveal valuable information especially
because such protein inhibitor complexes are successfully applied for enantioselective
catalysis of [add ref.]. The fluorine spectra of F2-Complex show that even when bound
to the protein the aromatic ring with the two flourines has to be able to rotate freely,
because only one fluorine signal was observable for this compound. 19F PCS for both
protein inhibitor complexes have been recorded by one dimensional 19F spectroscopy
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profiting of the high sensitivity of the 19F nuclei and no solvent suppression is required.
3.8 1H-19F HOESY experiments for additional PCS restraints
In order illustrate the possibility to expand the number of PCS that could be deter-
mined from such a sample a 1H-19F HOESY spectra of the protein inhibitor complex
of hCA-II with F2-Inh was determined. Due to the 19F detection this experiment does
not requires any water suppression. The basic idea of this experiment is to determine
19F-proton distance information. But because most likely heteronuclear Overhauser
effect (HOE) contacts that are are expected for such a sample are either intramolecu-
lar contacts to the proton of the inhibitor or interactions between the fluorine and
sidechain protons of the protein. For side-chain protons in most cases no assignment
is available, or most likely is not unambiguous when only the proton frequency is
determined. On this basis the idea was developed to determine PCS for these HOE
contacts. This would give access to structural information without the requirement of
an assignment of protein side-chain protons. Further more even PCS of intramolec-
ular HOE contacts deliver valuable information, because the more restraint for the
inhibitor are available the higher the precision of the structure determination.
The major drawback of this experiment has been found to be the low sensitivity of the
HOESY type experiment. For a one dimensional 19F experiment of this complex on a
spectrometer equipped with a cryo probehead after 6 min of experiment time already
a good signal to noise was obtained, where for a 1H-19F HOESY experiment times in
the order of 96 h were required for the same sample. The best way to circumvent this
would be by increasing the sample concentration. The sample concentration in this
case was rather low with 200µM. In order to achieve a sufficient resolution in the
indirect 1H dimension it was decided to record the spectra with reduced sweep width
instead of increasing the number of points, because only few signals were expected to
be observable. Signals outside of the spectral window were therefore observed at the
corresponding aliased frequency in the spectra. On the determined PCS this had no
unfavourable influence, because the determined shift difference remains the same
whether a peak is aliased or not. Rather precise PCS can be determined the higher the
resolution of the spectra. For the unlikely case that two peaks would overlap due to
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the aliasing, a second experiment with a different sweep width was recorded to reveal
possible peak overlap, as much as it allowed to determine the original shift of the
aliased signals. It has to be mentioned that at the time when the HOESY experiments
were recorded, the samples used were already more than two years old, and for two
samples including the diamagnetic reference significant amount of decomposition of
protein was observable. Additionally over this period of time the pH was found to be
not as constant as this has been observed for a period of several months. Apparently
these were the reasons why of the four sets of PCS only two delivered reasonable shifts
that could be used for a structure determination, as discussed later in this section.
Therefore the later PCS structure determination was only performed in order to illus-
trate the potential of this method. For the determination of quantitative data for the
structure determination it is recommended to use a different data set.
Theoretically it would be more beneficial to record the HOESY experiment proton de-
tected, because in this case the proton signals are determined with high resolution in
the direct dimension and increments in the indirect dimension would only be required
as much as necessary for a minimal resolution between the different flourine signals
if there are multiple fluorines present at all. Unfortunately for the proton detected
HOESY when tested on small molecules much lower sensitivity was observed than for
the fluorine detected experiment. It is speculated that the reason for this could be the
higher T1 time for the fluorine than for the proton allowing the magnetisation transfer
in one direction but not in the other.
3.9 19F position determination from PCS
The fluorine position based on the PCS were determined using the X-ray structure
and the four different ∆χ-tensors of the corresponding protein mutant. The PCS as-
signment of the protein mutants has already shown that the solution structure has
to be very close to the X-ray structure therefore the position of the inhibitor can be
determined based on the same structure, as it should match equally well as the experi-
mental PCS, provided the protein structure is not affected by the inhibitor binding.
That this was not the case could be concluded from the 1H-15N HSQC spectra before
and after the inhibitor binding. No changes in the chemical shifts have been observed
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nor differences in the PCS, that would accompany a larger change in the protein
structure. Only chemical shift changes for the residues in the binding pocket that
are expected upon ligand binding, were observed. In the case of the S50C mutant
additionally determined RDC did not indicate a major change in the protein struc-
ture as well. This would have been very unlikely because for all X-ray structures of
hCA-II-inhibitor complexes the basic protein structure is retained. The F2-Inh was
selected as model compound, because a X-ray structure of the corresponding protein
inhibitor complex was already available59. During the course of this thesis a X-ray
structure of the complex without the two fluorines corresponding to the F2-complex
was published.36 This allows to bring the determined fluorine position in relation with
a position obtained by a different method for both protein-inhibitor complexes.
For the F2-Inh the position determined for the two fluorines from their PCS deviated
by as much as 8 Å form the X-ray structure. In contrast the F-F distance between the
fluorine in ortho and the fluorine in meta position could be determined very precisely
based on the PCS alone. This situation could be explained by a systematic error on
the 19F PCS which has a comparable magnitude for both PCS. A reasonable candidate
that could not be taken into account in the presented structure determination were
RACS. These small chemical shifts depend on the orientation of a nuclei with respect
to the magnetic susceptibility tensor. When the orientation of a nucleus as well as
the corresponding ∆χ-tensor are known, RACS can be predicted for a certain type of
nuclei, based on the corresponding CSA. For 15N the possible RACS are already in a
range that could be responsible for the deviation in the PCS position from the X-ray
structure. The influence of the RACS on the PCS tensor for 15N was already taken
into account during the earlier tensor determination. The RACS depend on the CSA
and within a rough approximation the maximum CSA depends on the chemical shift
range of the nucleus.77 For aromatic fluorines reported values for the CSA are in a
comparable order of magnitude64,65 than for 15N.19 From this it follows that for the
RACS of fluorine at least similar values than for 15N can be expected but arguing with
the larger chemical shift range for 19F compared to 15N, even much larger RACS are
possible.
To compensate for the influence of the RACS these have to be determined experi-
mentally, because for the prediction of the RACS from from tensor parameters and
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a given CSA previous knowledge of the orientation of the nuclei is required, which
is not available if the position is determined from PCS alone. A possibility for the
experimental determination of the RACS would be, using the field dependence of the
RACS which is quadratic with respect to the magnetic field, compare to equation 1.3.
For PCS no field dependence is expected from equation 2.3 and indeed when the field
dependence of the PCS has been investigated the only field dependent term that has
been found was equivalent to the RACS contribution.78 Therefore determination of
the PCS at different magnetic field strength should allow the order of magnitude of the
RACS This experiment has not been carried out so far due to the lowered sensitivity at
smaller magnetic fields and limited time during the course of this thesis, and because
for accessible NMR spectrometer at higher magnetic field strength the hardware for
the determination of fluorine chemical shift was not available.
Another possibility to circumvent the influence of the RACS would be to determine
the PCS only for protons, where the influence of the RACS can be neglected.20 As
demonstrated, the 1H-19F HOESY experiment could deliver exactly such PCS for the
neighbouring protons to the fluorine. And indeed the calculated proton position
from their PCS from the HOESY experiment indicate a much smaller deviation to the
X-ray structure as for the fluorines. This interpretation was taken with care, because
the sample conditions were not completely comparable any more, for the HOESY
experiments.
For the second inhibitor, the F2-Complex, two different minima were found during
the fluorine structure determination. One of them was significant closer to the ex-
pected fluorine position. For the S217C mutant a PCS of almost 0 ppm was observed.
Consequently the fluorine position had to be in the node-plane of this tensor. Unfor-
tunately in this region the tensor has the largest gradient and the position is less well
defined than for larger PCS. Already a difference in the PCS of −0.05 ppm would have
exclusively delivered the position closer to the tag. This is difference again lies in the
same order of magnitude that was observed for the F2-Inh. That in this case a position
closer to the expected position in the X-ray structure was obtained can be explained
by the higher motional freedom that is observed for the fluorine atoms. Even when the
F2-complex is bound to the protein only one fluorine signal is observed, indicating
that the phenyl ring with the two fluorine atoms can rotate freely. This rotation would
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also average the CSA contribution perpendicular to the rotation axis thereby reducing
the size of the RACS. Still the contribution alongside the rotation axis could still be
responsible for the observed differences observed in the case of the S217C mutant.
As an indirect proof of the RACS being the source of error, it was tried to determine
the amide proton and nitrogen position of ten selected residues based on their PCS.
Tensor parameters were redetermined where these ten residue have additionally been
excluded. Because the position of these residues was known from the X-ray structure
it was possible to calculate the expected RACS. The position of these 20 nuclei was
determined twice, one time using the experimental PCS and another time using the
effective PCS where the determined RACS were used to correct the experimental PCS.
The calculated RACS for the protons were as expected much smaller than for nitrogen.
Therefore it was expected that the RACS correction should have a positive influence on
the nitrogen position and an negligible effect on the proton position. Unfortunately no
effect of the RACS correction was observed. It is likely that the prediction of the RACS is
not as precise as necessary. It is reported that RACS used for structural restraints show
large errors in the order of 10 % to 20 %.67 The same would be true for their prediction.
Nevertheless this validation showed two different findings: First, the average position
for the protons was twice as close to the X-ray structure than for nitrogen and lied
within the determined uncertainty. Probably due to the lower precision of the nitrogen
chemical shift in the 1H-15N HSQC spectra. Second, the two residues with the largest
deviation from the X-ray structure showed the smallest average PCS and the largest
average distance to the four different lanthanide tags. This illustrates that the larger a
PCS, the preciser its structural information.
In general an uncertainty for the proton position of 1 Å to 2 Å might look only moderate
for high resolution spectroscopy, but in this case only the positions of single indepen-
dent atoms were determined. It has to be emphasized, that when PCS from multiple
tagging sites are used, such a precision of the proton position can be obtained almost
throughout the entire protein. So PCS from four different tagging sites may not deliver
positions with atomic resolution, but if these restraints are used in combination with
other restraints for the overall protein structure determination they demonstrate their
outstanding value.54 Especially regarding to the relatively small effort for their assign-
ment compared for example to the clearly much more demanding determination of a
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sufficient number of NOE restraints for protein structure determination.
Finally it has to be added that the uncertainties of the tensor parameters were deter-
mined conservatively, because the focus was laid on the general use of the presented
methods, especially when only an X-ray structure of the protein is available. So the
determined uncertainties should clearly be considered as an upper limit. Furthermore,
with regard to the possibility that the overall agreement of the determined PCS should
further improve if a solution state structure is determined and consequently a better
accuracy and higher precision are very likely, even for the position of single atoms.
Eventually, the data presented has been determined using only (8S)-TmM8-SPy, repre-
senting only one of twelve possible lanthanide metals. Each of the remaining lantanide
metals can deliver additional PCS restraints. Furthermore, the comparison with the
(4R,4S)-LnM8-SPy complexes has proven an equal or even higher potential for PCS
NMR spectroscopy, thus doubling the number of PCS restraints that can easily be ob-
tained using the same four protein mutants, once the basic system is well characterised
as in the described case.
3.10 RDC of S50C mutant
The determined RDC for the S50C mutant show good agreement between the deter-
mined PCS and RDC tensors. As expected a smaller agreement between experimental
and predicted RDC is found, reflected in the lager Q-factors of 0.48 and 0.31 of the
full set and the optimized set of RDC respectively. This is caused due to the higher
sensitivity of RDC towards local mobility, especially because an X-ray structure was
used for the prediction of the RDC and the dynamic regions are usually frozen within
one of several possible conformations. This would explain the large deviations that
have been observed for several residues. Due to their sensitivity towards motion of the
RDC usually a smaller tensor is obtained from RDC than from PCS. But this is not the
case in the present sample. This would either indicate a very rigid attachment of the
lanthanide metal or this is an artefact observed due to the use of an X-ray structure
for the determination of the RDC tensor. This could best be differentiated by the
determination of a solution state structure of the protein.

CHAPTER 4
Conclusion and Outlook
In the course of this thesis LnM8-SPy complexes were successfully applied for PCS
NMR spectroscopy of the medium sized human carbonic anhydrase II (hCA-II). Point
mutation of the protein sequence allowed the specific attachment of the paramagnetic
tag to five different sites of the protein. Four of these protein mutants showed large
and very useful PCS demonstrating the good practicability of the selection criteria for
the mutation sites. For one protein mutant 90 % of the protein backbone was assigned
in order to ensure the correct assignment of the large number of resonances in the
1H-15N HSQC spectra of the uniformly 15N labelled protein tagged with diamagnetic
LuM8-SPy. A very useful strategy for the PCS assignment was presented. Based on
the PCS assigned in selective 15N leucine labelled protein initial ∆χ-tensor parameters
were determined. These allowed the successive assignment of the PCS in the uniformly
15N labelled protein. For every mutant PCS for more than 80 % of the residues in the
protein were assigned. Overall more than 1600 PCS (1H and 15N) were assigned for the
four different mutants. Systematic exclusion of PCS in the neighbourhood of the tag
and in flexible parts of the protein allowed to determine a subset of PCS with less than
0.1 ppm deviation between experimentally determined PCS and predicted PCS. This
allowed to determine precise ∆χ-tensor parameters based on the X-ray structure. This
subset of PCS still consisted of almost 1500 PCS. This showed an excellent agreement
between the protein structure in solution and X-ray structure. The determined PCS
should be more than sufficient to determine a low resolution solution state structure
of the protein using only PCS as experimentally determined restraints. This would
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be the first published solution sate structure of hCA-II. For a protein where such an
approach has been demonstrated a far lower number of PCS has been assigned.30 This
set of PCS will provide as well very valuable data for future testing and validation of
algorithms that use PCS for structure determination or for protein assignment.
In this study the first example was presented where the fluorine position of fluo-
rinated ligands in complex with a protein were determined alone on the PCS derived
from one-dimensional 19F-NMR spectra. For the ligand with two fluorine atoms the
fluorine-fluorine distance was reproduced very precisely by the 19F-PCS but for the
position of the two fluorines in the protein a deviation of 8 Å to the X-ray structure
was observed. The most likely reason for this systematic error was assumed to be
residual anisotropic chemical shift (RACS) that could not be taken into account in the
structure calculation. This was supported by the second fluorinated ligand, where
a smaller deviation to the X-ray structure was observed. The fluorine atoms for this
ligand showed higher motional freedom and therefore a reduction of the RACS effect is
very likely. To prove this assumption the following future experiments are suggested:
• A 15N edited 1H-19F HOESY experiment should allow to unambiguously iden-
tify any NH group in the neighbourhood of the fluorine atoms. Thus allowing
to confirm the equivalence between X-ray structure and protein structure in
solution.
• The magnetic field dependence of the RACS should allow to determine the order
of magnitude of this effect by determination of the PCS at different field strength.
This will allow to correct the determined PCS and to determine a position with
higher accuracy, if the systematic error is caused by RACS.
• A ligand containing a CF3-group should show smaller influence of the RACS due
to the free rotation of the CF3-group. Therefore a higher accuracy of the position
determined from PCS is expected.
• A repetition of the 1H-19F HOESY experiments with new protein samples should
confirm the demonstrated principle of determining 1H-PCS that have a higher
accuracy due to the negligible effect of the RACS on the protons.
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Once the different tensors are determined the method presented offers quick access
to structural information for any kind of fluorine containing inhibitor. This can be
used as a general method, provided the overall protein fold is not affected upon
binding. For certain protein inhibitor complexes even a deviation of 8 Å could still
give valuable information, such as identifying a binding site. In general, detailed
3D structural data can be obtained using only uniform 15N labelled protein with
four different tagging sites and a corresponding X-ray structure. Such information
would be very demanding to acquire with a different method, e.g. complete side
chain assignment of the protein and NOE analysis. Especially for high throughput
screening in pharmaceutical industry, this approach would be well suited. Fluorinated
pharmacological compounds have been a largely growing field in the last decades,
because the introduction of fluorines at specific positions a molecule allows the fine
tuning of the pharmacological properties of promising drug candidates.38,79 And finally
if more detailed structural information is desired, with 1H-19F HOESY spectra 1H PCS
of the ligands are available allowing to determine PCS that are less affected by RACS
and therefore deliver accurate structural information.

CHAPTER 5
Experimental
5.1 Materials and methods
5.1.1 Reagents
All commercial reagents used were of the highest grade available. The quality of the
solvents for reactions corresponds to "puriss" or even higher in the case of small
scale reactions. For aqueous solutions ultrapure water was used, if not mentioned
otherwise. M4-cyclen (1) was a gift from Dr. R. A. Byrd (National Cancer Institute,
Frederick, USA) and 2-(pyridyldithio)-ethylamine hydrochloride (7) was synthesised
according to published procedures.80
5.1.2 Methods and Devices
Standard methods like primer design, deoxyribonucleic acid (DNA) extraction and
purification, gel electrophoresis, protein affinity chromatography and spectroscopic
quantification of cell growth were carried out according to published protocols with
minor adjustments (when necessary). Commercial kits such as Pd10 ion exchange
columns, Sep pak C18 collumns, Amicon ultrafiltration tubes were used according to
manufacturer instructions.
NMR spectroscopy: All NMR spectra were recorded either on a Bruker Avance III
NMR spectrometer operating at 600.13 MHz, equipped with a 5 mm BBFO+ probe
head with z-axis pulsed field gradients or a 5 mm 1H/13C/15N TXI probe head with
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z-axis pulsed field gradients, or on a Bruker Avance III HD spectrometer operating at
600.13 MHz, equipped with a 5 mm 1H/19F-13C/15N-D QCI cryo probe head with z-axis
pulsed field gradients. Experiments for the determination of RDC were performed on
a Bruker Avance III HD spectrometer operating at 900.18 MHz, equipped with a 5 mm
1H-13C/15N-D TCI cryo probe head with z-axis pulsed field gradients.
HPLC: HPLC purification was performed on a Prep LC 4000 System in combination
with a 2487 Dual λ Absorbance Detector both from Waters (Baden-Dättwil, Switzer-
land) equipped with a 150×20 mm column packed with ReproSil-Pur 120 ODS-3.5µm
from Dr. Maisch Gmbh (Ammerbach, Germany) using 0.1 % TFA in degassed H2O as
aqueous phase and 90 % aceto nitrile (AcN) with 10 % H2O and 0.085 % TFA as organic
phase. For each purification the following program was used: Flow rate: 10 mL/min
10 % for 2 min, 10 % to 55 % in 20 min, 55 % for 5 min, 55 % to 100 % in 2 min and 100 %
until complete elution of all material. All values correspond to the percentage of the
organic phase.
Sep Pak C18 columns: Single use Sep-Pak Vac RC (500 mg C18 cartridges from Waters
(Baden-Dättwil, Switzerland) were used in combination with an Econo Pump Model
EP-1 and an Econo UV Monitor Model EM-1 both from Bio-Rad (Hercules CA, USA)
always according to the following protocol. Conditioning of the column with 10 ml
MeOH (flow: 3 mL/min) and equilibration with 30 ml H2O (3 mL/min). The sample
was loaded to the column at neutral pH in aqueous solution (2 mL/min) and washed
with 20 ml of H2O (2 mL/min). Finally the product was eluted using MeOH/H2O (80:20,
2 mL/min).
PD MiniTrap G-25 columns: Single use PD MiniTrap G-25 Size exclusion columns
from GE Healthcare (Uppsala, Sweden) for desating of protein solutions were applies
according to manufacturers instructions. Columns were equilibrated with total 8 mL
of desired final buffer, the sample was loaded on the column with a volume of 0.5 mL
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and eluted with 1 mL of the desired final buffer.
Mass spectrometry: ESI-MS analysis of small molecules and lanthanide complexes
was performed on a Bruker Daltonics Esquire 3000 plus spectrometer. All compounds
were applied with a concentration of 10µg/mL to 1µg/mL, or even lower, dissolved in
either pure methanol (MeOH), in a MeOH/H2O/TFA mixture or using properly diluted
fractions direct from HPLC. Mass spectrometric analysis of protein samples were
performed on a Bruker Daltonics microTOF ESI/time of flight (TOF)-MS spectrometer
combined with an Agilent HPLC system with autosampler. Samples were diluted
into an 0.1 % TFA solution to a final concentration of 0.1 mg/mL or below. 40µL were
applied directly to the spectrometer trough the hplc system.
Polymerase chain reaction (PCR): PCRs were carried out in an Mastercycler Gradient
from Eppendorf (Schönenbuch, Switzerland).
UV spectroscopy: UV spectra for the determination of DNA concentrations were
recorded on a Thermo Fisher Scientific NanoDrop 1000 spectrometer. Concentrations
of proteins, M8-SPy and LnM8-SPy complexes were determined on a Agilent Tech-
nologies 8453 UV-Visible Diode Array spectrophotometer using cuvettes suitable for
50µL sample volume from Hellma Analytics (Müllheim, Germany). Determination of
cell growth was performed on a Varian Cary 50 Scan UV-Vis spectrometer.
Gel electrophoresis: Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-
PAGE) were performed on Bio-Rad Mini-PROTEAN and Sub-Cell systems, respectively.
The gels were analysed using a Molecular Image Gel Doc XR (Reinach, Switzerland).
Protein expression: Expression of protein in shaking flasks were performed either
in an Infors HT Ecotron (Bottmingen, Switzerland) or a New Brunswick Scientific
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INNOVA 44 (Edison NJ, USA). Expression of triple labelled protein was carried out in
an 2 L Infors HT Labforce 5 Cell fermenter (Bottmingen, Switzerland) equipped with
pH sensor, pO2 sensor and four peristaltic pump channels.
Protein purification: Chromatografic purification of proteins was carried out on an
ÄKTA prime plus from GE Healthcare (Glattbrugg, Switzerland).
Centrifugation: Centrifugation steps were carried out on the following centrifuges:
An Heraeus Multifuge 4KR centrifuge equipped with a swinging bucket rotor (4440 rpm
correspond to 5346× g), a Sorvall RC-6 plus centrifuge equipped with a fixed angel
rotor either for 6× 250 mL samples (14 000 rpm correspond to 30 000× g) or for 6× 1 L
samples (9500 rpm correspond to 16 880× g), a Heraeus Fresco 21 centrifuge for eppen-
dorf samples (14 800 rpm correspond to 21 100× g) all from Thermo Fisher Scientific
(Waltham, MA USA) or a Universal 320 from Hettich (Tuttlingen, Germany) equipped
with a rotor for 12 × 15 mL falcon tubes (12 000 rpm correspond to 13 201× g).
Lyophilization: Lyophilization steps were carried out in a Labonco benchtop lyophiliser
FreeZone 2.5 L (Kansas City, MO USA).
Ultrapure water: Ultrapure water was obtained either from a Merck Millipore Milli-Q
Reference water purification system (Molsheim, France) or from a Labtec ELGA Pure-
lab ultra water purification system (Villmergen, Switzerland).
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5.2 Protein expression
The site directed mutation and the expression of all the double mutants of hCA-II both
uniform 15N labelled and selective 15N leucine labelled were performed in collabora-
tion with Dr. Elisa S. Pereira Nogueira and are described as well in her PhD thesis39.
Throughout the whole thesis the numbering system for the residues of hCA-I was used
for hCA-II, where Thr-125 is followed directly by Lys-127. hCA-I has an additional
alanine residue at the position 126 which is missing for hCA-II.40
All solutions used were either heated in an autoclave at 121 ◦C for 15 min or filter-
sterilised using a 0.22µm sterile filter.
5.2.1 pACA plasmid
The pACA plasmid used for the production of hCA-II was generous gift from Prof.
Carol A. Fierke (University of Michigan, USA).44 It consists of the hCA-II gene45 behind
a T7 RNA polymersae promoter, a f1 origin of replication,46 and an ampr gene as well
as a cmr gene in a pMa5-8 vector.47 The gene for hCA-II has an alanine instead of a
serine at position 2 which does not affect the expression of the protein nor its catalytic
activity. This plasmid was used as a template for single point mutations by PCR.
5.2.2 Site-directed mutagenesis
Plasmid amplification:
The plasmid containing the gene for hCA-II was amplified by transformation into
E. coli DH5α cells (genotype: F – Φ 80lac Z∆M15∆(lacZYA-argF) U169 recA1 endA1
hsdR17 (r −K , m+K ) phoA supE44 λ-thi-1 gyrA96 relA1), according to the Invitrogen proto-
col with minor changes. 50µL DH5α chemically competent cells were allowed to thaw
on ice. 10 ng of the plasmid were mixed gently with the cells and incubated on ice dur-
ing 30 min. Then the cells were heat-shocked by keeping the tube for exactly 20 s in a
42 ◦C water bath without shaking and then immediately place the tube on ice for 2 min.
950µL of pre-warmed Super Optimal Broth with Catabolic repressor (SOC) medium
were added and incubated for 2 h in a shaking inkubator (37 ◦C, 250 rpm). 20µL to
200µL of the medium from the transformation were spread on a pre-warmed lysogeny
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broth (LB) (LB-Miller) plate (containing 60µg/mL ampicillin (amp) and 34µg/mL
chloramphenicol (cm)). Different volumes were applied to ensure that at least one
plate will have well spread colonies. The plates were incubated upside down at 37 ◦C
over night. Three colonies were selected for extraction of the plasmid using a Promega
AG Wizard Plus SV Miniprep DNA purification system (Dübendorf, Switzerland), which
were analysed by sequencing at Microsynth AG (Balgach. Switzerland).
Site-directed mutagenesis:
hCA-II double and triple mutants were prepared by site-directed mutagenesis using
the wt hCA-II plasmid (pACA) as initial template for the first mutation and for the
final double and triple mutants plasmids already containing one respectively two
mutations were used. The site-directed mutagenesis steps were carried out according
to the procedure described by Zheng et al.24 and primer candidates were tested in silico
to minimise hairpin formation.81 Resulting primers were ordered from Microsynth
(Balgach, Switzerland) and are listed in Table 5.1
Only the C206S mutant was used for further mutation steps resulting in the plasmids
for the following protein mutants (see table 5.2).
5.2.3 Transformation of plasmids for protein expression
For protein expression the desired plasmid was transformed into E. coli BL21(DE3)pLysS
cells (genotype: F – ompT lon hsdSB (r
−
B , m
−
B ) dcm gal λ(DE3) [pLysS (cm
r)] (produced
in house).
100µL of ultra-competent E. coli BL21(DE3)pLysS cells were allowed to thaw on ice,
8µl dithiothreitol (DTT) (200 mM) and 3µL of the plasmid (0.2µg to 0.5µg of DNA)
were added and mixed gently. The mixture was kept on ice for 15 min and then plated
on pre-warmed LB plates (containing 60µg/mL amp and 34µg/mL cm and 2 % w/v
glucose). The plates were incubated upside down at 37 ◦C over night. When only chem-
ical competent cells were available the following steps lead to the desired result. As far
as the 15 min incubation on ice the protocol followed the same steps as above, then
the cells were heat-shocked (30 s to 60 s at 42 ◦C followed by 2 min on ice). 900µL LB
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Table 5.1: List of primers (f: forward, r: reverse)
Mutant Primers (5’→ 3’) Tm (◦C) Length
(bases)
C206A f CTT CTG GAG gct GTG ACC TGG ATT GTG CTG AAG 67.3 33
r CCA GGT CAC agc CTC CAG AAG AGG AGG AGG GG 69.7 29
C206S f CTT CTG GAG tct GTG ACC TGG ATT GTG CTC AAG 66.1 33
r CCA GGT CAC aga CTC CAG AAG AGG AGG GG 68.1 29
S50C f CTG TCT GTT tgc TAT GAT CAA GCG ACT TCC CTG 64.4 33
r TTG ATC ATA gca AAC AGA CAG GGG CTT CAG 62.5 30
S166C f GTG CTG GAT tgc ATT AAA ACA AAG GGG AAG AGT GC 64.5 35
r GT TTT AAT gca ATC CAG CAC ATC AAC AAC 58.2 29
S173C f AAG GGC AAA tgc GCT GAC TTC ACT AAC TTC G 63.5 31
r GAA GTC AGC gca TTT GCC CTT TGT TTT AAT G 61.0 31
S217C f AAG GAA CCC ATC tcg GTC AGC AGC GAG CAG GTG 69.8 33
r GCT GCT GAC gca GAT GGG TTC CTT GAG CAC AAT CC 69.0 35
S220C f AGC GTC AGC tgc GAG CAA GTG TTG AAA TTC CG 66.0 32
r CAC TTG CTC gca GCT GAC GCT GAT GGG TTC 67.8 30
medium (or SOC medium) were added and the mixture was incubated for 1 h at 37 ◦C
in a shaking incubator (250 rpm) The cells were spun down in a centrifuge at top speed
for 20 s, 950µL of the supernatant was discarded and the cells were resuspended in the
remaining 50µL. Finally the cells were spread on a pre-warmed LB plate (containing
60µg/mL amp and 34µg/mL cm and 0.2 % w/v glucose) and were incubated upside
down at 37 ◦C over night.
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Table 5.2: Yields [mg/L] of hCA-II mutants for a given isotope labelling scheme according
to conditions given in section 5.2.4 to 5.2.6 and their calculated and determined masses
(calculated mass corresponds to protein without N-terminal methionine).
Mutant Yield
[mg/L]
Calculated
Mass [Da]
Determined
Mass [Da]
unif. 15N hCA-II_S50C_C206S 95 29452 29447
unif. 15N hCA-II_S166C_C206S 95 29452 29449
unif. 15N hCA-II_S173C_C206S 85 29452 29450
unif. 15N hCA-II_S217C_C206S 60 29452 29450
unif. 15N hCA-II_S220C_C206S 80 29452 29450
unif. 15N hCA-II_S50C_S166C_C206S 33 29469 29467
unif. 15N hCA-II_S50C_S217C_C206S 1 a 29469 29522 b
unif. 15N hCA-II_S50C_S220C_C206S 7 a 29469 29523 b (100 %),
29467 (90 %)
unif. 15N hCA-II_S166C_S217C_C206S 7 a 29469 29523 b
sel. 15N-Leu hCA-II_S50C_C206S 230 29125 29116
sel. 15N-Leu hCA-II_S166C_C206S 140 29125 29116
sel. 15N-Leu hCA-II_S173C_C206S 180 29125 29116
sel. 15N-Leu hCA-II_S217C_C206S 180 29125 29117
sel. 15N-Leu hCA-II_S220C_C206S 165 29125 29117
unif. 2H13C15N hCA-II_S50C_C206S 84 32763 32157 c
a Bacteriophage contamination was assumed to be responsible for low expression level. b Mass
difference possibly caused by N-terminal acetylation or similar modification. c Corresponds to a
deuteration level of 85 %.
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5.2.4 Expression of uniform 15N labelled hCA-II mutants in 1 L shaking flasks
All double mutants and all triple hCA-II mutants mentioned in table 5.2 with the ex-
ception of hCA-II_S50C_S166C_C206S were expressed under the following conditions.
With the difference that for the double mutants LB medium and for the triple mutants
main culture medium was used for the pre-culture.
Inoculum
Early in the morning 15 mL of LB medium (containing 100µg/mL amp and 34µg/mL
cm and 2 % w/v glucose) in a 75 mL baffled shaking flask were inoculated with a tip
dipped into a single colony from the transformation. The mixture was incubated at
37 ◦C for 6 h to 7 h at 250 rpm.
Pre-culture
The inoculum was centrifuged at 5346× g for 10 min at 4 ◦C, the supernatant was dis-
carded and the pellet was resuspended in 2.5 mL pre-culture medium. Early in the
evening either 50 mL LB medium (containing 60µg/mL amp and 34µg/mL cm and
0.2 % w/v glucose) or 50 mL of main culture medium (see below) in a 250 mL baffled
shaking flask were inoculated with the 2.5 mL of resuspended inoculum. In the case
of LB medium the culture was incubated overnight at 37 ◦C, 250 rpm until the optical
density at 600 nm (OD600) reached around 6.0. In the case of main culture medium
the culture was incubated overnight too, at a temperature between 25 ◦C to 33 ◦C in
order to reach a final OD600 of 1.0 to 2.0. In the next morning the pre-culture was
centrifuged at 5346× g for 10 min at 4 ◦C, the supernatant was discarded and the pellet
was resuspended in 50 mL main culture medium.
Main culture
1 L of main culture medium in 3 L baffled shaking flasks was inoculated with the cells
from the pre-culture. The medium was consisting of phosphate buffer (2 g/L Na2HPO4,
1 g/L KH2PO4, pH adjusted to 7.2) 0.5 g/L NaCl, 1 g/L
15NH4Cl (filter-sterilised), 2 mM
MgSO4, 0.1 mM CaCl2, 0.2 % w/v glucose, 0.5 mM ZnSO4, 100µg/mL amp, 34µg/mL
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cm, 1X BME vitamin solution (using a 100X stock solution from Sigma-Aldrich, Buchs,
Switzerland) and 1X of a trace element solution (using a 200X stock solution consisting
of: 6 g/L CaCl2 ·2 H2O, 6 g/L FeSO4 ·7 H2O, 1.15 g/L MnCl2 ·4 H2O, 0.8 g/L CoCl2 ·6 H2O,
0.7 g/L ZnSO4 ·7 H2O, 0.3 g/L CuCl2 ·2 H2O, 0.02 g/L H3BO4, 0.25 g/L (NH4)6Mo7O24 ·4 H2O
and 5 g/L EDTA disodium salt). The culture was incubated at 37 ◦C in a shaking incu-
bator at 250 rpm until OD600 reached around 0.6. Then the temperature was decreased
to 25 ◦C and the expression was induced when OD600 reached 1.0 to 1.3 by the addi-
tion of 250µM Isopropyl-β-D-thiogalactopyranosid (IPTG) and 450µM ZnSO4. The
cells were incubated for 4 h to 6 h after the induction and the OD600 was monitored
continuously. 1 mL samples were taken before induction and then every hour until
the end of expression. All samples were kept on ice and were treated the same way as
the main culture after the end of the expression. To prevent the leaking of the labelling
the expression was not left for more than 6 h after the induction, even if the OD600 was
still increasing. Cells were harvested by centrifugation at 4 ◦C and 5346× g for 15 min.
The supernatant was deactivated by the addition of NaClO and the cell pellet was kept
overnight at −20 ◦C.
5.2.5 Expression of selective 15N leucine labelled hCA-II mutants
All double mutants listet in table 5.2 were expressed 15N leucine labelled.
Inoculum
The inoculum followed the same procedure as described in section 5.2.4.
Pre-culture
The inoculum was centrifuged at 5346× g for 10 min at 4 ◦C, the supernatant was dis-
carded and the pellet was resuspended in 2.5 mL pre-culture medium. Early in the
evening 50 mL LB medium (containing 60µg/mL amp and 34µg/mL cm and 0.2 %
w/v glucose) in a 250 mL baffled shaking flask were inoculated with the 2.5 mL of
resuspended inoculum. The culture was incubated overnight at 37 ◦C, 250 rpm until
the OD600 reached around 6.0. In the next morning the pre-culture was centrifuged
5.2 Protein expression 115
at 5346× g for 10 min at 4 ◦C, the supernatant was discarded and the pellet was resus-
pended in 20 mL main culture medium.
Main culture
1 L of main culture medium in 3 L baffled shaking flasks was inoculated with the
cells from the pre-culture. The medium was consisting of phosphate buffer (4.5 g/L
Na2HPO4, 3 g/L KH2PO4, pH adjusted to 7.2) 0.5 g/L NaCl, 1 g/L, amino acid mix (see
table 5.3), 0.2 % w/v glucose, 2 mM MgSO4, 0.1 mM CaCl2, 10µM ZnSO4, 100µg/mL
amp, 34µg/mL cm, 1X BME vitamin solution (using a 100X stock solution from Sigma-
Aldrich, Buchs, Switzerland) and 1X of a trace element solution (using a 200X stock
solution consisting of: 6 g/L CaCl2 ·2 H2O, 6 g/L FeSO4 ·7 H2O, 1.15 g/L MnCl2 ·4 H2O,
0.8 g/L CoCl2 ·6 H2O, 0.7 g/L ZnSO4 ·7 H2O, 0.3 g/L CuCl2 ·2 H2O, 0.02 g/L H3BO3, 0.25 g/L
(NH4)6Mo7O24 ·4 H2O and 5 g/L EDTA disodium salt). The culture was incubated at
37 ◦C in a shaking incubator at 250 rpm until OD600 reached around 0.8. Then the tem-
perature was decreased to 25 ◦C and the expression was induced when OD600 reached
1.0 to 1.3 by the addition of 250µM IPTG, 450µM ZnSO4 and 60 mg
15N leucine dis-
solved in 50 mL main culture medium (filter sterilised). The cells were incubated
for 4 h to 6 h after the induction and the OD600 was monitored continuously. 1 mL
samples were taken before induction and then every hour until the end of expression.
All samples were kept on ice and were treated the same way as the main culture after
the end of the expression. Cells were harvested by centrifugation at 4 ◦C and 5346× g
for 15 min. The supernatant was deactivated by the addition of NaClO and the cell
pellet was kept overnight at −20 ◦C.
5.2.6 Uniform 2H, 13C, 15N labelled hCA-II_S50C_C206S
Only hCA-II_S50C_C206S was expressed in triple labelled medium. The same proto-
col with only 15NH4Cl as the sole labelled compound in the medium was applied to
express uniform 15N labelled hCA-II_S50C_S166C_C206S.
For expression of triple labelled protein all solutions were prepared in D2O apart from
the BME vitamin solution and the trace element solution where only small volumes
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Table 5.3: Recipe for amino acid mixture. The amino acids are listed in the order they
were mixed.
Order Amino acid mg/L
1 Alanine 500
2 Arginine 400
3 Aspartic acid 400
4 Glutamic acid 650
5 Glycine 550
6 Histidine 100
7 Isoleucine 230
8 Lysine-HCl 420
9 Methionine 250
10 Proline 100
11 Serine 2100
12 Threonine 230
13 Valine 230
14 Phenylalanine 130
15 Tryptophan 50
16 Asparagine -
17 Cysteine-HCl 50
18 Tyrosine 170
19 Glutamine 400
Leucine (15N labelled) 60
15N labelled leucine was not added to the medium until the time of induction.
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were added to the medium. All solutions were filter sterilised (not autoclaved) and
used directly after preparation.
Inoculum
The inoculum followed the same procedure as described in section 5.2.4, no labelled
compounds were used in this step.
Pre-culture
The inoculum was centrifuged at 5346× g for 10 min at 4 ◦C, the supernatant was dis-
carded and the pellet was resuspended in 2.5 mL pre-culture medium. Early in the
evening 50 mL of main culture medium (see below), with 0.375 % w/v D7-
13C-glucose
instead of 0.08 %, in a 250 mL baffled shaking flask were inoculated with the 2.5 mL
of resuspended inoculum. The culture was incubated overnight at a temperature
between 30 ◦C to 37 ◦C in order to reach a final OD600 of 1.0 to 2.0. In the next morning
the pre-culture was centrifuged at 5346× g for 10 min at 4 ◦C, the supernatant was
discarded and the pellet was resuspended in 50 mL main culture medium.
Main culture
All parts of the fermenter with 2 L working volume were autoclaved and dried properly.
The medium for the main culture was consisting of phosphate buffer (9 g/L Na2HPO4,
13 g/L KH2PO4, 10 g/L K2HPO4, 2.4 g/L K2SO4, pH adjusted to 7.2), 1 g/L
15NH4Cl (filter-
sterilised), 0.08 % w/v D7-
13C-glucose, 5 mM MgSO4, 500µM ZnSO4, 100µg/mL amp,
34µg/mL cm, 1X BME vitamin solution (using a 100X stock solution from Sigma-
Aldrich, Buchs, Switzerland) and 1X of a trace element solution (using a 200X stock
solution consisting of: 6 g/L CaCl2 ·2 H2O, 6 g/L FeSO4 ·7 H2O, 1.15 g/L MnCl2 ·4 H2O,
0.8 g/L CoCl2 ·6 H2O, 0.7 g/L ZnSO4 ·7 H2O, 0.3 g/L CuCl2 ·2 H2O, 0.02 g/L H3BO3, 0.25 g/L
(NH4)6Mo7O24 ·4 H2O and 5 g/L EDTA disodium salt). 1 L of main culture medium was
inoculated in the fermenter with the cells from the pre-culture. The fermentation was
initiated at 37 ◦C with the stirring at 250 rpm and an oxygen level kept between 50 %
to 90 %. Antifoam solution was applied manually, if required. The glucose level was
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monitored using Merckoquant Glucose-Test strips (from Merck, Darmstadt, Germany).
After around 3 h, when the all initial glucose was consumed (also indicated by a short
drop, followed by an increase of the oxygen level) a slow feed containing a total amount
of 5.5 g D7-
13C-glucose and 0.5 g 15NH4Cl was applied with such a feed rate that 60 %
of the glucose is delivered over night to the culture. In the morning, the OD600 was
around 3.0 to 3.5, the temperature was decreased to 20 ◦C and protein expression was
induced by the addition of of 250µM IPTG and 450µM ZnSO4. 1 mL samples were
taken before induction and then every hour until the end of expression. All samples
were kept on ice and were treated the same way as the main culture after the end of the
expression. The remaining 40 % of the feed was delivered to the culture over a period
of 5 h to 6 h. 3 h after induction 0.5 mM phenylmethanesulfonylfluoride (PMFS) was
added. When all glucose is consumed the cells are harvested by centrifugation at 4 ◦C
and 5346× g for 15 min. The supernatant was deactivated by the addition of NaClO
and the cell pellet was kept overnight at −20 ◦C.
5.2.7 Protein purification
All cell pellets from the different expressions were treated the same way. In order to ob-
tain the protein in the reduced state with regard to the free thiol group, all buffers used
for purification were prepared with 1 mM DTT, or in the case of dialysis buffer with
at least 100µM DTT. If no DTT was used the protein was obtained with glutathione
bound to the thiol.
Cell lysis
Lysis of the cells was achieved by three cycles of freezing and thawing of the cell pellet,
which activated the gene encoding for T7 lysozyme. The pellet was resuspended in
25 mL lysis buffer (50 mM Tris-SO4, pH 8.0, 50 mM NaCl, 0.5 mM ZnSO4, 1 mM DTT and
10µg/mL PMFS). The resuspension was shaken vigorously (300 rpm ) at room tem-
perature (RT) for 30 min then Deoxyribonuclease I (DNase I) (1µg/L) was added and
the mixture was shaken for another 30 min. The lysate was centrifuged at 16 880× g
for 30 min at 4 ◦C. The supernatant was recovered and the pellet was resuspended
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another two times in 25 mL lysis buffer (followed by 30 min shaking and cenrifugation
each time) to extract as much protein as possible. The total 75 mL solution from the
extraction was filtered trough a 0.45µm filter and used directly for affinity chromatog-
raphy.
Inhibitor affinity chromatography
Affinity chromatography was performed using 25 mL of p-amino-ethylbenzene sulfon-
amide agarose resin packed into a XK 16 column (GE Healthcare, Glattbrugg, Switzer-
land). The collumn was equilibrated with 5 column volume (CV) activity buffer (50 mM
Tris-SO4, pH 8.0, 0.5 mM ZnSO4, 1 mM DTT) and the protein in 75 mL lysis buffer was
loadet onto the column at a slow flow rate (1 mL/min. Then the column was washed
with 5 CV of wash buffer (50 mM Na2SO4, 50 mM NaClO4, 25 mM Tris-SO4, pH 8.8, 1 mM
DTT) and the protein was was eluted with 10 CV of elution buffer (200 mM NaClO4,
100 mM NaAc, pH 5.6, 1 mM DTT). 10 mL fractions were collected and those contain-
ing the protein (detected by UV absorption were pooled and dialysed at 4 ◦C against
activity buffer for 12 h, followed by deionised H2O for 24 h and finally against ultrapure
water for another 24 h. Dialysis buffer contained 100µM DTT and were exchanged
at least three times a day. The resulting solution was frozen in liquid nitrogen and
lyophilised. The resulting protein was stored at 4 ◦C.
5.2.8 Protein analysis by gel electrophoresis
Sample preparation
The Samples taken during the expression were lysed by tree cycles of freezing and
thawing of the cell pellet, which activated the gene encoding for T7 lysozyme. The pel-
let was resuspended in ultrapure water. For each sample 40µL water times the OD600
at the time of sampling was used to normalize the concentration over the number of
cells. 1µL of DNase I (1 mg/mL dissolved in 5 mM Tris-HCl pH 7.5, 75 mM MgCl2 and
50 % v/v glycerol). The samples were vortexed and shaken vigorously (300 rpm ) at
RT for 30 min to 60 min. The samples were centrifuged at 21 100× g for 5 min at RT.
The soluble fraction (supernatant) was separated and the insoluble fraction (pellet)
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was dissolved in 8 M urea (again 40µL urea solution times the OD600 was used). Each
sample fraction (soluble and insoluble) as well as a positive control (around 5µg to
20µg pure hCA-II dissolved in 20µL water) were mixed with 4µL 6X loading buffer
(100 mM Tris-HCl pH 6.8, 2 % v/v β-mercaptoethanol, 20 % w/v sucrose, 0.012 % w/v
bromophenol blue and 60 mM). The samples were heated to 98 ◦C for 5 min and then
loaded immediately on a 12 % acrylamide gel.
SDS-PAGE
A 12 % acrylamide running gel for gel electrophoresis was prepared as follows. 5 mL ul-
trapure water, 6 mL of 30 %/0.8 % w/v acrylamide/bis-acrylamide, 3.8 mL of 1.5 M Tris-
HCl pH 8.8, 75µL of 20 % w/v sodium dodecyl sulfate (SDS), 100µL of 15 % w/v ammo-
nium peroxodisulfate (APS) and 6µL of tetramethylethylenediamine (TEMED) were
mixed well and the solution was directly poured into a chamber between glass plates
and left for polymerisation for 30 min. A 5 % acrylamide stacking gel was prepared
by mixing 3.4 mL ultrapure water, 1 mL of 30 %/0.8 % w/v acrylamide/bis-acrylamide,
1.5 mL of 0.5 M Tris-HCl pH 6.8, 30µL of 20 % w/v SDS, 40µL of 15 % w/v APS and 6µL
of TEMED. The solution was poured directly after preparation on top of the running
gel and a comb was inserted into the solution in order to prepare the spaces required
for loading the different samples onto the gel. The stacking gel again left for 30 min
for polymerisation. To keep the gel from dryness, the gel was clamped into the holder
and the holder was placed in a tank containing SDS buffer (25 mM Tris-HCl, 0.192 M
glycine and 0.1 % SDS). Then 20µL of each sample were loaded onto the gel and 6µL
of the protein marker (Prestained Protein Marker, Broad Range, from New England
BioLabs Inc., Bioconcept, Allschwil, Switzerland). The gel ran at 200 V until the blue
front line reached the end of the gel (after about 1.5 h). The gel was transferred into a
container with 100 mL of staining solution (25 % w/v Coomassie Brilliant Blue R-250,
50 % v/v MeOH, 7.5 % v/v glacial acetic acid) and was rocked gently for 1 h. Then the
gel was placed in 100 mL of a destaining solution (20 % v/v MeOH and 7.5 % v/v glacial
acetic acid) and was rocked gently until the protein pattern appeared (around 3 h or
longer). The gel was left in water overnight and a Kimwipe towel was placed in the
solution to absorb the stain in the solution.
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5.2.9 Refolding of hCA-II_S50C_C206S
For denaturation the hCA-II was dissolved in 5 M GdmCl, 100 mM Tris-SO4, 1 mM TCEP
at pH 7.5 to obtain a final protein concentration of 14.25µM. Protein concentration
was controlled by UV absorption at 280 nm (ε280 =54 700 M−1 cm−1)37 after every step
of the protocol. Refolding of the protein was initialised by fast dilution of the whole
sample into 100 mM Tris-SO4 buffer at pH 7.5 containing 10µM TCEP to obtain a final
concentration of 0.3 M GdmCl and 0.855µM of protein. The resulting solution was
stirred for 3 h to allow the protein to subsequently refold. To reduce the large sample
volume the protein solution was loaded on a sulafonamide affinity column according
to the same conditions as described above in section 5.2.7 with the exception that
instead of buffer exchange to the described the activity buffer the protein was loaded
directly in the present buffer after the dilution onto the column. The resulting fractions
containing the protein were pooled and dialysed at 4 ◦C against activity buffer for 12 h,
followed by deionised H2O for 24 h and finally against ultrapure water for another 24 h.
All dialysis buffer contained 10µM TCEP. The final solution was concentrated using
15 ml Vivaspin ultrafiltration tubes (MW.co. 10 kDa) to a volume of 2 mL by successive
addition of the protein solution. The final buffer exchange to 10 mM PO 3 –4 pH 6.8 was
carried out using a 4 mL Amicon ultrafiltration tube to obtain a final volume of 280µL.
5.3 Ln-M8-SPy Synthesis
The following synthesis was carried out according to published procedures with minor
adjustments given in the protocols below. The analytical data was in accordance to
the literature. (R)-Bn-lactic acid-OTf (2) and (R)-tBu-lactic acid-OTf (4) were taken
from stocks kept at −20 ◦C which were synthesized according to the literature.28
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5.3.1 Synthesis of M4cyclen-Bn-lactate, 3
NH HN
HNNH
NH HN
NNH
OBnO
TfO
O OBn
1 3
2
in CH2Cl2
RT 30 min
M4cyclen, 1 (402.2 mg, 1.76 mmol, 1 eq.) was dissolved in 50 mL of CH2Cl2 and (R)-Bn-
lactic acid-OTf, 2 (385.5 mg, 1.76 mmol, 0.7 eq.) in 2 mL of CH2Cl2 was added during
30 min and the reaction was monitored by ESI-MS. NEt3 (1 mL, 7.21 mmol, 4.1 eq.)
was added to quench the reaction and volatile material was removed under reduced
pressure. The resulting oil was purified by flash column chromatography (25 g SiO2,
ethyl acetate (EtOAc):ethanol (EtOH):NEt3 10:1:0.4). The fractions were analysed by
ESI-MS, and those containing the product were combined and evaporated to yield a
yellowish waxy solid (396.7 mg, 1.02 mmol, 82 %).
C22H38N4O2, FW: 390.57 g/mol ESI-MS: m/z 391.3 [M+H]
+.
5.3.2 Synthesis of (8S) tBu3-M4DOTMA-Bn, 5
NH HN
NNH
OBnO
N N
NN
OBnO
tBuO
O
OtBuO
O
OtBu
TfO
O OtBu
3 5
4
+ K2CO3
in MeCN
RT 6 h
M4cyclen-Bn-lactate, 3 (400 mg, 1.03 mmol) was dissolved in 15 mL AcN under argon
atmosphere. (R)-tBu-lactic acid-OTf, 4 (1.11 g, 3.99 mmol, 3.9 eq.) in 6 mL AcN and
freshly powdered K2CO3 was added and the resulting mixture was stirred for 6 h, until
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completion of the reaction was indicated by ESI-MS. NEt3 (200µL, 1.44 mmol, 1.4 eq.)
was added to quench the excess reagent and after an additional 10 min of stirring, the
mixture was filtered trough celite. Removal of volatile material under reduced pressure
yielded a waxy yellowish solid that was purified by flash column chromatography (25 g
SiO2, CHCl3/EtOH 9:1) to yield a off-white waxy solid (1.06 g, 90 %). C43H74N4O8, FW:
775.09 g/mol ESI-MS: m/z 797.7 [M+Na]+.
5.3.3 Synthesis of tBu3-M4DOTMA-OH, 6
N N
NN
OBnO
tBuO
O
OtBuO
O
OtBu N N
NN
OHO
tBuO
O
OtBuO
O
OtBu
5 6
H2 
10% Pd|C (50% H2O)
in MeOH
RT 1 h
tBu3-M4DOTMA-Bn, 5 (100.6 mg, 0.13 mmol) was dissolved in 5 mL MeOH under
argon atmosphere and palladium on carbon (30.8 mg, 10 % Pd, 50 % H2o) as hydro-
genation catalyst was added. The mixture was stirred while a total amount of 500 mL of
hydrogen gas was allowed to bubble gently trough the solution at atmospheric pressure
over a period of 1 h and the reaction was monitored by ESI-MS. After completion of
the reaction the mixture was filtrated through celite and volatile material was removed
under reduced pressure, yielding a colourless glassy solid which was used for the next
reaction step without further purification (84.1 mg, 0.12 mmol, 94 %). C36H68N4O8,
FW: 684.95 g/mol, ESI-MS: m/z 685.7 (47 %, [M+H]+), 707.6 (100 %, [M+Na]+).
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5.3.4 Synthesis of M8-SPy, 8
N N
NN
OHO
tBuO
O
OtBuO
O
OtBu
6
N N
NN
O
HO
O
OHO
O
OH
H
N S S
N
1. pyBOP, in DMF 5 min
NH3+ SS
N
2.
 
     
    + DIPEA in DMF 1.5 h
Cl-
3. TFA / Thioanisol / H2O
RT 6 h
7
8
tBu3-M4DOTMA-OH, 6 (84.1 mg, 0.12 mmol) dissolved in 1.6 mL DMF was activated
with pyBOP (64.2 mg, 0.12 mmol, 1 eq.) in 0.8 mL DMF for 2 min under argon atmo-
sphere to yield a pale yellow solution. Then a mixture of 2-(pyridyldithio)-ethylamine
hydrochloride, 7 (27.5 mg, 0.12 mmol, 1 eq.) and DIPEA (42.8µL, 0.24 mmol, 2 eq.)
in 2 mL DMF was added and the resulting solution stirred at RT under argon atmo-
sphere until ESI-MS indicated complete consumtion of the starting material after
1 h. Then 5 mL EtOAc and 5 mL sat. aq. Na2CO3 were added and vigorously mixed.
After phase separation, the aqueous layer was extracted with additional 5 mL EtOAc.
The combined organic layers were extracted twice with 5 mL sat. aq. Na2CO3 and
dried over Na2SO4. Volatile material was removed under reduced pressure to yield a
yellow oil. This oil was immediately used for the following deprotection, otherwise
the overall yield was very low. The oil was dissolved in 4 mL deprotection mixture
(TFA/thioanisol/H2O 92:6:2) and stirred under argon. The right reaction time of the
deprotection step was crucial because apart from the deprotection a second reaction,
(either a cleavage of the disulfide bond or a decomposition of the DOTA backbone)
reducing the amount of desired product, could be observed. The reaction was followed
by ESI-MS in order to monitor the signal intensity of the product peaks. In order to
obtain comparable results the intensity of the product peak was normalised by the
intensity of a peak at m/z 515 which is expected to be byproduct of the initial coupling
reaction. After 6 h the intensity of the signals corresponding to the product started
to reach a plateau and the reaction was interrupted by removal of the solvent under
reduced pressure. The residue was dissolved in 10 mL H2O and purified by HPLC. Eight
different fractions were isolated thereof the fourth one eluting at 42 % organic phase
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of contained the desired product. Organic solvent in the hplc fraction was removed
under reduced pressure and the pH of the resulting aqueous solution was adjusted to
5.4 by the addition of ammonium acetate. The concentration of the product was de-
termined by UV spectroscopy (ε280 =4232 M−1 cm−1). Yield: 34.6 mg, 50.6µmol, 42 %.
C31H52N6O7S2, FW: 684.91 g/mol, ESI-MS: m/z = 685.4 (100 % [M+H]
+, 343.3 (15 %,
[M+2H]2+), 707.3 (12 %, [M+Na]+).
5.3.5 Synthesis for [Ln(M8-SPy)] complexes
The following complexation was carried out with different Lanthanide metals therefore
a general synthesis protocol is given and the details for the different complexes are
summarised in the table below. As ligands both, (8S) M8-SPy, synthesized as described
above, and (4R4S)-M8-SPy, synthesized by Dr. Roché Walliser during his masters
thesis57 according an analogous synthesis, were used.
N N
NN
O
HO
O
OHO
O
OH
H
N S S
N
N N
NN
O
O
O
OO
O
O
H
N S S
N
Ln
LnCl3
 
in 100 mM 
NH4Ac (aq)
75°C o/n
M8-SPy, 8 [Ln(M8-SPy)]
To an aqueous solution of M8-SPy, 9 (2 mM to 4 mM) and ammonium acetate (100 mM)
three equivalents of the desired lanthanide chloride or lanthanide bromide were added.
The mixture was stirred at 75 ◦C over night and completion of the reaction was con-
firmed by ESI-MS. The product was purified by HPLC where in the case of the (8S)
ligand two different fractions could be isolated, one eluting at 39 % of the organic
solvent and the second at 43 %, both showing the desired mass of the product in the
ESI-MS spectrum. The ratio of the two fractions depends on the lanthanide metal.
For Gd a ration of 8:2 was observed for the earlier to the later fraction, for Dy 6:4, for
Tm 0.5:9.5 and for Lu only the second fraction was observable. When substituted
to a protein no differences could be observed between the two fractions (both pro-
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tein samples show exactly the same 15N-HSQC spectrum). In the case of the (4R4S)
ligand only one fraction was observed. The fractions containing the product were
further purified using a single use Sep-Pak C18 column to yield the product as a glassy
solid after removing the solvent under reduced pressure. For further use the product
was dissolved in 1 mL H2O, the concentration was determined by UV spectroscopy
(ε280 =4232 M−1 cm−1) and the solution was stored at −20 ◦C.
Table 5.4: Specific conditions for the complexation of M8-SPy using different lanthanide
metals and analytic data
Product M8-SPy Yield ESI-MS
[mg] [mg] (%) m/z (rel. Int., [Assignment])
LuM8-SPy
(8S)
5 5.5 (88 %) 857.3 (100 % [M+H]+), 858.3 (42 %), 859.3
(17 %), 860.4 (4 %), 861.4 (1 %), 429.2 (25 %
[M+2H]2+) a
TmM8-
SPy
(8S)
5 5.8 (93 %) 873.6 (100 % [M+Na]+), 874.6 (36 %), 875.6
(12 %)
DyM8-
SPy
(8S)
10 7.5 (60 %) 868.4 (100 % [M+Na]+), 867.4 (95 %), 866.4
(66 %), 865.4 (42 %), 869.4 (38 %), 870.4 (13 %),
864.4 (4 %), 871.4 (4 %), 846.4 (14 % [M+H]+) a,
884.3 (9 % [M+K]+)a
GdM8-
SPy
(8S)
5 5.6 (91 %) 862.3 (100 % [M+Na]+), 864.3 (72 %), 861.3
(66 %), 860.3 (63 %), 859.3 (37 %), 863.3 (33 %),
865.3 (23 %), 866.3 (7 %), 858.3 (4 %), 442.6
(23 % [M+H+Na]2+]) a
GdM8-
SPy
(4R4S)
5 2.7 (44 %) 862.2 (100 % [M+Na]+), 864.2 (67 %), 861.2
(64 %), 860.2 (64 %), 859.2 (33 %), 863.2 (32 %),
865.2 (18 %), 866.2 (8 %), 858.2 (2 %), 442.6
(13 % [M+H+Na]2+) a
a Only the relative intensity of the main isotopomer is given, the intensity distribution of the corre-
sponding isotopomers is the same as for the main species.
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5.4 Protein tagging
The general protocol for the tagging of the protein with the individual LnM8-SPy
compound is given in the following section. And the individual conditions for the
different samples are listed afterwards.
5.4.1 General procedure for M8 tagging
2 mg to 5 mg of protein were dissolved in 200µL to 500µL of 10 mM PO 3 –4 pH 6.8 to
yield a 300µM to 350µM solution. The concentration was confirmed by UV absorption
at 280 nm (ε280 =54 700 M−1 cm−1)37. 100 mM TCEP solution at neutral pH was added
to obtain a final concentration of 1 mM TCEP. The sample was kept at 4 ◦C overnight.
The full reduction of the protein was confirmed by ESI-MS (in the case of not complete
reduction concentrations of up to 10 mM TCEP in the protein sample were successfully
applied). The buffer was exchanged to 10 mM PO 3 –4 , 100µM TCEP pH 6.8 by ultrafiltra-
tion using 4 mL Amicon Ultrafiltration tubes (MW.co. 10 kDa) in 3 to 4 centrifugation
steps. In each step the spinning time was adjusted that the sample volume did not de-
crease below 500µL to avoid the aggregation of the protein. The TCEP concentration
was further decreased using a PD MiniTrap G-25 desalting column and the protein
was eluted directly into 3 eq. of the desired LnM8-SPy in aqueous solution (for the
double cystein mutants 6 eq. of LnM8-SPy were used). To ensure complete tagging of
the protein, the solution was kept under agitation at 4 ◦C overnight. The reaction was
monitored with ESI-MS. The excess of LnM8-SPy was removed by ultrafiltration with
10 mM PO 3 –4 pH 6.8 in 3 to 4 centrifugation steps to ensure that more than 99 % of
the LnM8-SPy has been removed. Appart from the last step again the sample volume
was not allowed to decrease below 500µL. In the final step the sample volume was
reduced to around 250µL. The sample was removed and the centrifugation tube was
washed 2 times to obtain a final volume of 280µL. 5 % D2O were added and the pH
was adjusted to 6.80. The concentration was determined again by UV absorption and
the sample was transferred into a shigemi NMR tube.
5.4.2 Specific conditions
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Table 5.5: Specific conditions for the tagging of hCA-II with the corresponding LnM8-SPy
complex.
Product Protein a Concen-
tration b
Yield ESI-
MS
[mg] [µM] [%] [m/z]
unif. 15N hCA-II_S50C_C206S-GdM8 (8S) 2.2 200 74 30175
unif. 15N hCA-II_S50C_C206S-DyM8 (8S) 3.8 120 20 30179
unif. 15N hCA-II_S50C_C206S-TmM8 (8S) 3 90 25 30187
unif. 15N hCA-II_S50C_C206S-LuM8 (8S) 2.2 180 67 30193
sel. 15N-Leu hCA-II_S50C_C206S-DyM8 (8S) 6.4 620 79 29849
sel. 15N-Leu hCA-II_S50C_C206S-TmM8 (8S) 5.8 560 79 29856
sel. 15N-Leu hCA-II_S50C_C206S-LuM8 (8S) 6.0 550 75 29862
unif. 15N hCA-II_S166C_C206S-GdM8 (8S) 2.4 230 79 30178
unif. 15N hCA-II_S166C_C206S-DyM8 (8S) 2.4 220 76 30180
unif. 15N hCA-II_S166C_C206S-TmM8 (8S) 3.9 320 68 30189
unif. 15N hCA-II_S166C_C206S-LuM8 (8S) 2.6 210 68 30195
sel. 15N-Leu hCA-II_S166C_C206S-TmM8 (8S) 2.1 230 78 29857
sel. 15N-Leu hCA-II_S166C_C206S-LuM8 (8S) 2.9 240 67 29864
unif. 15N hCA-II_S173C_C206S-TmM8 (8S) 5 340 56 30190
sel. 15N-Leu hCA-II_S173C_C206S-TmM8 (8S) 4.1 440 87 29859
sel. 15N-Leu hCA-II_S173C_C206S-LuM8 (8S) 6.1 520 70 29864
unif. 15N hCA-II_S217C_C206S-GdM8 (8S) 2.3 210 75 30180
unif. 15N hCA-II_S217C_C206S-DyM8 (8S) 2.3 240 86 30184
unif. 15N hCA-II_S217C_C206S-TmM8 (8S) 3.4 280 68 30192
unif. 15N hCA-II_S217C_C206S-LuM8 (8S) 2.0 200 82 30199
sel. 15N-Leu hCA-II_S217C_C206S-TmM8 (8S) 3.5 240 60 29859
continued on next page . . .
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Product Protein a Concen-
tration b
Yield ESI-
MS
[mg] [µM] [%] [m/z]
sel. 15N-Leu hCA-II_S217C_C206S-LuM8 (8S) 4.9 400 67 29864
unif. 15N hCA-II_S220C_C206S-GdM8 (8S) 2.3 140 50 30179
unif. 15N hCA-II_S220C_C206S-DyM8 (8S) 2.3 220 79 30182
unif. 15N hCA-II_S220C_C206S-TmM8 (8S) 3.5 240 57 30190
unif. 15N hCA-II_S220C_C206S-LuM8 (8S) 2.3 200 72 30195
sel. 15N-Leu hCA-II_S220C_C206S-TmM8 (8S) 2.5 270 88 29857
sel. 15N-Leu hCA-II_S220C_C206S-LuM8 (8S) 5.0 500 81 29863
unif. 15N hCA-II_S50C_S166C_C206S-GdM82 (8S) 4.3 190 36 30922
unif. 15N hCA-II_S50C_S217C_C206S-GdM82 (8S) 0.6 70 c 17 29975
unif. 15N hCA-II_S50C_S220C_C206S-GdM82 (8S) 2.4 120 41 30979 d
unif. 15N hCA-II_S166C_S217C_C206S-GdM82 (8S) 2.4 60 19 30979
unif. 2H13C15N hCA-II_S50C_C206S-TmM8 (8S) 4.5 330 66 32952
unif. 2H13C15N hCA-II_S50C_C206S-LuM8 (8S) 6.2 460 67 32902
a Initial amount of protein used for the reaction, b Final concentration of the NMR sample (Volume
= 280µL if not further specified), c Sample volume was 50µL, d Second peak with 90 % intensity at
m/z=30923 was observable.
5.5 hCA-II inhibitor complexes
The following inhibitors (see figure 5.1) were used to form hCA-II-Inhibitor complexes:
N-(2,3-Difluorobenzyl)-4-sulfamoylbenzamide (9) abbreviated as F2-Inh, [(Cp?)Ir(2,6-
difluoro-N-((4-(4-sulfamoylphenyl)pyridin-2-yl)methyl)benzenesulfonamide)Cl]Cl (10)
abbreviated as F2-Complex and 2,2,5,5-tetramethyl-3-((4-sulfamoylphenyl)carbamoyl)-
2,5-dihydro-1H-pyrrol-1-oxyl (11) abbreviated as NOX-Inh.
F2-Inh and F2-Complex were synthesized by Dr. Fabien W. Monnard, and are de-
scribed in his PhD. thesis.60 NOX-Inh was synthesized by Guido Grassi from the ETH
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Zürich, Switzerland.
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Figure 5.1: sulfonamide based inhibitors used for the preparation of hCA-II-inhibitor
complexes.
5.5.1 F2-Inh ⊂ hCA-II
To a protein sample 1.1 eq. of F2-Inh (24 mM) dissolved in deuterated dimethyl sulfox-
ide (DMSO-D6) were added and the sample was stirred well. The excess of inhibitor was
removed by ultrafiltration using 4 mL Amicon ultrafiltration tubes (MW.co. 10 kDa).
2µL of 100µM TFA as internal standard for fluorine chemical shift and 5 % v/v D2O
were added and the pH was adjusted to 6.80.
5.5.2 F2-Complex ⊂ hCA-II
F2-Complex appeared to be poorly soluble in DMSO-D6 unless it was acidified by
bubbling HCl (g) through the solvent. A 27 mM stock solution was prepared which
was stored at −20 ◦C. 1.1 eq. of F2-complex were added to a protein sample and excess
of inhibitor was removed by ultrafiltration using 4 mL Amicon ultrafiltration tubes
(MW.co. 10 kDa). 2µL of 100µM TFA as internal standard for fluorine chemical shift
and 5 % v/v D2O were added and the pH was adjusted to 6.80.
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5.5.3 NOX-Inh ⊂ hCA-II
To a protein sample 1.1 eq. of F2-Inh (24 mM) dissolved in DMSO-D6 were added ans
the sample was stirred well. The excess of inhibitor was removed by ultrafiltration
using 4 mL Amicon ultrafiltration tubes (MW.co. 10 kDa). After 3 cycles of ultrafil-
tration, addition of 5 % D2O and pH adjustment to 6.80, the
15N-HSQC spectrum
showed that only 0.8 eq. of the inhibitor retained in the protein, indicated by a shift
of a peak at 9.47 ppm in 1H dimension and 119.1 ppm in 15N dimension. This sample
was concentrated to 200µM if necessary using again Amicon ultrafiltration tubes but
without further dilution before the run, to avoid further influence on the inhibitor
concentration. Two samples were prepared from this solution, one with the given
0.8 eq. of the inhibitor and another with total 1.1 eq. of inhibitor. After addition of 50 %
v/v glycerol these samples were used for EPR spectroscopy.
5.6 NMR experiments
A handwritten 1H-15N-HSQC experiment with selective pulses and gradients for water
suppression was used for the characterisation of the protein samples and for the
determination of the PCSs and PRE. A IPAP variant of the 15N-HSQC experiment with
additional 13C decoupling during 15N evolution was used for the determination of
RDC. TROSY based HSQC experiments were used to record 1H-15N-HSQC spectra82,
as well as the determination of T1
83, T2
83 times andheteronuclear nuclear Overhauser
effects (hetNOEs)83,84. For backbone assignment of triple labelled hCA-II_S50C_C206S-
LuM8, TROSY based HNCO85,86, HNCA50, HNCOCA85,86, HNCACO85,86 and HNCACB50
experiments were used. The parameters used for set up these experiments, as well as
detail of the samples used, are given in tables 5.6 and 5.7. 1D 19F experiments of hCA-II-
Inhibitor complexes were recorded with an Offset of−135 ppm and a SW of 40 ppm for
F2-Inh and with an Offset of −115 ppm and a SW of 100 ppm for F2-Complex. 1H-19F
HOESY experiments were carried out with a mixing time of 0.5 s, a SW of 3.5 ppm
in the indirect dimension, and a TD of 80 points in the indirect dimension using a
standard pulsesequence delivered by Bruker.
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Table 5.6: Parameters for the 2D NMR experiments.
Parameter 15N
HSQC
IPAP
15N
HSQC
15N
TROSY
15N
TROSY
T1 a
15N
TROSY
T2 b
hetNOE
NS 32 - 512 16 - 48 4 8 16 36
SW F1 2000 2045 2270 2000 2000 2000
[Hz] F2 10822 14423 12019 11261 10823 11261
Offset F1 116.5 116.5 116.6 116.5 116.6 116.5
[ppm] F2 4.7 4.69 4.74 4.74 4.74 4.7
TD F1 200 600 256 256 256 512
[points] F2 2048 2048 2048 2048 2048 2048
AQ F1 50 147 56 64 64 128
[ms] F2 95 71 85 91 91 91
Nucleus F1 15N 15N 15N 15N 15N 15N
F2 1H 1H 1H 1H 1H 1H
a Delays [ms] for T1 time determination of individual experiments were set to 16, 40, 80, 400, 800,
1600, 3200, 6400, 8000, b Delays [ms] for T2 time determination of individual experiments were set to
16, 32, 64, 128, 256.
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Table 5.7: Parameters for the 3D NMR experiments used for backbone assignment of
hCA-II_S50C_C206S
Parameter HNCO HNCA HNCOCA HNCACO HNCACB
NS 8 16 32 32 36
SW F1 2113 1947 5634 2113 1947
[Hz] F2 2128 5585 1946 2270 10566
F3 12019 11261 11261 11261 11261
Offset F1 175 116.5 175 175 116.5
[ppm] F2 116.5 56 116.5 116.5 45
F3 4.74 4.74 4.74 4.74 4.74
TD F1 80 80 88 88 80
[points] F2 80 88 88 88 84
F3 2048 2048 2048 2048 2048
AQ F1 19 20 8 21 21
[ms] F2 19 8 23 19 4
F3 85 91 91 91 91
Nucleus F1 13C 15N 13C 13C 15N
F2 15N 13C 15N 15N 13C
F3 1H 1H 1H 1H 1H
5.7 Tensor and PCS position determination
For reproducibility of the tensors determined in Numbat18, the following random seed
numbers were used for every tensor of a specific protein mutant: hCA-II_S50C_C206S:
301, hCA-II_S166C_C206S: 840, hCA-II_S217C_C206S: 129 and hCA-II_S220C_C206S:
615. For the position calculation, based on PCS, in Matlab63 the seed of the random
number generator was set to 688 for every position determination.
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A.1 Backbone assignment
Table A.1: Backbone chemical shifts of hCA-II_S50C_C206S-LuM8. All values are given in
ppm.
Residue HN N CO Cα Cβ Residue HN N CO Cα Cβ
P21a N/A . . . 175.7 62.2 28.0 A142 8.77 123.9 173.7 47.9 18.5
I22 7.92 121.1 171.7 58.0 35.4 V143 7.16 124.8 170.2 56.7 28.1
A23 8.55 123.3 176.8 50.4 15.6 L144 8.35 128.7 170.2 49.7 41.3
K24 7.07 115.3 173.6 52.0 27.8 G145 9.80 114.7 168.0 40.8 N/A
G25 8.17 109.3 171.5 41.9 N/A I146 9.02 124.7 182.0 56.0 39.2
E26 9.24 118.2 173.6 53.7 27.3 F147 9.99 129.3 172.0 55.1 36.6
R27 8.71 122.0 172.6 50.2 27.9 L148 8.10 120.7 172.3 52.1 39.4
Q28 7.58 115.9 175.2 52.2 28.6 K149 8.85 119.8 171.8 49.8 32.7
S29 7.94 118.3 181.8 54.2 60.5 V150 8.32 121.8 175.2 59.4 27.9
P30 N/A . . . 170.2 59.0 29.7 G151 8.97 118.5 169.9 43.7 N/A
V31 6.14 107.5 171.0 56.0 32.2 S152 8.22 125.0 170.1 55.5 60.5
D32 8.19 118.7 172.0 50.2 39.1 A153 8.24 121.5 174.8 49.3 15.6
I33 8.59 129.0 170.2 58.0 33.6 K154 8.59 124.4 174.0 48.5 29.0
D34 7.40 128.7 175.4 49.2 38.0 P155 N/A . . . . . . . . . . . .
T35 10.15 122.7 174.4 62.2 65.8 G156 . . . . . . . . . . . . N/A
H36 8.67 119.3 173.7 54.7 25.5 L157 7.42 117.3 175.3 50.6 40.5
T37 7.51 109.2 172.5 58.7 66.6 Q158 7.65 122.8 173.7 56.2 24.5
A38 7.34 128.0 173.7 49.3 14.4 K159 8.71 116.3 176.7 56.4 30.0
K39 7.98 123.1 174.0 51.8 30.8 V160 6.89 113.6 173.5 61.5 28.3
Y40 8.57 127.1 172.2 53.9 34.3 V161 7.15 114.8 175.6 62.5 27.8
D41 7.61 129.4 171.3 46.0 39.3 D162 8.26 117.9 174.7 53.6 37.4
P42 N/A . . . 173.9 59.7 28.2 V163 7.00 114.5 174.7 58.0 29.8
S43 8.35 115.6 172.7 56.2 60.7 L164 6.92 122.1 175.9 54.3 36.2
L44 6.86 123.5 174.6 52.1 37.2 D165 8.08 116.6 175.3 53.7 36.7
K45 7.42 123.6 172.0 51.2 28.0 S166 7.85 114.0 171.9 57.0 60.9
P46 N/A . . . 175.1 60.0 28.0 I167 7.27 117.0 171.7 55.8 34.5
L47 8.84 127.0 173.1 52.0 39.9 K168 7.25 117.9 173.0 57.4 30.0
S48 8.45 122.0 168.8 54.2 60.3 T169 6.44 99.6 171.4 55.3 68.3
V49 8.13 126.7 172.7 58.1 27.8 K170 7.34 121.0 175.0 54.8 28.1
a Residues 1 to 20 were not assigned.
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Table A.1 – continued from previous page
Residue HN N CO Cα Cβ Residue HN N CO Cα Cβ
S50 8.38 127.4 172.0 50.1 36.4 G171 8.74 117.3 172.2 41.4 N/A
Y51 8.73 123.9 174.0 49.8 35.2 K172 7.68 120.7 172.3 53.0 30.0
D52 8.61 122.2 173.9 55.0 37.2 S173 8.21 114.2 170.2 53.6 63.8
Q53 7.93 114.9 172.4 51.4 25.1 A174 8.90 123.9 173.5 47.9 18.3
A54 7.26 120.6 175.3 50.4 15.9 D175 8.48 122.4 173.1 52.8 37.8
T55 9.26 121.1 170.4 57.6 68.7 F176 7.88 125.8 170.7 54.7 36.1
S56 9.88 127.0 170.8 55.9 60.6 T177 7.97 115.4 171.8 57.3 68.0
L57 8.81 118.0 175.4 52.5 42.0 N178 9.58 115.9 171.5 51.4 33.9
R58 7.07 115.3 169.0 52.0 30.3 F179 8.14 119.4 171.9 55.3 37.6
I59 8.91 122.6 169.7 54.7 38.2 D180 7.89 128.6 173.2 46.6 37.9
L60 8.56 124.1 172.1 51.2 41.6 P181 N/A . . . 174.2 60.9 27.7
N61 8.31 121.5 173.8 48.8 35.5 R182 8.19 118.7 176.4 56.2 25.7
N62 7.90 123.7 174.1 48.4 35.3 G183 7.16 103.3 171.2 42.8 N/A
G63 9.56 109.7 170.2 42.1 N/A L184 7.10 117.8 170.5 50.6 38.1
H64 . . . . . . . . . . . . . . . L185 6.49 113.6 174.1 49.7 37.7
A65 8.46 123.9 172.6 49.0 16.5 P186 N/A . . . 171.9 59.0 28.7
F66 7.07 110.5 171.2 52.0 38.5 E187 8.03 116.9 174.2 55.4 26.3
N67 8.85 121.2 172.4 47.3 36.6 S188 7.50 111.9 173.0 53.5 61.0
V68 8.53 122.4 172.5 58.3 27.2 L189 8.51 126.2 173.7 50.3 37.1
E69 8.35 124.3 173.4 52.1 28.7 D190 7.30 122.4 174.2 52.7 36.9
F70 8.51 119.5 172.2 53.8 38.5 Y191 8.64 119.4 169.8 53.8 39.8
D71 8.32 117.4 173.5 51.4 38.0 W192 9.42 117.6 174.3 54.7 27.9
D72 8.82 132.1 173.8 49.8 37.0 T193 9.57 115.6 168.1 55.3 67.5
S73 8.59 116.1 171.4 57.7 60.9 Y194 7.90 126.0 168.3 53.2 36.0
Q74 7.53 118.1 172.7 50.4 30.1 P195 N/A . . . 174.1 58.6 27.8
D75 8.76 123.4 172.0 51.8 35.6 G196 9.23 111.2 171.3 43.0 N/A
K76 7.85 124.6 172.5 54.7 31.0 S197 8.56 120.5 173.2 53.9 67.1
A77 7.93 122.9 172.2 48.1 15.6 L198 7.89 118.7 177.4 52.3 39.9
V78 8.23 117.3 169.8 55.2 33.1 T199 . . . . . . . . . . . . . . .
L79 8.84 123.2 171.8 49.7 42.4 T200 6.84 109.2 169.2 53.4 65.8
K80 8.28 120.4 172.0 51.4 33.2 P201 N/A . . . . . . . . . . . .
G81 8.92 107.0 171.4 41.2 N/A P202 N/A . . . 172.3 61.0 30.2
G82 6.97 109.5 171.4 41.4 N/A L203 9.01 120.9 170.8 53.9 33.4
P83 N/A . . . 172.6 59.5 28.4 L204 5.80 111.7 176.3 52.3 37.9
L84 7.66 120.9 174.3 51.4 37.5 E205 8.55 125.4 174.1 52.8 22.9
D85 8.95 125.6 173.0 50.0 38.0 C206 7.34 114.1 170.7 52.9 63.1
G86 7.79 110.1 170.3 41.2 N/A V207 7.09 117.2 173.6 58.3 32.2
T87 8.35 116.9 170.0 59.5 67.0 T208 8.22 125.8 170.3 60.2 64.9
Y88 8.30 126.1 172.6 52.1 36.0 W209 8.10 129.7 173.9 55.5 27.7
R89 8.48 123.4 173.3 52.5 29.8 I210 8.65 127.8 170.7 58.0 35.9
L90 8.40 124.4 172.0 52.7 38.0 V211 9.60 128.8 172.7 58.0 30.0
I91 . . . . . . . . . . . . . . . L212 8.80 126.9 173.9 52.2 36.0
Q92 7.15 115.6 172.3 51.8 26.4 K213 7.26 122.8 174.2 54.5 28.9
F93 8.47 113.9 169.7 52.8 41.3 E214 8.77 122.2 172.1 50.4 27.2
H94 8.06 113.5 168.3 52.6 28.6 P215 N/A . . . 176.1 58.6 29.7
F95 9.01 117.6 169.8 52.7 40.1 I216 8.81 114.0 171.7 56.9 37.4
H96 8.62 115.6 171.6 51.2 28.0 S217 7.95 117.0 170.1 53.8 61.7
W97 9.39 119.6 172.7 55.5 28.0 V218 8.41 116.4 172.0 55.7 30.3
G98 7.94 108.4 172.1 41.0 N/A S219 8.28 116.4 174.1 53.2 62.4
S99 8.26 112.4 170.7 55.4 59.4 S220 9.17 117.7 174.0 58.8 62.5
L100 7.21 119.5 174.8 50.4 41.7 E221 8.27 118.9 175.8 56.6 25.8
D101 8.76 120.9 173.6 54.0 36.8 Q222 7.40 118.4 173.6 56.3 24.8
G102 7.54 103.3 169.6 42.3 N/A V223 7.23 115.2 174.8 61.4 27.9
Q103 7.71 115.5 168.6 50.1 27.2 L224 7.87 121.3 176.6 55.1 37.9
G104 8.11 106.6 168.2 43.0 N/A K225 6.77 115.5 176.9 55.2 27.8
S105 7.21 108.2 170.0 55.0 60.0 F226 6.98 119.2 173.1 55.5 30.2
E106 8.16 119.5 175.0 55.4 27.1 R227 6.55 109.5 172.5 53.9 26.1
H107 10.56 118.2 170.9 56.9 25.5 K228 6.72 114.6 175.2 52.0 29.2
a Residues 1 to 20 were not assigned.
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Table A.1 – continued from previous page
Residue HN N CO Cα Cβ Residue HN N CO Cα Cβ
T108 7.22 109.8 170.7 56.2 68.3 L229 6.97 119.7 173.3 52.6 40.2
V109 7.50 119.0 174.4 57.9 30.1 N230 8.78 118.8 171.8 48.8 38.1
D110 9.57 132.8 173.6 53.3 35.8 F231 8.75 117.5 173.9 56.2 37.7
K111 9.72 110.4 173.1 55.0 26.5 N232 8.03 111.0 172.9 50.1 37.8
K112 8.10 125.1 172.1 53.5 29.0 G233 8.54 105.2 171.7 40.9 N/A
K113 7.84 122.4 173.9 51.9 31.7 E234 8.26 121.9 174.9 54.9 26.1
Y114 8.06 121.8 170.8 54.6 36.0 G235 8.94 114.6 171.0 42.1 N/A
A115 7.44 121.3 175.2 50.6 15.9 E236 7.23 120.5 170.6 50.6 26.5
A116 8.01 112.5 172.7 48.2 18.7 P237 N/A . . . 173.8 60.1 . . .
E117 9.30 121.4 170.2 52.8 32.5 E238 8.12 123.7 174.1 54.8 27.4
L118 9.77 130.9 171.8 50.0 39.9 E239 8.89 130.3 172.5 52.2 29.5
H119 8.87 125.6 171.0 49.0 29.9 L240 8.62 126.3 173.1 53.0 38.0
L120 8.90 124.1 172.0 52.5 38.5 M241 8.50 123.5 168.3 50.9 28.3
V121 9.07 126.9 170.9 60.8 29.3 V242 6.59 115.4 171.7 56.0 34.1
H122 8.41 124.6 . . . 50.8 37.8 D243 7.01 115.2 172.2 53.3 34.8
W123 8.95 119.5 171.4 50.6 30.3 N244 8.26 119.8 170.4 47.5 32.4
N124 8.94 120.3 174.3 50.3 35.6 W245 6.35 114.7 170.2 47.9 29.3
T125 8.07 117.9 174.0 60.9 65.3 R246 10.29 127.3 171.1 49.5 29.1
K127 7.81 123.4 174.6 55.1 28.4 P247 N/A . . . 173.3 58.7 29.4
Y128 7.56 116.1 174.3 54.7 35.1 A248 7.86 120.7 174.3 50.3 14.9
G129 7.73 107.9 170.5 44.7 N/A Q249 8.58 122.5 170.1 48.5 24.9
D130 7.30 116.8 171.4 49.5 39.6 P250 N/A . . . 174.6 59.5 28.0
F131 7.48 120.1 172.5 58.3 36.1 L251 8.55 126.3 176.0 54.1 38.6
G132 7.95 105.0 173.9 43.3 N/A K252 8.74 115.1 174.0 54.4 25.9
K133 7.50 120.1 176.4 54.8 29.3 N253 8.57 120.2 172.2 50.6 34.7
A134 7.80 123.8 176.8 52.1 16.3 R254 7.17 119.1 171.7 52.9 30.8
V135 7.80 113.9 171.0 60.7 27.6 Q255 8.46 118.7 172.0 51.2 28.0
Q136 6.44 113.9 173.5 51.9 26.1 I256 8.79 124.8 173.5 58.0 34.1
Q137 7.54 119.6 172.7 49.2 25.2 K257 8.66 127.0 172.4 51.3 32.5
P138 N/A . . . 173.5 61.9 28.3 A258 8.23 124.0 173.7 46.3 18.7
D139 7.77 115.0 175.6 48.8 35.7 S259 8.84 116.9 169.4 55.7 60.4
G140 8.15 108.7 171.7 45.3 N/A F260 6.51 118.4 168.4 50.3 38.7
L141 8.63 116.1 174.5 49.3 43.3 K261 7.62 124.9 178.7 54.0 30.0
a Residues 1 to 20 were not assigned.
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Figure A.1: Overlay of the 1H-15N-HSQC spectra (600 MHz, 298 K) of selective 15N leucine
labelled hCA-II_S166C_C206S-LuM8 (black) and hCA-II_S166C_C206S-TmM8 (red). As-
signment and PCS are indicated.
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Figure A.2: Overlay of the 1H-15N-HSQC spectra (600 MHz, 298 K) of selective 15N leucine
labelled hCA-II_S217C_C206S-LuM8 (black) and hCA-II_S217C_C206S-TmM8 (red). As-
signment and PCS are indicated.
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Figure A.3: Overlay of the 1H-15N-HSQC spectra (600 MHz, 298 K) of selective 15N leucine
labelled hCA-II_S220C_C206S-LuM8 (black) and hCA-II_S220C_C206S-TmM8 (red). As-
signment and PCS are indicated.
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Figure A.4: Overlay of the 1H-15N-HSQC spectra (600 MHz, 298 K) of uniform 15N labelled
hCA-II_S166C_C206S-LuM8 (black) and hCA-II_S166C_C206S-TmM8 (red). Aliased sig-
nals with negative intensity are shown with dashed contour lines. Assignment and PCS
are indicated with solid and NH2 groups with dashed lines.
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Figure A.5: Overlay of the 1H-15N-HSQC spectra (600 MHz, 298 K) of uniform 15N labelled
hCA-II_S217C_C206S-LuM8 (black) and hCA-II_S217C_C206S-TmM8 (red). Aliased sig-
nals with negative intensity are shown with dashed contour lines. Assignment and PCS
are indicated with solid and NH2 groups with dashed lines.
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Figure A.6: Overlay of the 1H-15N-HSQC spectra (600 MHz, 298 K) of uniform 15N labelled
hCA-II_S220C_C206S-LuM8 (black) and hCA-II_S220C_C206S-TmM8 (red). Aliased sig-
nals with negative intensity are shown with dashed contour lines. Assignment and PCS
are indicated with solid and NH2 groups with dashed lines.
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Table A.2: PCS of all four hCA-II mutants. Shifts which were excluded from tensor calcula-
tion are marked. All values are given in ppm.
Residue a S50C S166C S217C S220C
HN N HN N HN N HN N
I22 −0.010 b 0.167 b −0.150 c −0.085 c −0.089 −0.136 −0.082 −0.051
A23 0.032 b 0.052 b −0.163 −0.094 −0.100 −0.137 −0.094 −0.093
K24 0.019 0.063 −0.132 −0.061 −0.096 −0.098 . . . . . .
G25 0.026 0.033 −0.124 −0.146 −0.141 −0.189 −0.080 −0.045
E26 0.053 0.101 −0.102 −0.034 −0.171 −0.205 −0.057 −0.069
R27 0.055 0.090 −0.111 −0.066 −0.220 −0.220 −0.068 −0.038
Q28 0.094 0.060 −0.102 −0.167 −0.252 −0.361 −0.076 −0.057
S29 0.094 0.235 d −0.160 −0.098 −0.270 −0.303 −0.111 −0.102
V31 0.135 0.083 −0.096 −0.178 −0.592 −0.538 −0.087 −0.080
D32 0.128 −0.006 d −0.072 −0.112 −0.616 −0.660 −0.038 −0.061
I33 0.165 0.131 −0.022 −0.058 −1.192 −1.165 0.033 0.034
D34 0.200 0.166 −0.020 0.010 −1.099 −1.239 0.051 0.034
T35 0.189 0.143 0.014 −0.021 −1.752 −1.612 0.136 0.118
H36 0.207 b 0.126 b 0.013 0.000 −1.380 −1.384 0.117 0.148
T37 0.214 0.242 0.000 −0.045 −1.087 −1.054 0.080 0.082
A38 0.261 0.206 0.001 −0.003 −1.146 −1.017 0.070 0.020
K39 0.360 0.376 −0.011 0.024 −0.817 −0.857 0.036 0.048
Y40 0.410 0.493 0.005 0.005 −0.800 −0.782 0.051 0.026
D41 0.653 0.571 0.002 −0.037 −0.571 −0.585 0.023 0.029
S43 0.779 0.879 −0.005 −0.042 −0.249 −0.160 0.005 −0.005
L44 1.039 1.213 −0.010 0.024 −0.252 −0.237 −0.001 0.003
K45 1.949 1.928 −0.020 −0.026 −0.130 −0.114 −0.019 −0.022
L47 3.001 b 3.747 b 0.000 0.051 0.066 0.062 −0.035 −0.044
S48 . . . . . . −0.037 −0.082 0.072 0.105 −0.063 −0.071
V49 . . . . . . −0.015 0.026 0.284 0.207 −0.088 −0.077
S50 . . . . . . −0.088 −0.134 0.124 0.145 −0.107 −0.111
Y51 . . . . . . −0.068 −0.079 0.216 0.150 −0.130 −0.138
D52 . . . . . . −0.093 −0.191 0.204 0.116 −0.124 −0.111
Q53 . . . . . . −0.181 −0.209 0.129 0.061 −0.121 −0.083
A54 −3.566 b −2.908 b −0.254 −0.227 0.066 0.031 −0.145 −0.122
T55 −1.195 −1.220 −0.493 −0.596 0.004 −0.057 −0.151 −0.186
S56 −0.746 −0.698 −0.824 −0.885 −0.034 −0.043 −0.189 −0.196
L57 −0.396 −0.341 −1.216 −1.318 −0.047 −0.091 −0.196 −0.172
R58 −0.296 −0.319 −1.623 c −1.880 c −0.057 −0.056 −0.209 −0.264 d
I59 −0.205 −0.174 −3.301 −2.859 −0.040 −0.072 −0.241 −0.213
L60 −0.216 −0.304 d −2.226 −2.466 −0.022 −0.021 −0.290 −0.259
N61 −0.118 −0.130 . . . . . . . . . . . . −0.239 −0.236
N62 −0.112 −0.120 −1.424 −1.325 0.003 b 0.019 b −0.267 −0.230
G63 −0.082 0.012 −1.353 −1.248 0.026 −0.010 −0.247 −0.270
H64 . . . . . . . . . . . . . . . . . . . . . . . .
A65 . . . . . . −1.065 −0.904 . . . . . . . . . . . .
F66 −0.149 −0.079 −1.196 −1.299 0.011 −0.019 −0.447 −0.395
N67 −0.207 −0.200 −1.580 −1.409 −0.016 −0.026 −0.315 −0.297
V68 −0.346 −0.338 −1.049 −1.224 . . . . . . −0.412 −0.362
E69 −0.338 −0.482 −1.378 −1.217 −0.056 −0.072 −0.238 −0.217
F70 −0.488 −0.513 −0.708 −0.869 −0.058 −0.075 −0.182 −0.196
D71 −0.433 b −0.157 b −0.648 −0.601 −0.032 −0.086 −0.148 −0.148
D72 −0.343 b −0.426 b −0.425 −0.372 −0.022 −0.011 −0.119 −0.082
S73 0.132 0.068 −0.351 −0.381 −0.010 −0.063 −0.105 −0.141
Q74 0.677 b 0.772 b −0.286 −0.331 0.000 0.025 −0.094 −0.109
a Residues 1 to 20 (not assigned) and proline residues 21, 30, 42, 46, 83, 138, 155, 181, 186, 195, 201, 202, 215, 237, 247 and 250
(no resonance in 1H-15N-HSQC) were omitted. b PCS which were excluded from tensor calculation for set 1. c PCS excluded
for set 2, additionally to set 1. d PCS excluded for set 3, additionally to set 1 and 2.
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Residue a S50C S166C S217C S220C
HN N HN N HN N HN N
D75 . . . . . . −0.176 −0.066 d −0.018 0.010 −0.163 −0.116
K76 . . . . . . −0.250 −0.229 0.021 0.029 −0.100 −0.105
A77 . . . . . . −0.259 −0.129 0.018 0.059 −0.115 −0.117
V78 . . . . . . −0.167 −0.255 0.060 0.004 −0.113 −0.130
L79 . . . . . . −0.152 −0.144 d −0.022 −0.073 −0.109 −0.101
K80 . . . . . . −0.074 −0.105 0.012 −0.034 −0.079 −0.112
G81 . . . . . . −0.066 0.001 −0.010 −0.014 −0.053 −0.076
G82 4.147 b 3.804 b −0.027 −0.090 −0.040 −0.037 −0.033 −0.035
L84 2.332 d 1.941 d −0.063 −0.037 −0.167 −0.215 −0.050 −0.029
D85 0.929 1.117 −0.069 −0.077 −0.125 −0.042 −0.045 −0.042
G86 1.082 0.737 −0.078 −0.043 −0.050 −0.044 −0.052 −0.036
T87 −1.097 b −0.668 b −0.110 −0.103 −0.024 −0.048 −0.062 −0.097
Y88 0.837 b 0.016 b −0.136 −0.101 −0.042 −0.046 −0.083 −0.072
R89 −1.027 b −1.328 b −0.203 −0.246 −0.062 −0.072 −0.098 −0.126
L90 −1.632 −1.318 −0.253 −0.339 −0.049 0.023 −0.134 −0.145
I91 . . . . . . . . . . . . . . . . . . . . . . . .
Q92 −0.415 −0.419 −0.462 −0.524 −0.116 −0.198 −0.199 −0.179
F93 −0.415 −0.433 −0.708 −0.556 −0.099 b −0.161 b −0.267 −0.215
H94 −0.233 −0.182 −0.484 −0.572 −0.173 −0.149 −0.324 −0.306
F95 −0.192 b −0.234 b −0.651 −0.533 −0.030 −0.066 −0.470 −0.451
H96 −0.062 0.024 d −0.310 −0.412 −0.028 0.021 −0.501 c −0.515 c
W97 −0.042 −0.055 −0.415 −0.290 0.201 0.214 −0.711 −0.726
G98 −0.061 −0.113 −0.172 −0.265 0.629 0.575 −1.252 c −1.188 c
S99 −0.024 −0.041 −0.235 −0.290 0.589 0.495 −0.901 b −0.815 b
L100 −0.023 −0.078 −0.133 −0.162 0.781 0.770 −0.786 −0.741
D101 −0.030 −0.057 0.074 −0.006 1.413 d 1.407 d . . . . . .
G102 −0.014 −0.032 0.047 0.004 1.506 1.557 −1.441 b −1.016 b
Q103 −0.016 0.000 −0.018 −0.084 1.107 0.951 . . . . . .
G104 −0.001 0.050 −0.100 −0.145 0.450 0.500 −0.558 b −0.649 b
S105 −0.003 −0.029 −0.076 −0.078 0.361 0.244 −0.356 −0.419
E106 0.005 0.159 d −0.130 −0.148 −0.314 −0.208 −0.238 −0.305
H107 0.092 0.161 −0.101 −0.128 −0.574 −0.601 −0.156 −0.128
T108 0.115 −0.005 −0.054 −0.091 −0.864 −0.890 −0.031 −0.060
V109 0.106 0.072 0.004 −0.047 −1.409 d −1.520 d 0.138 0.119
D110 0.155 0.111 0.004 0.003 −1.642 d −1.682 d 0.130 0.133
K111 0.108 0.056 −0.008 −0.029 −1.039 d −0.964 d 0.102 0.097
K112 0.091 0.053 0.018 −0.019 −1.216 b −0.902 b 0.195 0.199
K113 0.046 0.049 0.010 0.006 0.157 b −0.005 b 0.155 0.107
Y114 0.026 −0.037 0.000 0.024 . . . . . . −0.006 c 0.082 c
A115 −0.014 −0.002 0.109 0.096 . . . . . . . . . . . .
A116 −0.032 0.012 0.042 0.080 0.856 b 0.776 b −0.237 c −0.379 c
E117 −0.057 0.011 −0.148 −0.052 0.019 −0.032 −0.469 −0.334
L118 −0.065 −0.056 −0.068 −0.030 −0.585 −0.437 −0.288 −0.303
H119 −0.148 0.039 c −0.299 −0.291 −0.278 −0.396 −0.326 −0.247
L120 −0.065 −0.170 −0.184 −0.148 −0.390 −0.285 −0.194 −0.170
V121 −0.292 −0.275 −0.358 −0.386 −0.183 −0.302 −0.204 −0.177
H122 −0.050 −0.065 −0.244 −0.280 −0.187 −0.221 −0.138 −0.128
W123 −0.528 −0.415 −0.270 −0.232 −0.093 −0.172 −0.113 −0.106
N124 −0.320 −0.516 −0.175 −0.294 −0.107 −0.027 −0.086 −0.091
T125 −1.262 −1.159 −0.151 −0.067 −0.052 −0.062 −0.074 −0.074
K127 −1.193 −1.268 −0.129 −0.072 −0.048 −0.037 −0.063 −0.092
Y128 −0.850 −0.917 d −0.141 −0.074 −0.057 −0.077 −0.062 −0.075
a Residues 1 to 20 (not assigned) and proline residues 21, 30, 42, 46, 83, 138, 155, 181, 186, 195, 201, 202, 215, 237, 247 and 250
(no resonance in 1H-15N-HSQC) were omitted. b PCS which were excluded from tensor calculation for set 1. c PCS excluded
for set 2, additionally to set 1. d PCS excluded for set 3, additionally to set 1 and 2.
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Residue a S50C S166C S217C S220C
HN N HN N HN N HN N
G129 −0.756 −0.625 −0.143 −0.096 −0.039 −0.053 −0.067 −0.042
D130 −0.445 −0.490 −0.163 −0.244 −0.047 −0.058 −0.074 −0.067
F131 −0.359 −0.282 −0.252 −0.231 −0.052 −0.089 −0.085 −0.091
G132 −0.243 −0.236 −0.228 −0.297 −0.055 −0.077 −0.092 −0.094
K133 −0.260 −0.255 −0.174 −0.249 −0.058 −0.122 −0.076 −0.090
A134 −0.311 −0.256 −0.181 −0.178 −0.068 −0.123 −0.081 −0.055
V135 −0.211 −0.230 d −0.199 −0.140 −0.091 −0.111 −0.092 −0.084
Q136 −0.162 −0.089 −0.167 −0.230 −0.091 −0.111 −0.078 −0.092
Q137 −0.140 −0.161 −0.148 −0.195 −0.108 −0.182 −0.076 −0.059
D139 −0.062 −0.046 −0.111 −0.073 −0.140 −0.175 −0.059 −0.084
G140 −0.043 −0.036 −0.134 −0.211 −0.147 −0.157 −0.074 −0.073
L141 0.036 −0.010 −0.159 −0.220 −0.173 −0.234 −0.083 −0.081
A142 0.135 0.295 −0.191 −0.140 −0.191 −0.237 −0.106 −0.089
V143 0.392 0.409 −0.150 −0.214 −0.353 −0.398 −0.109 −0.094
L144 0.175 0.240 −0.172 −0.078 −0.380 −0.464 −0.152 −0.124
G145 0.304 0.127 −0.076 −0.114 −0.831 −0.788 −0.113 −0.110
I146 0.037 0.091 −0.065 0.025 −0.895 −1.081 −0.192 −0.140
F147 0.058 −0.026 0.070 0.036 −2.143 c −1.916 c −0.039 −0.052
L148 −0.024 −0.020 0.106 0.090 1.956 b 2.110 b −0.104 b −0.073 b
K149 −0.067 −0.021 0.316 0.204 . . . . . . . . . . . .
V150 −0.051 −0.034 0.321 0.298 . . . . . . 0.655 b 0.846 b
G151 −0.107 −0.064 0.627 0.669 . . . . . . . . . . . .
S152 −0.122 −0.099 0.686 0.741 . . . . . . . . . . . .
A153 −0.178 −0.258 1.219 1.136 . . . . . . −0.956 b −0.842 b
K154 −0.237 −0.256 1.351 1.281 . . . . . . . . . . . .
G156 . . . . . . . . . . . . . . . . . . . . . . . .
L157 −0.433 −0.458 1.475 1.494 . . . . . . −0.916 d −0.841 d
Q158 −0.403 −0.342 2.423 2.608 −0.360 −0.302 −0.974 −0.971
K159 −0.431 −0.371 3.115 3.731 −0.276 −0.248 −0.687 −0.657
V160 −0.384 −0.366 1.663 c 1.813 c . . . . . . −0.731 −0.665
V161 −0.291 −0.368 . . . . . . −0.066 −0.036 −0.988 b −0.916 b
D162 −0.264 −0.248 . . . . . . −0.132 −0.084 −0.855 −0.818
V163 −0.236 −0.247 . . . . . . −0.079 −0.112 −0.608 −0.490
L164 −0.194 −0.182 . . . . . . −0.012 −0.005 −0.644 −0.557
D165 −0.138 −0.144 . . . . . . −0.010 0.016 −0.477 −0.417
S166 −0.139 −0.126 . . . . . . −0.024 −0.030 −0.315 −0.236
I167 −0.136 −0.098 −11.203 b −10.446 b 0.039 −0.028 −0.298 −0.274
K168 −0.098 −0.089 −7.403 b −6.021 b 0.016 −0.013 −0.204 −0.204
T169 −0.082 −0.077 −3.833 −3.513 0.029 0.020 −0.161 −0.173
K170 −0.063 −0.041 −1.722 −1.836 0.035 0.091 −0.148 −0.180
G171 −0.103 −0.005 −1.681 d −1.393 0.008 −0.012 −0.178 −0.093
K172 −0.080 −0.054 −1.996 c −1.842 c −0.010 −0.030 −0.158 −0.187
S173 −0.089 −0.103 . . . . . . −0.010 −0.023 −0.152 −0.133
A174 −0.143 −0.075 . . . . . . −0.025 −0.102 −0.210 −0.129
D175 −0.120 −0.155 . . . . . . −0.045 −0.088 −0.165 −0.125
F176 −0.224 −0.314 . . . . . . −0.052 −0.081 −0.195 −0.248
T177 −0.283 −0.349 . . . . . . −0.073 −0.081 −0.205 −0.210
N178 −0.481 −0.557 −1.283 −1.278 −0.051 −0.085 −0.184 −0.225
F179 −0.703 −0.747 −0.885 −0.618 −0.069 −0.104 −0.238 −0.264
D180 −1.028 −1.191 0.139 −0.073 −0.106 −0.114 −0.305 −0.305
R182 −1.995 −1.801 0.085 0.138 0.024 0.009 −0.248 −0.209
G183 −1.296 −1.218 0.307 0.410 −0.079 −0.068 −0.319 −0.334
L184 −0.901 −0.769 0.281 0.349 −0.163 −0.179 −0.344 −0.401
a Residues 1 to 20 (not assigned) and proline residues 21, 30, 42, 46, 83, 138, 155, 181, 186, 195, 201, 202, 215, 237, 247 and 250
(no resonance in 1H-15N-HSQC) were omitted. b PCS which were excluded from tensor calculation for set 1. c PCS excluded
for set 2, additionally to set 1. d PCS excluded for set 3, additionally to set 1 and 2.
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Residue a S50C S166C S217C S220C
HN N HN N HN N HN N
L185 −0.757 −0.580 0.281 0.195 −0.167 −0.333 −0.290 −0.273
E187 −0.057 −0.028 0.260 0.196 . . . . . . −0.007 −0.001
S188 0.126 0.130 0.188 0.144 . . . . . . −0.018 −0.025
L189 0.471 c 0.425 c 0.099 0.108 0.927 0.614 −0.025 −0.012
D190 0.558 d 0.611 d 0.005 0.059 −0.297 b −0.527 b 0.014 −0.014
Y191 0.831 0.749 0.019 0.061 −1.046 c −1.063 c . . . . . .
W192 0.567 0.608 0.008 −0.074 −1.559 −1.547 0.002 0.033
T193 0.591 0.646 −0.030 0.025 −0.865 −0.864 −0.006 0.015
Y194 0.502 0.551 −0.070 −0.117 −0.596 −0.678 −0.046 −0.019
G196 0.225 0.220 −0.116 −0.186 −0.335 −0.291 −0.072 −0.088
S197 0.123 0.278 c −0.150 0.049 d −0.306 −0.240 −0.085 0.028 d
L198 −0.011 b −0.044 b −0.194 −0.245 −0.188 −0.259 −0.116 −0.154
T199 . . . . . . . . . . . . . . . . . . . . . . . .
T200 . . . . . . −0.305 −0.339 −0.142 −0.028 −0.182 −0.177
L203 0.002 0.136 d −0.257 −0.291 −0.111 −0.212 −0.135 −0.118
L204 −0.028 −0.078 −0.217 −0.216 −0.130 −0.176 −0.113 −0.071
E205 −0.004 −0.035 −0.151 −0.119 −0.145 −0.167 −0.083 −0.095
C206 0.031 0.032 −0.163 c −0.333 c −0.191 −0.150 −0.092 −0.097
V207 0.108 0.155 −0.151 −0.232 −0.232 −0.209 −0.085 −0.085
T208 0.307 0.385 −0.137 −0.110 −0.275 −0.329 −0.085 −0.063
W209 0.418 0.469 −0.101 −0.186 −0.456 −0.513 −0.067 −0.061
I210 0.532 0.659 −0.101 −0.045 −0.595 −0.632 −0.091 −0.042
V211 0.540 0.459 −0.038 −0.074 −1.062 −1.108 −0.040 −0.032
L212 0.328 0.495 −0.003 0.071 −1.656 −1.761 −0.056 0.002
K213 0.416 0.326 0.061 0.118 . . . . . . 0.042 0.112
E214 0.260 0.210 0.115 0.142 . . . . . . 0.071 0.073
I216 −0.061 −0.102 0.248 0.234 . . . . . . −0.022 −0.018
S217 −0.152 −0.155 0.514 0.429 . . . . . . . . . . . .
V218 −0.131 −0.103 0.585 0.658 . . . . . . . . . . . .
S219 −0.184 −0.159 1.143 1.136 . . . . . . . . . . . .
S220 −0.108 −0.112 0.850 0.897 1.370 b 1.267 b . . . . . .
E221 −0.121 −0.103 1.191 1.196 0.539 b 0.595 b . . . . . .
Q222 −0.150 −0.122 1.345 1.563 0.504 0.395 . . . . . .
V223 −0.145 −0.160 0.760 0.718 0.818 b 0.603 b . . . . . .
L224 −0.114 −0.148 0.570 0.422 0.652 0.620 . . . . . .
K225 −0.131 −0.121 0.523 0.347 0.346 0.338 . . . . . .
F226 −0.130 −0.130 −0.144 −0.368 0.349 0.269 . . . . . .
R227 −0.103 −0.160 −0.466 −0.663 0.372 0.315 . . . . . .
K228 −0.098 −0.129 −1.091 −1.159 0.243 0.322 . . . . . .
L229 −0.095 −0.037 −1.652 −1.877 0.183 0.138 −0.632 d −0.467 d
N230 −0.080 −0.064 −2.396 −2.143 0.093 0.151 −0.282 −0.309
F231 −0.060 −0.052 −1.234 −1.323 0.108 0.129 −0.231 −0.311
N232 −0.046 −0.031 −1.250 −1.151 0.079 0.035 −0.143 −0.169
G233 −0.047 −0.072 −0.987 −1.209 0.039 0.039 −0.074 −0.081
E234 −0.046 −0.057 −1.285 −1.276 0.020 0.097 −0.051 −0.054
G235 −0.033 −0.028 −1.229 −1.090 d 0.034 0.014 0.031 0.023
E236 −0.037 −0.069 −0.983 −0.932 0.044 0.099 0.011 0.019
E238 −0.027 −0.055 −0.932 −1.002 0.093 0.110 0.118 0.109
E239 −0.049 −0.027 −1.108 −1.012 0.105 0.129 −0.053 −0.047
L240 −0.043 −0.075 −0.858 −1.013 0.172 0.236 −0.154 −0.224
M241 −0.066 −0.006 −1.149 −1.162 0.169 0.075 −0.561 −0.437
V242 −0.053 −0.068 −0.708 −0.686 0.215 0.253 −0.610 −0.706
D243 −0.055 −0.072 −0.412 −0.484 0.349 0.341 −0.871 −0.837
a Residues 1 to 20 (not assigned) and proline residues 21, 30, 42, 46, 83, 138, 155, 181, 186, 195, 201, 202, 215, 237, 247 and 250
(no resonance in 1H-15N-HSQC) were omitted. b PCS which were excluded from tensor calculation for set 1. c PCS excluded
for set 2, additionally to set 1. d PCS excluded for set 3, additionally to set 1 and 2.
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Residue a S50C S166C S217C S220C
HN N HN N HN N HN N
N244 −0.040 −0.042 −0.450 −0.485 0.193 0.111 −0.663 −0.620
W245 −0.027 −0.135 −0.344 −0.395 0.107 0.136 −0.487 −0.474
R246 −0.022 −0.052 −0.264 −0.326 −0.089 b −0.042 b −0.303 −0.332
A248 0.051 0.023 −0.121 −0.187 −0.205 −0.213 −0.163 −0.193
Q249 0.105 0.071 −0.096 −0.171 −0.280 −0.268 −0.100 −0.094
L251 0.112 0.121 −0.068 −0.082 −0.385 −0.363 −0.041 −0.084
K252 0.098 0.071 −0.058 −0.084 −0.321 −0.292 −0.029 −0.049
N253 0.118 0.114 −0.060 −0.014 −0.304 −0.353 −0.028 −0.016
R254 0.155 0.157 −0.052 −0.089 −0.362 −0.276 −0.023 −0.022
Q255 0.248 0.232 −0.048 0.012 −0.431 −0.477 −0.012 −0.024
I256 0.287 0.347 −0.028 −0.041 −0.666 −0.692 0.007 0.011
K257 0.477 0.450 −0.034 0.065 −0.729 −0.779 −0.002 0.037
A258 0.539 0.559 −0.006 −0.043 −0.830 −0.959 0.027 0.012
S259 0.759 0.727 0.011 −0.008 −0.973 −0.809 0.021 0.032
F260 0.655 0.673 0.023 0.004 −0.985 −0.786 0.047 0.051
K261 0.542 0.524 0.047 −0.034 −0.633 −0.785 0.066 0.066
aResidues 1 to 21 (not assigned) and proline residues 21, 30, 42, 46, 83, 138, 155, 181, 186, 195, 201, 202, 215, 237, 247 and 250
(no resonance in 1H-15N-HSQC) were omitted. bPCS which were excluded from tensor calculation for set 1. c PCS excluded
for set 2, additionally to set 1. d PCS excluded for set 3, additionally to set 1 and 2.
Table A.3: 1H-15N HSQC peak assignments for untagged, LuM8 tagged and TmM8 tagged
hCA-II mutants S50C and S166C. All values are given in ppm.
Residue a S50C S50C-Lu S50C-Tm S166C S166C-Lu S166C-Tm
HN N HN N HN N HN N HN N HN N
I22 8.07 120.4 8.07 120.4 8.06 120.6 8.06 120.4 8.06 120.6 7.91 120.5
A23 8.67 123.0 8.67 123.0 8.71 123.0 8.67 123.0 8.70 123.0 8.54 122.9
K24 7.21 114.8 7.21 114.8 7.23 114.8 7.20 114.7 7.21 114.8 7.08 114.7
G25 8.32 108.8 8.32 108.8 8.34 108.8 8.31 108.8 8.32 108.8 8.20 108.7
E26 9.37 117.7 9.37 117.7 9.42 117.8 9.36 117.7 9.37 117.7 9.27 117.7
R27 8.87 121.4 8.87 121.4 8.92 121.5 8.86 121.4 8.86 121.5 8.75 121.4
Q28 7.71 115.5 7.71 115.5 7.81 115.5 7.71 115.5 7.71 115.5 7.61 115.3
S29 8.07 117.8 8.07 117.8 8.16 118.1 8.05 117.8 8.08 117.9 7.92 117.8
V31 6.30 107.0 6.30 107.0 6.44 107.1 6.30 107.0 6.30 106.9 6.21 106.8
D32 8.33 118.3 8.33 118.3 8.46 118.3 8.35 118.3 8.35 118.3 8.27 118.2
I33 8.73 128.5 8.73 128.5 8.90 128.6 8.72 128.5 8.73 128.5 8.71 128.4
D34 7.53 128.2 7.53 128.2 7.73 128.4 7.53 128.2 7.53 128.2 7.50 128.2
T35 10.30 122.3 10.30 122.3 10.49 122.4 10.29 122.2 10.30 122.2 10.31 122.2
H36 8.80 118.9 8.80 118.9 9.01 119.0 8.81 118.8 8.82 118.8 8.83 118.8
T37 7.65 108.6 7.65 108.6 7.86 108.8 7.64 108.6 7.65 108.7 7.65 108.6
A38 7.49 127.6 7.49 127.6 7.75 127.8 7.48 127.5 7.48 127.5 7.48 127.5
K39 8.15 122.7 8.15 122.7 8.51 123.1 8.14 122.7 8.15 122.7 8.14 122.7
Y40 8.72 126.7 8.72 126.7 9.13 127.2 8.72 126.8 8.72 126.8 8.73 126.8
D41 7.76 128.9 7.76 128.9 8.41 129.4 7.74 128.8 7.74 128.8 7.74 128.8
S43 8.50 115.2 8.50 115.2 9.28 116.1 8.49 115.2 8.50 115.2 8.50 115.2
L44 7.01 123.1 7.01 123.1 8.05 124.3 6.99 123.1 7.00 123.1 6.99 123.1
K45 7.58 123.2 7.58 123.2 9.53 125.2 7.57 123.2 7.58 123.2 7.56 123.2
L47 8.98 126.4 8.98 126.4 11.98 130.2 8.97 126.1 8.97 126.1 8.97 126.1
a Residues 1 to 20 (not assigned) and proline residues 21, 30, 42, 46, 83, 138, 155, 181, 186, 195, 201, 202, 215, 237, 247 and 250
(no resonance in 1H-15N-HSQC) were omitted.
continued on next page . . .
A.2 PCS spectra 171
Table A.3 – continued from previous page
Residue a S50C S50C-Lu S50C-Tm S166C S166C-Lu S166C-Tm
HN N HN N HN N HN N HN N HN N
S48 8.58 121.4 8.58 121.4 . . . . . . 8.52 120.2 8.53 120.2 8.49 120.1
V49 8.27 126.2 8.27 126.2 . . . . . . 8.41 127.6 8.41 127.6 8.40 127.6
S50 8.52 127.0 8.52 127.0 . . . . . . 8.37 122.8 8.38 122.8 8.29 122.6
Y51 8.90 123.5 8.90 123.5 . . . . . . 8.99 124.6 9.00 124.5 8.93 124.4
D52 8.74 121.7 8.74 121.7 . . . . . . 8.88 121.4 8.90 121.5 8.80 121.3
Q53 8.05 114.4 8.05 114.4 . . . . . . 8.05 114.4 8.07 114.4 7.88 114.2
A54 7.40 120.1 7.40 120.1 3.83 117.2 7.42 120.2 7.42 120.2 7.16 120.0
T55 9.40 120.8 9.40 120.8 8.21 119.6 9.43 120.7 9.44 120.7 8.95 120.1
S56 10.02 126.6 10.02 126.6 9.28 125.9 9.99 126.5 10.00 126.4 9.17 125.6
L57 8.94 117.5 8.94 117.5 8.54 117.2 8.92 117.6 8.92 117.6 7.70 116.3
R58 7.21 114.8 7.21 114.8 6.92 114.4 7.20 114.7 7.20 114.5 5.57 112.6
I59 9.05 122.1 9.05 122.1 8.84 121.9 9.02 122.0 9.03 122.0 5.73 119.1
L60 8.72 123.9 8.72 123.9 8.50 123.6 8.71 123.9 8.72 123.9 6.49 121.5
N61 8.45 121.2 8.45 121.2 8.33 121.1 . . . . . . . . . . . . . . . . . .
N62 8.05 123.3 8.05 123.3 7.94 123.2 8.06 123.4 8.05 123.3 6.63 122.0
G63 9.71 108.9 9.71 108.9 9.63 108.9 9.74 109.0 9.70 109.1 8.35 107.8
H64 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
A65 . . . . . . . . . . . . . . . . . . . . . . . . 8.62 123.5 7.56 122.6
F66 7.23 110.1 7.23 110.1 7.08 110.0 7.23 110.1 7.24 110.1 6.04 108.8
N67 9.00 120.8 9.00 120.8 8.80 120.6 8.99 120.8 8.95 120.8 7.37 119.4
V68 8.70 122.0 8.70 122.0 8.36 121.7 8.68 122.0 8.68 122.0 7.63 120.8
E69 8.49 124.0 8.49 124.0 8.16 123.5 8.45 124.0 8.46 123.9 7.09 122.7
F70 8.65 119.1 8.65 119.1 8.16 118.6 8.63 119.0 8.63 119.0 7.92 118.1
D71 8.46 117.0 8.46 117.0 8.02 116.8 8.44 117.1 8.44 117.1 7.80 116.5
D72 8.97 131.6 8.97 131.6 8.63 131.2 8.98 131.7 8.99 131.7 8.56 131.4
S73 8.76 115.6 8.76 115.6 8.89 115.7 8.72 115.5 8.72 115.5 8.37 115.1
Q74 7.66 117.5 7.66 117.5 8.34 118.3 7.70 117.7 7.71 117.8 7.42 117.4
D75 8.86 123.0 8.86 123.0 . . . . . . 8.87 123.1 8.88 123.1 8.70 123.0
K76 8.01 124.2 8.01 124.2 . . . . . . 7.96 124.1 7.96 124.1 7.71 123.9
A77 8.08 122.5 8.08 122.5 . . . . . . 8.26 123.4 8.27 123.5 8.01 123.3
V78 8.37 116.7 8.37 116.7 . . . . . . 8.39 115.9 8.40 115.9 8.23 115.6
L79 8.98 122.8 8.98 122.8 . . . . . . 9.02 123.6 9.03 123.6 8.87 123.5
K80 8.42 119.9 8.42 119.9 . . . . . . 8.37 120.5 8.37 120.5 8.30 120.4
G81 9.06 106.6 9.06 106.6 . . . . . . 9.03 106.5 9.03 106.5 8.97 106.5
G82 7.13 109.0 7.13 109.0 11.28 112.8 7.04 108.7 7.04 108.7 7.02 108.7
L84 7.80 120.3 7.80 120.3 10.13 122.2 7.78 120.3 7.78 120.3 7.72 120.3
D85 9.08 125.2 9.08 125.2 10.01 126.3 9.08 125.2 9.09 125.2 9.02 125.1
G86 7.92 109.5 7.92 109.5 9.00 110.3 7.91 109.5 7.92 109.5 7.84 109.5
T87 8.50 116.4 8.50 116.4 7.40 115.7 8.52 116.7 8.53 116.7 8.42 116.6
Y88 8.44 125.8 8.44 125.8 9.28 125.9 8.43 126.0 8.44 126.0 8.30 125.9
R89 8.63 123.0 8.63 123.0 7.60 121.6 8.60 122.8 8.60 122.8 8.40 122.5
L90 8.55 124.1 8.55 124.1 6.92 122.8 8.54 123.9 8.54 123.9 8.28 123.5
I91 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Q92 7.30 115.2 7.30 115.2 6.89 114.8 7.30 115.2 7.30 115.1 6.84 114.6
F93 8.63 113.5 8.63 113.5 8.22 113.1 8.62 113.5 8.60 113.4 7.89 112.9
H94 8.22 113.1 8.22 113.1 7.98 112.9 8.21 113.0 8.21 113.1 7.72 112.6
F95 9.18 117.3 9.18 117.3 8.99 117.0 9.16 117.3 9.16 117.2 8.51 116.7
H96 8.74 115.0 8.74 115.0 8.68 115.0 8.73 115.1 8.76 115.2 8.45 114.7
W97 9.53 119.1 9.53 119.1 9.48 119.1 9.53 119.2 9.54 119.2 9.13 118.9
G98 8.10 108.0 8.10 108.0 8.04 107.9 8.10 108.0 8.11 108.0 7.94 107.7
S99 8.41 111.9 8.41 111.9 8.39 111.8 8.41 111.9 8.42 111.9 8.18 111.6
L100 7.35 119.0 7.35 119.0 7.32 118.9 7.35 119.0 7.36 119.0 7.23 118.9
D101 8.91 120.5 8.91 120.5 8.88 120.5 8.90 120.5 8.91 120.5 8.98 120.5
G102 7.69 102.8 7.69 102.8 7.67 102.7 7.68 102.8 7.69 102.8 7.73 102.8
Q103 7.87 114.9 7.87 114.9 7.85 114.9 7.86 114.9 7.86 114.9 7.85 114.9
G104 8.27 106.3 8.27 106.3 8.27 106.3 8.26 106.3 8.27 106.3 8.17 106.1
a Residues 1 to 20 (not assigned) and proline residues 21, 30, 42, 46, 83, 138, 155, 181, 186, 195, 201, 202, 215, 237, 247 and 250
(no resonance in 1H-15N-HSQC) were omitted.
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Residue a S50C S50C-Lu S50C-Tm S166C S166C-Lu S166C-Tm
HN N HN N HN N HN N HN N HN N
S105 7.36 107.7 7.36 107.7 7.35 107.7 7.35 107.7 7.36 107.7 7.28 107.7
E106 8.31 119.0 8.31 119.0 8.31 119.1 8.29 119.0 8.31 119.0 8.18 118.8
H107 10.69 117.8 10.69 117.8 10.78 117.9 10.68 117.8 10.69 117.8 10.59 117.7
T108 7.38 109.3 7.38 109.3 7.49 109.3 7.37 109.3 7.37 109.3 7.32 109.2
V109 7.64 118.5 7.64 118.5 7.74 118.6 7.63 118.5 7.63 118.5 7.63 118.5
D110 9.71 132.3 9.71 132.3 9.87 132.4 9.71 132.3 9.72 132.3 9.72 132.3
K111 9.88 109.8 9.88 109.8 9.99 109.9 9.87 109.8 9.88 109.8 9.87 109.8
K112 8.26 124.6 8.26 124.6 8.35 124.6 8.25 124.6 8.26 124.6 8.27 124.6
K113 7.98 122.0 7.98 122.0 8.03 122.1 7.98 122.1 7.98 122.0 7.99 122.1
Y114 8.20 121.4 8.20 121.4 8.22 121.3 8.18 121.3 8.19 121.3 8.19 121.4
A115 7.58 120.9 7.58 120.9 7.57 120.9 7.58 120.9 7.59 120.9 7.69 121.0
A116 8.16 112.0 8.16 112.0 8.13 112.0 8.15 112.0 8.16 112.0 8.20 112.1
E117 9.44 120.9 9.44 120.9 9.38 120.9 9.41 120.8 9.41 120.9 9.27 120.8
L118 9.90 130.5 9.90 130.5 9.83 130.4 9.89 130.4 9.90 130.5 9.84 130.4
H119 9.00 125.1 9.00 125.1 8.86 125.2 9.00 125.2 9.00 125.2 8.71 124.9
L120 9.03 123.7 9.03 123.7 8.97 123.6 9.02 123.6 9.03 123.6 8.84 123.5
V121 9.22 126.6 9.22 126.6 8.93 126.3 9.22 126.6 9.21 126.6 8.85 126.2
H122 8.55 124.1 8.55 124.1 8.50 124.0 8.58 124.2 8.58 124.2 8.34 123.9
W123 9.10 119.1 9.10 119.1 8.57 118.7 9.10 119.1 9.10 119.0 8.83 118.8
N124 9.08 120.0 9.08 120.0 8.76 119.4 9.06 119.8 9.06 119.8 8.89 119.5
T125 8.21 117.4 8.21 117.4 6.94 116.2 8.21 117.3 8.22 117.3 8.06 117.2
K127 7.96 122.9 7.96 122.9 6.77 121.7 7.96 123.0 7.96 123.0 7.83 123.0
Y128 7.69 115.6 7.69 115.6 6.84 114.7 7.68 115.6 7.69 115.6 7.54 115.5
G129 7.88 107.3 7.88 107.3 7.13 106.7 7.88 107.4 7.89 107.4 7.74 107.3
D130 7.45 116.3 7.45 116.3 7.00 115.8 7.46 116.3 7.46 116.3 7.30 116.1
F131 7.63 119.6 7.63 119.6 7.28 119.3 7.63 119.6 7.63 119.6 7.38 119.4
G132 8.11 104.5 8.11 104.5 7.87 104.3 8.10 104.5 8.11 104.5 7.88 104.2
K133 7.65 119.6 7.65 119.6 7.39 119.3 7.65 119.5 7.65 119.6 7.47 119.3
A134 7.95 123.4 7.95 123.4 7.64 123.1 7.95 123.4 7.95 123.4 7.77 123.3
V135 7.94 113.4 7.94 113.4 7.73 113.1 7.94 113.4 7.94 113.4 7.74 113.2
Q136 6.59 113.5 6.59 113.5 6.43 113.4 6.58 113.5 6.59 113.5 6.42 113.3
Q137 7.68 119.1 7.68 119.1 7.54 119.0 7.67 119.1 7.68 119.1 7.53 118.9
D139 7.92 114.6 7.92 114.6 7.86 114.6 7.92 114.6 7.93 114.6 7.82 114.5
G140 8.28 108.1 8.28 108.1 8.24 108.1 8.28 108.1 8.29 108.1 8.15 107.9
L141 8.76 115.6 8.76 115.6 8.79 115.6 8.76 115.6 8.75 115.6 8.59 115.4
A142 8.90 123.5 8.90 123.5 9.03 123.8 8.90 123.5 8.91 123.5 8.72 123.4
V143 7.28 124.2 7.28 124.2 7.68 124.6 7.27 124.2 7.28 124.2 7.13 124.0
L144 8.48 128.4 8.48 128.4 8.66 128.6 8.45 128.2 8.46 128.2 8.29 128.1
G145 9.96 114.4 9.96 114.4 10.26 114.5 9.93 114.2 9.93 114.2 9.85 114.1
I146 9.14 124.2 9.14 124.2 9.17 124.3 9.14 124.3 9.16 124.3 9.10 124.3
F147 10.13 129.0 10.13 129.0 10.19 128.9 10.12 129.0 10.13 129.0 10.20 129.0
L148 8.24 120.3 8.24 120.3 8.22 120.3 8.23 120.4 8.24 120.4 8.35 120.4
K149 8.98 119.3 8.98 119.3 8.92 119.3 8.97 119.4 8.98 119.4 9.30 119.6
V150 8.48 121.4 8.48 121.4 8.43 121.4 8.47 121.4 8.47 121.5 8.79 121.7
G151 9.13 118.2 9.13 118.2 9.02 118.1 9.12 118.2 9.12 118.1 9.75 118.8
S152 8.37 124.6 8.37 124.6 8.25 124.5 8.36 124.5 8.38 124.5 9.06 125.2
A153 8.39 121.1 8.39 121.1 8.21 120.9 8.38 121.2 8.40 121.3 9.61 122.4
K154 8.72 123.9 8.72 123.9 8.48 123.6 8.71 123.9 8.72 123.9 10.07 125.2
G156 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
L157 7.56 116.8 7.56 116.8 7.13 116.3 7.55 116.8 7.55 116.8 9.03 118.3
Q158 7.80 122.4 7.80 122.4 7.40 122.0 7.80 122.3 7.82 122.3 10.24 124.9
K159 8.85 115.8 8.85 115.8 8.42 115.5 8.85 115.9 8.85 115.8 11.96 119.5
V160 7.04 113.2 7.04 113.2 6.66 112.8 7.04 113.3 7.07 113.7 8.73 115.5
V161 7.30 114.5 7.30 114.5 7.01 114.1 7.28 114.6 7.30 114.7 . . . . . .
D162 8.40 117.5 8.40 117.5 8.14 117.3 8.41 117.6 8.42 117.6 . . . . . .
V163 7.15 113.9 7.15 113.9 6.91 113.7 7.15 115.1 7.08 114.6 . . . . . .
a Residues 1 to 20 (not assigned) and proline residues 21, 30, 42, 46, 83, 138, 155, 181, 186, 195, 201, 202, 215, 237, 247 and 250
(no resonance in 1H-15N-HSQC) were omitted.
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Residue a S50C S50C-Lu S50C-Tm S166C S166C-Lu S166C-Tm
HN N HN N HN N HN N HN N HN N
L164 7.08 121.7 7.08 121.7 6.88 121.5 7.05 120.9 7.10 121.1 . . . . . .
D165 8.23 116.2 8.23 116.2 8.09 116.1 8.15 115.9 8.15 116.2 . . . . . .
S166 8.01 113.5 8.01 113.5 7.87 113.4 . . . . . . . . . . . . . . . . . .
I167 7.43 116.4 7.43 116.4 7.29 116.3 . . . . . . 8.14 114.5 -3.06 104.1
K168 7.41 117.5 7.41 117.5 7.31 117.4 . . . . . . 7.71 117.8 0.28 111.8
T169 6.59 131.5 6.59 131.5 6.51 131.4 6.58 131.4 6.58 131.4 2.74 127.9
K170 7.49 120.5 7.49 120.5 7.42 120.5 7.47 120.5 7.49 120.6 5.77 118.8
G171 8.91 116.9 8.91 116.9 8.81 116.9 8.92 116.9 8.92 116.9 7.24 115.5
K172 7.81 120.2 7.81 120.2 7.73 120.2 7.81 120.2 7.81 120.2 5.82 118.4
S173 8.36 113.7 8.36 113.7 8.27 113.6 8.37 113.8 8.38 113.8 . . . . . .
A174 9.03 123.3 9.03 123.3 8.89 123.2 8.99 123.1 9.00 122.8 . . . . . .
D175 8.63 122.1 8.63 122.1 8.51 121.9 8.62 122.1 8.61 122.2 . . . . . .
F176 8.03 125.4 8.03 125.4 7.80 125.0 7.99 125.2 8.00 125.0 . . . . . .
T177 8.11 114.8 8.11 114.8 7.83 114.5 8.10 114.9 8.07 114.7 . . . . . .
N178 9.72 115.5 9.72 115.5 9.24 114.9 9.72 115.5 9.74 115.6 8.46 114.3
F179 8.28 118.8 8.28 118.8 7.58 118.1 8.28 118.9 8.29 118.9 7.41 118.3
D180 8.04 128.0 8.04 128.0 7.01 126.8 8.02 128.1 8.00 128.1 8.14 128.0
R182 8.33 118.3 8.33 118.3 6.34 116.5 8.35 118.3 8.35 118.3 8.43 118.4
G183 7.31 102.7 7.31 102.7 6.01 101.5 7.31 102.7 7.31 102.7 7.62 103.1
L184 7.24 117.3 7.24 117.3 6.34 116.5 7.25 117.3 7.26 117.3 7.54 117.7
L185 6.64 113.2 6.64 113.2 5.88 112.6 6.65 113.1 6.65 113.1 6.93 113.3
E187 8.18 116.3 8.18 116.3 8.13 116.3 8.18 116.4 8.19 116.4 8.45 116.6
S188 7.64 111.3 7.64 111.3 7.76 111.5 7.63 111.3 7.64 111.3 7.83 111.5
L189 8.65 125.7 8.65 125.7 9.12 126.1 8.65 125.7 8.65 125.7 8.75 125.8
D190 7.43 121.9 7.43 121.9 7.98 122.5 7.42 121.9 7.42 121.9 7.43 121.9
Y191 8.77 119.0 8.77 119.0 9.60 119.7 8.76 118.9 8.77 118.9 8.79 118.9
W192 9.55 117.2 9.55 117.2 10.11 117.8 9.54 117.2 9.55 117.2 9.56 117.1
T193 9.71 115.2 9.71 115.2 10.30 115.8 9.71 115.2 9.71 115.2 9.68 115.2
Y194 8.05 125.5 8.05 125.5 8.55 126.1 8.04 125.5 8.06 125.6 7.99 125.5
G196 9.38 110.8 9.38 110.8 9.60 111.0 9.37 110.8 9.37 110.8 9.26 110.6
S197 8.70 120.0 8.70 120.0 8.82 120.3 . . . . . . 8.70 120.0 8.55 120.0
L198 8.03 118.3 8.03 118.3 8.02 118.3 8.01 118.4 8.02 118.3 7.82 118.1
T199 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
T200 6.98 108.8 6.98 108.8 6.98 108.6 6.97 108.7 7.00 108.8 6.70 108.4
L203 9.12 120.2 9.12 120.2 9.13 120.3 9.13 120.3 9.14 120.3 8.88 120.0
L204 5.95 111.4 5.95 111.4 5.92 111.3 5.95 111.4 5.96 111.3 5.74 111.1
E205 8.68 125.0 8.68 125.0 8.68 125.0 8.68 125.0 8.68 125.0 8.53 124.9
C206 7.46 113.7 7.46 113.7 7.49 113.8 7.46 113.7 7.47 113.9 7.31 113.6
V207 7.25 116.7 7.25 116.7 7.36 116.8 7.24 116.7 7.25 116.7 7.10 116.5
T208 8.35 125.3 8.35 125.3 8.65 125.7 8.34 125.4 8.35 125.4 8.21 125.3
W209 8.24 129.3 8.24 129.3 8.65 129.8 8.23 129.3 8.23 129.3 8.13 129.2
I210 8.78 127.2 8.78 127.2 9.31 127.9 8.76 127.3 8.77 127.3 8.67 127.3
V211 9.75 128.4 9.75 128.4 10.29 128.9 9.74 128.4 9.75 128.4 9.71 128.4
L212 8.95 126.5 8.95 126.5 9.28 127.0 8.97 126.7 8.98 126.7 8.98 126.8
K213 7.41 122.4 7.41 122.4 7.83 122.7 7.40 122.4 7.41 122.3 7.47 122.4
E214 8.90 121.6 8.90 121.6 9.16 121.8 8.90 121.5 8.90 121.6 9.02 121.7
I216 8.93 113.4 8.93 113.4 8.87 113.3 8.92 113.4 8.93 113.4 9.18 113.6
S217 8.10 116.7 8.10 116.7 7.94 116.5 8.09 116.7 8.10 116.6 8.62 117.1
V218 8.55 115.8 8.55 115.8 8.42 115.7 8.54 115.8 8.54 115.9 9.13 116.5
S219 8.42 115.9 8.42 115.9 8.24 115.8 8.42 115.9 8.42 116.0 9.56 117.1
S220 9.32 117.3 9.32 117.3 9.21 117.2 9.31 117.3 9.31 117.3 10.16 118.2
E221 8.41 118.4 8.41 118.4 8.29 118.3 8.42 118.4 8.41 118.5 9.60 119.6
Q222 7.55 117.9 7.55 117.9 7.39 117.8 7.54 118.0 7.54 118.0 8.89 119.5
V223 7.38 114.7 7.38 114.7 7.24 114.6 7.37 114.7 7.35 114.6 8.11 115.3
L224 8.03 120.9 8.03 120.9 7.91 120.8 8.02 120.9 8.01 120.9 8.58 121.3
K225 6.92 115.0 6.92 115.0 6.79 114.9 6.91 115.2 6.92 115.1 7.44 115.5
a Residues 1 to 20 (not assigned) and proline residues 21, 30, 42, 46, 83, 138, 155, 181, 186, 195, 201, 202, 215, 237, 247 and 250
(no resonance in 1H-15N-HSQC) were omitted.
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Residue a S50C S50C-Lu S50C-Tm S166C S166C-Lu S166C-Tm
HN N HN N HN N HN N HN N HN N
F226 7.13 118.7 7.13 118.7 7.00 118.6 7.13 118.7 7.13 118.7 6.99 118.4
R227 6.70 109.1 6.70 109.1 6.60 108.9 6.70 109.1 6.71 109.0 6.24 108.4
K228 6.86 114.1 6.86 114.1 6.76 114.0 6.86 114.2 6.87 114.1 5.78 112.9
L229 7.11 119.3 7.11 119.3 7.01 119.3 7.10 119.2 7.10 119.2 5.45 117.3
N230 8.92 118.4 8.92 118.4 8.84 118.4 8.91 118.4 8.89 118.3 6.49 116.2
F231 8.89 117.2 8.89 117.2 8.83 117.1 8.90 117.2 8.90 117.4 7.67 116.0
N232 8.17 110.6 8.17 110.6 8.12 110.6 8.16 110.7 8.17 110.7 6.92 109.5
G233 8.68 104.8 8.68 104.8 8.64 104.7 8.68 104.8 8.68 104.8 7.70 103.6
E234 8.40 121.3 8.40 121.3 8.36 121.2 8.40 121.3 8.40 121.3 7.11 120.0
G235 9.09 114.1 9.09 114.1 9.05 114.1 9.09 114.1 9.09 114.1 7.86 113.0
E236 7.35 120.0 7.35 120.0 7.32 119.9 7.35 120.0 7.36 120.0 6.37 119.0
E238 8.27 123.3 8.27 123.3 8.24 123.2 8.27 123.3 8.27 123.3 7.34 122.3
E239 9.03 130.0 9.03 130.0 8.98 130.0 9.01 129.9 9.01 129.9 7.90 128.9
L240 8.75 126.0 8.75 126.0 8.71 125.9 8.75 126.0 8.75 126.0 7.90 125.0
M241 8.63 123.0 8.63 123.0 8.56 123.0 8.66 123.0 8.66 123.1 7.51 121.9
V242 6.74 114.8 6.74 114.8 6.69 114.8 6.74 114.8 6.75 114.8 6.04 114.1
D243 7.16 114.8 7.16 114.8 7.10 114.7 7.14 114.7 7.14 114.8 6.73 114.3
N244 8.40 119.3 8.40 119.3 8.36 119.2 8.39 119.3 8.40 119.3 7.95 118.8
W245 6.50 114.2 6.50 114.2 6.47 114.1 6.50 114.2 6.51 114.2 6.16 113.8
R246 10.44 127.0 10.44 127.0 10.42 126.9 10.38 126.8 10.40 126.8 10.13 126.5
A248 8.02 120.3 8.02 120.3 8.07 120.3 8.01 120.4 8.01 120.4 7.89 120.2
Q249 8.70 122.0 8.70 122.0 8.81 122.1 8.70 122.0 8.71 122.0 8.61 121.8
L251 8.70 125.9 8.70 125.9 8.81 126.0 8.70 125.9 8.70 125.8 8.63 125.8
K252 8.89 114.6 8.89 114.6 8.99 114.6 8.89 114.6 8.89 114.6 8.83 114.5
N253 8.70 119.7 8.70 119.7 8.82 119.8 8.70 119.6 8.71 119.7 8.65 119.7
R254 7.31 118.5 7.31 118.5 7.47 118.7 7.31 118.6 7.32 118.6 7.26 118.5
Q255 8.60 118.2 8.60 118.2 8.85 118.5 8.59 118.3 8.59 118.2 8.55 118.3
I256 8.94 124.4 8.94 124.4 9.22 124.8 8.92 124.4 8.93 124.4 8.90 124.4
K257 8.81 126.6 8.81 126.6 9.28 127.0 8.80 126.6 8.81 126.6 8.77 126.7
A258 8.40 123.6 8.40 123.6 8.93 124.2 8.39 123.6 8.40 123.6 8.39 123.6
S259 8.98 116.5 8.98 116.5 9.74 117.2 8.96 116.4 8.97 116.4 8.98 116.4
F260 6.67 118.0 6.67 118.0 7.32 118.7 6.66 118.0 6.67 118.0 6.69 118.0
K261 7.77 124.4 7.77 124.4 8.31 125.0 7.76 124.4 7.76 124.4 7.81 124.4
aResidues 1 to 21 (not assigned) and proline residues 21, 30, 42, 46, 83, 138, 155, 181, 186, 195, 201, 202, 215, 237, 247 and 250
(no resonance in 1H-15N-HSQC) were omitted.
Table A.4: 1H-15N HSQC peak assignments for untagged, LuM8 tagged and TmM8 tagged
hCA-II mutants S217C and S220C. All values are given in ppm.
Residue a S217C S217C-Lu S217C-Tm S220C S220C-Lu S220C-Tm
HN N HN N HN N HN N HN N HN N
I22 8.07 120.5 8.06 120.6 7.98 120.4 8.07 120.4 8.07 120.6 7.98 120.5
A23 8.69 123.0 8.70 123.0 8.60 122.9 8.67 122.9 8.70 123.0 8.60 122.9
K24 7.21 114.7 7.21 114.8 7.11 114.7 7.20 114.7 7.21 114.7 . . . . . .
G25 8.32 108.8 8.32 108.8 8.18 108.6 8.31 108.8 8.32 108.8 8.24 108.8
E26 9.37 117.7 9.37 117.7 9.20 117.5 9.37 117.7 9.36 117.7 9.31 117.6
R27 8.87 121.4 8.87 121.4 8.65 121.2 8.86 121.4 8.87 121.5 8.80 121.5
Q28 7.71 115.5 7.72 115.5 7.46 115.1 7.71 115.5 7.71 115.4 7.64 115.4
a Residues 1 to 20 (not assigned) and proline residues 21, 30, 42, 46, 83, 138, 155, 181, 186, 195, 201, 202, 215, 237, 247 and 250
(no resonance in 1H-15N-HSQC) were omitted.
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Residue a S217C S217C-Lu S217C-Tm S220C S220C-Lu S220C-Tm
HN N HN N HN N HN N HN N HN N
S29 8.07 117.9 8.08 117.9 7.81 117.6 8.05 117.8 8.09 117.9 7.98 117.8
V31 6.31 107.0 6.30 107.0 5.71 106.4 6.30 107.0 6.30 106.9 6.21 106.9
D32 8.35 118.3 8.35 118.3 7.73 117.6 8.35 118.3 8.33 118.2 8.30 118.2
I33 8.73 128.5 8.73 128.5 7.54 127.3 8.73 128.5 8.72 128.5 8.75 128.5
D34 7.53 128.2 7.52 128.2 6.43 127.0 7.54 128.2 7.52 128.2 7.57 128.3
T35 10.30 122.2 10.30 122.2 8.54 120.6 10.29 122.3 10.30 122.2 10.43 122.3
H36 8.81 118.8 8.82 118.8 7.44 117.4 8.80 118.8 8.81 118.8 8.93 119.0
T37 7.65 108.6 7.66 108.6 6.57 107.6 7.64 108.6 7.65 108.6 7.73 108.7
A38 7.49 127.5 7.49 127.5 6.34 126.5 7.48 127.6 7.49 127.5 7.56 127.6
K39 8.15 122.7 8.15 122.7 7.34 121.9 8.13 122.7 8.14 122.7 8.17 122.7
Y40 8.72 126.7 8.72 126.8 7.92 126.0 8.72 126.7 8.72 126.7 8.77 126.8
D41 7.75 128.8 7.75 128.9 7.18 128.3 7.74 128.9 7.73 128.8 7.75 128.8
S43 8.50 115.2 8.50 115.2 8.25 115.1 8.50 115.2 8.50 115.2 8.51 115.2
L44 7.00 123.1 7.01 123.1 6.76 122.9 6.99 123.1 6.99 123.1 6.99 123.1
K45 7.58 123.2 7.58 123.1 7.45 123.0 7.58 123.2 7.58 123.2 7.56 123.2
L47 8.98 126.0 8.98 126.0 9.05 126.1 8.97 126.1 8.97 126.1 8.94 126.0
S48 8.52 120.1 8.52 120.1 8.59 120.2 8.53 120.2 8.54 120.2 8.47 120.2
V49 8.42 127.6 8.41 127.6 8.70 127.8 8.41 127.6 8.41 127.6 8.33 127.5
S50 8.38 122.8 8.38 122.8 8.51 122.9 8.37 122.8 8.38 122.8 8.28 122.7
Y51 9.01 124.6 9.02 124.6 9.23 124.7 9.00 124.6 9.00 124.6 8.87 124.4
D52 8.89 121.4 8.89 121.4 9.10 121.5 8.89 121.4 8.89 121.3 8.76 121.2
Q53 8.06 114.4 8.06 114.4 8.19 114.4 8.05 114.4 8.05 114.4 7.93 114.3
A54 7.42 120.2 7.42 120.2 7.48 120.2 7.42 120.2 7.43 120.2 7.28 120.0
T55 9.43 120.7 9.43 120.7 9.43 120.7 9.44 120.7 9.44 120.7 9.29 120.5
S56 10.00 126.5 10.01 126.5 9.97 126.5 10.01 126.5 10.01 126.5 9.82 126.3
L57 8.93 117.6 8.94 117.6 8.89 117.6 8.93 117.6 8.94 117.6 8.75 117.4
R58 7.21 114.7 7.21 114.8 7.15 114.7 7.20 114.7 7.21 114.7 7.01 114.5
I59 9.05 122.1 9.06 122.1 9.02 122.0 9.04 122.1 9.05 122.0 8.81 121.8
L60 8.71 123.8 8.70 123.8 8.68 123.7 8.70 123.8 8.70 123.7 8.41 123.5
N61 8.44 121.2 8.45 121.1 . . . . . . 8.44 121.2 8.45 121.1 8.21 120.9
N62 8.06 123.4 8.04 123.3 8.04 123.3 8.05 123.4 8.05 123.3 7.78 123.0
G63 9.74 109.1 9.71 109.1 9.74 109.1 9.72 108.9 9.71 109.1 9.46 108.8
H64 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
A65 . . . . . . 8.61 123.6 . . . . . . . . . . . . 8.63 123.5 . . . . . .
F66 7.22 110.1 7.22 110.1 7.23 110.1 7.23 110.1 7.23 110.1 6.78 109.7
N67 9.01 120.8 8.97 120.8 8.96 120.8 9.01 120.8 8.97 120.8 8.66 120.5
V68 8.72 122.0 8.72 122.0 . . . . . . 8.70 122.0 8.71 122.0 8.30 121.6
E69 8.48 124.0 8.48 123.9 8.42 123.8 8.47 123.9 8.48 123.9 8.24 123.7
F70 8.64 119.0 8.64 119.0 8.58 118.9 8.64 119.0 8.64 119.0 8.46 118.8
D71 8.44 117.0 8.44 117.0 8.40 117.0 8.45 117.1 8.46 117.1 8.32 117.0
D72 8.99 131.8 8.99 131.8 8.97 131.8 8.99 131.8 8.99 131.8 8.87 131.7
S73 8.73 115.5 8.73 115.5 8.72 115.4 8.72 115.5 8.72 115.5 8.62 115.3
Q74 7.70 117.7 7.70 117.7 7.70 117.8 7.70 117.7 7.70 117.7 7.61 117.6
D75 8.87 123.0 8.88 123.1 8.86 123.1 8.87 123.1 8.89 123.1 8.73 123.0
K76 7.96 124.1 7.96 124.1 7.98 124.2 7.96 124.2 7.96 124.2 7.86 124.0
A77 8.27 123.4 8.28 123.5 8.29 123.5 8.27 123.5 8.29 123.5 8.17 123.4
V78 8.40 115.9 8.39 115.9 8.45 115.9 8.39 115.9 8.40 115.9 8.29 115.7
L79 9.02 123.7 9.02 123.6 9.00 123.5 9.02 123.6 9.03 123.6 8.92 123.5
K80 8.38 120.5 8.38 120.6 8.39 120.5 8.37 120.5 8.37 120.5 8.29 120.4
G81 9.03 106.5 9.03 106.5 9.02 106.5 9.03 106.5 9.03 106.5 8.98 106.4
G82 7.05 108.7 7.06 108.7 7.02 108.7 7.04 108.8 7.03 108.8 7.00 108.7
L84 7.78 120.3 7.78 120.3 7.61 120.1 7.78 120.3 7.79 120.3 7.74 120.3
D85 9.09 125.2 9.09 125.2 8.96 125.2 9.09 125.3 9.09 125.2 9.05 125.2
G86 7.92 109.5 7.92 109.5 7.87 109.5 7.92 109.5 7.92 109.5 7.87 109.5
T87 8.53 116.7 8.53 116.7 8.50 116.7 8.53 116.8 8.53 116.7 8.47 116.6
Y88 8.44 126.0 8.45 126.0 8.41 126.0 8.43 126.0 8.44 126.0 8.36 125.9
a Residues 1 to 20 (not assigned) and proline residues 21, 30, 42, 46, 83, 138, 155, 181, 186, 195, 201, 202, 215, 237, 247 and 250
(no resonance in 1H-15N-HSQC) were omitted.
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Residue a S217C S217C-Lu S217C-Tm S220C S220C-Lu S220C-Tm
HN N HN N HN N HN N HN N HN N
R89 8.60 122.8 8.60 122.8 8.54 122.7 8.60 122.8 8.60 122.7 8.50 122.6
L90 8.55 123.9 8.54 123.8 8.49 123.9 8.55 123.8 8.55 123.8 8.42 123.6
I91 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Q92 7.31 115.2 7.30 115.1 7.19 114.9 7.30 115.3 7.30 115.1 7.10 114.9
F93 8.64 113.6 8.61 113.5 8.52 113.3 8.63 113.5 8.59 113.4 8.32 113.2
H94 8.20 113.0 8.20 113.1 8.03 113.0 8.20 113.0 8.21 113.0 7.88 112.7
F95 9.17 117.3 9.15 117.2 9.12 117.1 9.19 117.3 9.18 117.2 8.71 116.8
H96 8.73 115.0 8.74 115.1 8.72 115.1 8.74 115.1 8.81 115.2 8.31 114.7
W97 9.53 119.1 9.55 119.2 9.75 119.4 9.52 119.1 9.51 119.1 8.79 118.3
G98 8.13 108.0 8.14 108.0 8.77 108.6 8.09 108.0 8.03 107.8 6.78 106.6
S99 8.42 111.9 8.43 112.0 9.01 112.5 8.41 111.9 8.47 112.1 7.57 111.3
L100 7.37 119.0 7.39 119.0 8.17 119.8 7.32 119.1 7.26 119.6 6.48 118.9
D101 8.92 120.6 8.93 120.6 10.34 122.0 8.86 120.5 8.74 120.4 . . . . . .
G102 7.69 102.8 7.68 102.8 9.19 104.3 7.71 102.9 7.81 103.6 6.37 102.6
Q103 7.87 114.9 7.86 114.9 8.97 115.9 7.86 115.0 7.79 114.8 . . . . . .
G104 8.27 106.3 8.26 106.3 8.71 106.8 8.27 106.3 8.28 106.6 7.73 106.0
S105 7.36 107.7 7.36 107.7 7.72 108.0 7.35 107.7 7.36 107.8 7.00 107.4
E106 8.31 119.0 8.31 119.0 8.00 118.8 8.32 119.0 8.34 119.0 8.10 118.7
H107 10.69 117.8 10.71 117.8 10.14 117.2 10.68 117.8 10.67 117.8 10.52 117.7
T108 7.37 109.3 7.37 109.3 6.50 108.4 7.37 109.3 7.38 109.3 7.35 109.2
V109 7.63 118.6 7.64 118.6 6.23 117.0 7.64 118.6 7.69 118.6 7.83 118.7
D110 9.72 132.3 9.72 132.3 8.07 130.6 9.71 132.4 9.72 132.3 9.85 132.5
K111 9.87 109.8 9.88 109.8 8.84 108.8 9.88 109.8 9.89 109.8 9.99 109.9
K112 8.26 124.5 8.26 124.5 7.04 123.6 8.25 124.6 8.25 124.5 8.44 124.7
K113 7.98 121.8 7.98 121.6 8.14 121.6 7.98 122.1 7.97 122.1 8.13 122.3
Y114 8.18 121.3 8.15 121.1 . . . . . . 8.19 121.4 8.20 121.2 8.20 121.2
A115 7.59 120.9 7.65 120.8 . . . . . . 7.59 120.9 7.71 121.0 7.26 122.0
A116 8.15 111.9 8.11 111.7 8.96 112.5 8.16 112.1 8.15 112.0 7.91 111.6
E117 9.41 120.8 9.41 120.9 9.43 120.9 9.42 120.8 9.45 120.8 8.98 120.5
L118 9.90 130.4 9.92 130.5 9.33 130.1 9.90 130.5 9.92 130.5 9.63 130.2
H119 9.00 125.1 9.00 125.2 8.72 124.8 9.00 125.2 9.00 125.1 8.67 124.9
L120 9.02 123.7 9.02 123.6 8.63 123.3 9.02 123.6 9.03 123.6 8.83 123.4
V121 9.23 126.6 9.21 126.6 9.03 126.3 9.23 126.6 9.23 126.6 9.02 126.4
H122 8.58 124.2 8.58 124.2 8.40 124.0 8.58 124.3 8.59 124.2 8.45 124.1
W123 9.10 119.1 9.10 119.0 9.00 118.9 9.10 119.1 9.10 119.0 8.99 118.9
N124 9.06 119.8 9.06 119.8 8.95 119.8 9.06 119.8 9.07 119.8 8.98 119.7
T125 8.22 117.3 8.22 117.3 8.16 117.2 8.21 117.3 8.22 117.3 8.14 117.2
K127 7.96 123.0 7.96 123.0 7.91 123.0 7.95 123.0 7.96 123.0 7.90 122.9
Y128 7.68 115.6 7.68 115.5 7.63 115.5 7.68 115.6 7.69 115.5 7.62 115.4
G129 7.89 107.4 7.89 107.4 7.85 107.3 7.88 107.4 7.89 107.4 7.82 107.4
D130 7.46 116.3 7.47 116.3 7.42 116.3 7.46 116.3 7.47 116.3 7.39 116.3
F131 7.64 119.6 7.63 119.6 7.58 119.5 7.64 119.6 7.65 119.6 7.56 119.5
G132 8.11 104.5 8.11 104.5 8.06 104.4 8.11 104.6 8.11 104.5 8.02 104.4
K133 7.66 119.5 7.65 119.6 7.59 119.5 7.65 119.6 7.65 119.6 7.57 119.5
A134 7.95 123.4 7.96 123.4 7.89 123.3 7.95 123.5 7.96 123.5 7.88 123.4
V135 7.94 113.4 7.94 113.4 7.85 113.3 7.94 113.4 7.95 113.4 7.86 113.3
Q136 6.59 113.5 6.59 113.5 6.50 113.4 6.58 113.5 6.58 113.5 6.50 113.5
Q137 7.67 119.1 7.68 119.1 7.57 118.9 7.67 119.1 7.68 119.1 7.60 119.1
D139 7.93 114.6 7.93 114.6 7.79 114.4 7.92 114.6 7.94 114.6 7.88 114.5
G140 8.29 108.1 8.29 108.1 8.14 108.0 8.28 108.1 8.28 108.1 8.21 108.0
L141 8.74 115.5 8.75 115.6 8.58 115.4 8.76 115.6 8.77 115.6 8.69 115.6
A142 8.90 123.5 8.91 123.6 8.72 123.3 8.90 123.5 8.90 123.5 8.80 123.4
V143 7.27 124.2 7.28 124.2 6.93 123.8 7.28 124.2 7.29 124.2 7.18 124.1
L144 8.45 128.1 8.46 128.1 8.08 127.7 8.46 128.2 8.47 128.1 8.32 128.0
G145 9.93 114.2 9.92 114.2 9.09 113.4 9.93 114.2 9.93 114.2 9.82 114.1
I146 9.15 124.3 9.14 124.3 8.25 123.2 9.14 124.3 9.17 124.3 8.98 124.1
a Residues 1 to 20 (not assigned) and proline residues 21, 30, 42, 46, 83, 138, 155, 181, 186, 195, 201, 202, 215, 237, 247 and 250
(no resonance in 1H-15N-HSQC) were omitted.
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Residue a S217C S217C-Lu S217C-Tm S220C S220C-Lu S220C-Tm
HN N HN N HN N HN N HN N HN N
F147 10.13 129.0 10.10 129.0 7.96 127.1 10.14 129.0 10.15 129.0 10.11 129.0
L148 8.24 120.4 8.20 120.5 10.16 122.6 8.23 120.3 8.22 120.1 8.11 120.1
K149 9.00 120.1 9.08 121.9 . . . . . . 8.97 119.3 8.93 118.6 . . . . . .
V150 8.48 121.9 8.27 120.3 . . . . . . 8.47 120.8 8.62 121.4 9.27 122.3
G151 9.09 117.6 7.64 120.2 . . . . . . 9.07 117.6 9.14 118.3 . . . . . .
S152 8.26 124.0 8.34 122.3 . . . . . . 8.38 124.5 8.37 124.5 . . . . . .
A153 8.21 119.5 . . . . . . . . . . . . 8.40 121.3 8.38 121.0 7.42 120.2
K154 8.73 123.9 8.70 124.1 . . . . . . 8.71 124.0 8.67 123.9 . . . . . .
G156 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
L157 7.54 116.8 7.53 116.7 . . . . . . 7.55 116.7 7.58 116.8 6.66 116.0
Q158 7.80 122.2 7.79 122.2 7.43 121.9 7.80 122.4 7.80 122.3 6.83 121.4
K159 8.80 115.8 8.81 115.8 8.53 115.5 8.84 115.9 8.83 115.8 8.15 115.2
V160 7.04 113.2 7.03 113.2 . . . . . . 7.03 113.2 7.04 113.1 6.31 112.5
V161 7.30 114.4 7.30 114.3 7.23 114.3 7.30 114.5 7.31 114.1 6.32 113.2
D162 8.41 117.6 8.40 117.6 8.26 117.5 8.40 117.6 8.40 117.8 7.55 117.0
V163 7.14 113.9 7.14 113.8 7.06 113.7 7.14 113.9 7.15 113.8 6.54 113.3
L164 7.08 121.6 7.07 121.6 7.06 121.6 7.07 121.7 7.08 121.7 6.44 121.1
D165 8.22 116.2 8.22 116.2 8.21 116.2 8.23 116.3 8.24 116.2 7.76 115.8
S166 8.01 113.5 8.00 113.5 7.98 113.5 8.00 113.6 8.00 113.6 7.69 113.4
I167 7.42 116.4 7.42 116.4 7.46 116.3 7.42 116.5 7.42 116.4 7.12 116.1
K168 7.42 117.5 7.42 117.4 7.44 117.4 7.42 117.5 7.40 117.5 7.20 117.3
T169 6.59 131.5 6.60 131.6 6.63 131.6 6.58 131.4 6.59 131.4 6.43 131.2
K170 7.49 120.5 7.50 120.6 7.53 120.7 7.48 120.5 7.49 120.5 7.34 120.4
G171 8.92 116.9 8.89 116.9 8.90 116.9 8.91 116.9 8.89 116.9 8.71 116.8
K172 7.81 120.2 7.82 120.2 7.81 120.2 7.81 120.2 7.80 120.2 7.64 120.0
S173 8.36 113.8 8.36 113.7 8.35 113.7 8.36 113.8 8.36 113.8 8.21 113.6
A174 9.03 123.3 9.03 123.4 9.01 123.3 9.02 123.4 9.03 123.4 8.82 123.3
D175 8.63 122.0 8.63 122.0 8.59 122.0 8.63 122.1 8.63 122.1 8.47 121.9
F176 8.01 125.3 8.00 125.3 7.95 125.2 8.01 125.3 8.01 125.3 7.81 125.0
T177 8.12 114.9 8.12 114.9 8.04 114.8 8.12 114.9 8.12 114.9 7.92 114.7
N178 9.73 115.5 9.73 115.5 9.68 115.4 9.73 115.5 9.73 115.5 9.55 115.2
F179 8.28 118.9 8.28 118.9 8.21 118.8 8.27 118.9 8.28 118.9 8.05 118.6
D180 8.02 128.1 8.02 128.1 7.91 128.0 8.02 128.1 8.01 128.1 7.71 127.8
R182 8.35 118.3 8.35 118.3 8.37 118.3 8.35 118.3 8.36 118.4 8.11 118.2
G183 7.32 102.7 7.33 102.8 7.25 102.7 7.31 102.7 7.32 102.6 7.00 102.3
L184 7.26 117.3 7.26 117.4 7.09 117.2 7.25 117.3 7.25 117.3 6.91 116.9
L185 6.66 113.2 6.64 113.1 6.48 112.8 6.65 113.1 6.65 113.1 6.36 112.8
E187 8.20 116.4 8.18 116.3 . . . . . . 8.18 116.4 8.19 116.4 8.18 116.4
S188 7.64 111.3 7.62 111.6 . . . . . . 7.64 111.3 7.65 111.4 7.63 111.3
L189 8.65 125.7 8.63 125.8 9.56 126.4 8.66 125.7 8.65 125.7 8.63 125.7
D190 7.42 121.9 7.47 122.0 7.18 121.5 7.43 121.9 7.42 121.9 7.44 121.8
Y191 8.77 118.9 8.75 118.8 7.70 117.8 8.77 118.9 8.76 119.2 . . . . . .
W192 9.55 117.2 9.56 117.2 8.00 115.6 9.54 117.2 9.55 117.2 9.55 117.2
T193 9.71 115.2 9.71 115.1 8.84 114.3 9.71 115.2 9.71 115.2 9.71 115.2
Y194 8.05 125.5 8.06 125.5 7.46 124.9 8.04 125.5 8.06 125.6 8.02 125.6
G196 9.37 110.8 9.37 110.8 9.04 110.5 9.38 110.8 9.39 110.8 9.32 110.7
S197 . . . . . . 8.70 120.0 8.40 119.8 . . . . . . 8.70 120.0 8.62 120.0
L198 8.04 118.3 8.02 118.3 7.83 118.1 8.03 118.4 8.02 118.3 7.90 118.2
T199 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
T200 6.99 108.8 7.00 108.8 6.86 108.8 6.97 108.7 7.00 108.8 6.82 108.6
L203 9.13 120.2 9.14 120.3 9.03 120.1 9.13 120.3 9.14 120.3 9.00 120.2
L204 5.95 111.3 5.96 111.3 5.83 111.1 5.94 111.4 5.95 111.4 5.84 111.3
E205 8.69 125.0 8.68 125.0 8.54 124.8 8.68 125.0 8.68 125.0 8.60 124.9
C206 7.46 113.7 7.47 113.8 7.28 113.6 7.46 113.7 7.47 113.8 7.38 113.7
V207 7.24 116.7 7.25 116.7 7.01 116.5 7.25 116.7 7.25 116.7 7.17 116.6
T208 8.34 125.4 8.35 125.4 8.07 125.1 8.34 125.4 8.35 125.4 8.27 125.3
a Residues 1 to 20 (not assigned) and proline residues 21, 30, 42, 46, 83, 138, 155, 181, 186, 195, 201, 202, 215, 237, 247 and 250
(no resonance in 1H-15N-HSQC) were omitted.
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Residue a S217C S217C-Lu S217C-Tm S220C S220C-Lu S220C-Tm
HN N HN N HN N HN N HN N HN N
W209 8.23 129.3 8.23 129.3 7.77 128.8 8.23 129.3 8.24 129.4 8.18 129.3
I210 8.76 127.3 8.77 127.3 8.18 126.7 8.76 127.3 8.78 127.3 8.69 127.3
V211 9.75 128.5 9.74 128.4 8.68 127.3 9.75 128.5 9.75 128.5 9.71 128.4
L212 8.97 126.8 8.96 126.7 7.30 125.0 8.97 126.7 8.99 126.7 8.94 126.7
K213 7.41 122.4 7.40 122.2 . . . . . . 7.41 122.4 7.41 122.3 7.45 122.4
E214 8.91 121.7 8.95 122.3 . . . . . . 8.90 121.6 8.90 121.7 8.97 121.7
I216 8.91 113.0 8.77 110.2 . . . . . . 8.93 113.4 8.94 113.3 8.92 113.3
S217 8.15 119.8 7.72 121.0 . . . . . . 8.07 116.5 8.07 116.4 . . . . . .
V218 8.55 115.6 8.59 115.1 . . . . . . 8.52 115.6 8.56 115.6 . . . . . .
S219 8.42 116.0 8.38 116.3 . . . . . . . . . . . . . . . . . . . . . . . .
S220 9.32 117.4 9.42 118.1 10.79 119.3 . . . . . . . . . . . . . . . . . .
E221 8.41 118.6 8.44 118.8 8.98 119.4 8.51 118.1 8.48 118.1 . . . . . .
Q222 7.57 118.1 7.58 118.1 8.08 118.5 7.53 118.0 7.47 117.4 . . . . . .
V223 7.33 114.6 7.30 114.3 8.11 114.9 7.39 114.9 7.47 115.6 . . . . . .
L224 7.98 120.6 7.98 120.6 8.63 121.2 7.96 120.7 8.13 120.0 . . . . . .
K225 6.93 115.2 6.92 115.2 7.27 115.6 6.90 114.9 6.99 115.7 . . . . . .
F226 7.16 118.8 7.14 118.7 7.49 119.0 7.11 118.7 7.12 118.8 . . . . . .
R227 6.71 109.0 6.70 109.0 7.07 109.3 6.70 109.1 6.68 108.9 . . . . . .
K228 6.88 114.1 6.87 114.1 7.12 114.4 6.85 114.2 6.87 114.4 . . . . . .
L229 7.11 119.3 7.11 119.2 7.29 119.4 7.10 119.4 7.11 119.3 . . . . . .
N230 8.92 118.4 8.92 118.4 9.02 118.6 8.92 118.5 8.90 118.4 8.62 118.1
F231 8.90 117.2 8.89 117.3 9.00 117.4 8.89 117.1 8.89 117.2 8.66 116.9
N232 8.17 110.6 8.18 110.7 8.26 110.7 8.17 110.6 8.18 110.7 8.03 110.5
G233 8.68 104.8 8.68 104.8 8.72 104.8 8.68 104.8 8.69 104.8 8.62 104.7
E234 8.41 121.3 8.41 121.3 8.43 121.4 8.40 121.3 8.41 121.4 8.36 121.3
G235 9.09 114.1 9.10 114.1 9.13 114.1 9.09 114.1 9.09 114.1 9.12 114.2
E236 7.36 120.0 7.35 120.0 7.40 120.1 7.35 120.0 7.36 120.0 7.38 120.0
E238 8.27 123.3 8.27 123.3 8.37 123.4 8.27 123.3 8.27 123.3 8.39 123.4
E239 9.03 130.0 9.02 130.0 9.13 130.1 9.03 130.0 9.04 129.9 8.99 129.9
L240 8.75 125.9 8.75 125.9 8.92 126.2 8.76 126.0 8.76 125.9 8.61 125.7
M241 8.63 123.0 8.64 123.0 8.81 123.1 8.62 123.0 8.65 123.1 8.08 122.6
V242 6.75 114.9 6.75 114.9 6.96 115.2 6.73 114.8 6.73 115.0 6.11 114.3
D243 7.12 114.7 7.11 114.8 7.46 115.1 7.15 114.7 7.14 114.7 6.27 113.9
N244 8.39 119.2 8.40 119.3 8.59 119.4 8.39 119.3 8.38 119.2 7.72 118.5
W245 6.51 114.2 6.51 114.2 6.61 114.3 6.49 114.2 6.50 114.2 6.01 113.7
R246 10.36 126.7 10.39 126.8 10.30 126.8 10.36 126.7 10.38 126.7 10.08 126.3
A248 8.02 120.4 8.01 120.4 7.81 120.2 8.02 120.3 8.01 120.4 7.85 120.2
Q249 8.70 122.0 8.67 122.0 8.39 121.7 8.70 122.0 8.71 122.0 8.61 121.9
L251 8.71 125.8 8.70 125.8 8.32 125.5 8.70 125.9 8.70 125.8 8.66 125.7
K252 8.89 114.6 8.90 114.6 8.57 114.3 8.89 114.6 8.89 114.6 8.87 114.5
N253 8.71 119.7 8.71 119.7 8.41 119.3 8.70 119.7 8.71 119.7 8.68 119.6
R254 7.32 118.6 7.32 118.6 6.96 118.3 7.31 118.6 7.31 118.6 7.29 118.5
Q255 8.60 118.2 8.59 118.2 8.16 117.8 8.60 118.3 8.60 118.3 8.59 118.2
I256 8.93 124.4 8.93 124.4 8.26 123.7 8.93 124.4 8.93 124.4 8.94 124.4
K257 8.81 126.6 8.80 126.6 8.07 125.8 8.81 126.6 8.81 126.6 8.81 126.6
A258 8.40 123.6 8.40 123.6 7.57 122.7 8.38 123.6 8.39 123.6 8.42 123.6
S259 8.97 116.4 8.97 116.5 8.00 115.6 8.97 116.4 8.97 116.4 8.99 116.4
F260 6.67 118.0 6.67 118.0 5.69 117.2 6.66 118.0 6.67 118.0 6.72 118.1
K261 7.77 124.4 7.76 124.4 7.13 123.6 7.77 124.5 7.77 124.4 7.83 124.5
aResidues 1 to 21 (not assigned) and proline residues 21, 30, 42, 46, 83, 138, 155, 181, 186, 195, 201, 202, 215, 237, 247 and 250
(no resonance in 1H-15N-HSQC) were omitted.
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Table A.5: Arginine sidechain NH assignment of LuM8 and TmM8 tagged hCA-II mutants
S50C and S166C as well as the corresponding PCS. All values are given in ppm.
Residue S50C-Lu S50C-Tm PCS S166C-Lu S166C-Tm PCS
He Ne He Ne He Ne He Ne He Ne He Ne
R27 7.14 117.3 7.24 117.4 0.103 0.167 7.13 117.3 7.03 117.2 -0.101 -0.117
R58 7.49 116.1 7.36 116.0 -0.125 -0.163 7.50 116.1 6.44 115.0 -1.058 -1.098
R89 7.72 118.5 . . . . . . . . . . . . 7.72 118.5 7.52 118.3 -0.197 -0.245
R182 8.27 116.8 . . . . . . . . . . . . 8.26 116.8 8.35 116.8 0.089 0.078
R227 6.97 118.3 6.92 118.2 -0.053 -0.058 6.97 118.3 6.81 118.2 -0.161 -0.156
R246 7.09 118.2 7.14 118.2 0.050 0.039 7.12 118.2 6.93 118.0 -0.185 -0.239
R254 7.77 117.2 7.90 117.4 0.133 0.179 7.76 117.2 7.69 117.1 -0.076 -0.099
Table A.6: Arginine sidechain NH assignment of LuM8 and TmM8 tagged hCA-II mutants
S217C and S220C as well as the corresponding PCS. All values are given in ppm.
Residue S217C-Lu S217C-Tm PCS S220C-Lu S220C-Tm PCS
He Ne He Ne He Ne He Ne He Ne He Ne
R27 7.13 117.3 6.90 117.0 -0.234 -0.268 7.13 117.3 7.07 117.3 -0.058 -0.047
R58 7.49 116.1 7.47 116.1 -0.025 -0.048 7.49 116.1 7.33 116.0 -0.156 -0.122
R89 7.72 118.6 7.72 118.6 -0.006 -0.004 7.73 118.6 7.64 118.5 -0.092 -0.101
R182 8.27 116.8 8.49 117.0 0.218 0.238 8.26 116.8 8.06 116.6 -0.200 -0.155
R227 7.02 118.6 7.73 119.3 0.713 0.713 6.99 117.6 . . . . . . . . . . . .
R246 7.12 118.2 7.00 118.1 -0.116 -0.129 7.13 118.2 6.97 118.1 -0.157 -0.164
R254 7.76 117.2 7.40 116.9 -0.362 -0.312 7.77 117.2 7.72 117.1 -0.044 -0.057
Table A.7: Tryptophan sidechain NH assignment of LuM8 and TmM8 tagged hCA-II mu-
tants S50C and S166C as well as the corresponding PCS. All values are given in ppm.
Residue S50C-Lu S50C-Tm PCS S166C-Lu S166C-Tm PCS
He Ne He Ne He Ne He Ne He Ne He Ne
W5 9.82 129.9 9.76 129.7 -0.062 -0.129 9.82 129.9 9.44 129.5 -0.381 -0.358
W16 10.26 128.5 10.23 128.3 -0.036 -0.168 10.24 128.4 9.92 128.1 -0.322 -0.334
W97 10.22 130.6 10.13 130.5 -0.083 -0.120 10.21 130.6 9.50 130.0 -0.708 -0.616
W123 12.23 133.5 11.64 132.9 -0.588 -0.643 12.22 133.5 11.91 133.2 -0.306 -0.321
W192 10.51 129.0 10.87 129.4 0.352 0.368 10.51 129.0 10.52 129.0 0.011 0.050
W209 10.08 130.5 10.22 130.6 0.142 0.077 10.09 130.5 9.92 130.4 -0.164 -0.150
W245 10.82 126.8 10.81 126.7 -0.007 -0.048 10.83 126.8 10.60 126.5 -0.232 -0.282
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Table A.8: Tryptophan sidechain NH assignment of LuM8 and TmM8 tagged hCA-II mu-
tants S217C and S220C as well as the corresponding PCS. All values are given in ppm.
Residue S217C-Lu S217C-Tm PCS S220C-Lu S220C-Tm PCS
He Ne He Ne He Ne He Ne He Ne He Ne
W5 9.83 129.9 9.80 129.9 -0.030 0.060 9.82 129.9 9.68 129.7 -0.146 -0.162
W16 10.25 128.4 10.25 128.4 0.001 -0.009 10.24 128.4 10.05 128.2 -0.191 -0.160
W97 10.24 130.6 10.53 131.0 0.291 0.345 10.18 130.6 9.16 129.6 -1.025 -1.044
W123 12.22 133.5 12.16 133.4 -0.052 -0.089 12.22 133.5 12.11 133.4 -0.116 -0.107
W192 10.51 128.9 8.50 126.9 -2.008 -2.062 10.51 129.0 10.60 129.0 0.083 0.091
W209 10.09 130.5 9.74 130.1 -0.350 -0.428 10.09 130.5 9.98 130.4 -0.113 -0.105
W245 10.85 126.9 11.18 127.1 0.331 0.256 10.78 126.8 9.98 126.1 -0.802 -0.694
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Figure A.7: Correlation of experimental and back calculated PCS obtained from tensors
determined with the given type of Monte-Carlo protocol using the PCS of set 1.
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